data_2kmo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kmo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 120.256 0.074 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.8 165.24 28.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.418 2.745 . . . . 0.0 112.919 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -75.79 -8.09 56.01 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -56.02 131.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.55 1.94 . . . . 0.0 111.183 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -84.26 79.01 9.68 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 109.69 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -127.41 63.09 57.39 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 125.376 1.471 . . . . 0.0 110.963 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.86 161.99 33.99 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.859 2.373 . . . . 0.0 112.663 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.84 154.58 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.889 2.075 . . . . 0.0 110.454 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.26 113.78 25.06 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.415 0.686 . . . . 0.0 109.728 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.66 160.38 53.0 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.128 0.394 . . . . 0.0 113.313 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -64.76 -23.3 67.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.59 -19.14 58.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.097 1.359 . . . . 0.0 113.17 171.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.52 -7.92 47.03 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.16 2.315 . . . . 0.0 113.789 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -67.23 156.85 35.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.915 1.686 . . . . 0.0 111.964 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.4 m -113.64 136.28 53.0 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.021 2.128 . . . . 0.0 110.184 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.22 174.21 9.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.181 1.792 . . . . 0.0 111.133 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.67 72.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.391 1.076 . . . . 0.0 113.853 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -162.33 -176.7 5.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.314 1.446 . . . . 0.0 112.764 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -57.02 -39.95 75.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -55.46 -45.92 76.87 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.942 1.297 . . . . 0.0 111.843 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 tp -75.99 -43.0 39.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.212 -0.305 . . . . 0.0 110.479 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.35 -48.85 75.94 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.571 1.148 . . . . 0.0 112.526 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.953 1.701 . . . . 0.0 111.987 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.23 -30.79 67.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.995 0.918 . . . . 0.0 112.331 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -7.29 17.98 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.662 1.585 . . . . 0.0 114.191 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.08 18.92 52.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.813 1.197 . . . . 0.0 114.847 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.67 158.49 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.629 1.572 . . . . 0.0 110.908 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 t -96.52 166.05 11.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 0.0 110.574 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -102.66 142.37 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.215 1.406 . . . . 0.0 110.149 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -97.47 -31.34 12.4 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.347 1.459 . . . . 0.0 111.633 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.2 p -162.37 169.61 20.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.706 1.602 . . . . 0.0 112.474 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.61 160.44 29.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.903 1.281 . . . . 0.0 112.597 168.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.05 166.25 25.16 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.347 1.451 . . . . 0.0 112.811 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 p -64.06 146.7 53.71 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.443 -1.034 . . . . 0.0 111.94 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.14 146.66 40.78 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 122.931 0.492 . . . . 0.0 111.508 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 122.645 2.23 . . . . 0.0 112.032 178.197 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.53 166.89 26.56 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.513 2.808 . . . . 0.0 113.386 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -80.28 -6.65 58.26 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.6 133.35 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.455 1.902 . . . . 0.0 111.361 -172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 79.98 8.64 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.33 1.852 . . . . 0.0 110.469 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -129.83 66.88 78.51 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 125.269 1.428 . . . . 0.0 110.907 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.35 162.2 31.4 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.985 2.457 . . . . 0.0 113.065 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -144.83 155.83 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.505 1.922 . . . . 0.0 110.881 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t -94.98 111.09 22.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.916 0.887 . . . . 0.0 111.18 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.51 163.71 51.33 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.053 0.835 . . . . 0.0 114.307 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.4 t -63.62 -25.63 68.31 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.4 -17.12 60.85 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.072 1.349 . . . . 0.0 113.121 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.99 -5.68 63.69 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.872 2.177 . . . . 0.0 113.711 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -68.21 157.53 35.26 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.369 1.868 . . . . 0.0 111.775 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.6 m -113.76 137.94 50.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.48 1.912 . . . . 0.0 110.702 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.34 176.03 8.27 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.124 1.77 . . . . 0.0 111.395 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.3 -51.02 71.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.73 1.212 . . . . 0.0 113.814 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -159.78 -174.95 4.86 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.581 1.553 . . . . 0.0 112.569 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -58.4 -39.69 80.39 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.4 t -57.02 -48.45 78.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.284 1.434 . . . . 0.0 111.237 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 tp -71.12 -43.32 75.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -51.5 68.45 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.532 1.133 . . . . 0.0 112.347 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -61.14 -41.4 96.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.987 1.715 . . . . 0.0 111.835 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.1 t -74.15 -24.06 59.36 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.487 0.715 . . . . 0.0 112.413 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -10.89 59.07 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.903 1.681 . . . . 0.0 113.94 169.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.59 15.4 56.88 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.79 1.186 . . . . 0.0 115.184 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.06 148.65 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.666 1.586 . . . . 0.0 111.675 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -78.71 168.58 19.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.914 0.886 . . . . 0.0 111.231 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.68 134.85 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 110.532 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -69.61 -47.97 61.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.854 1.261 . . . . 0.0 110.768 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 t -165.81 177.67 7.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.225 1.41 . . . . 0.0 112.104 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.45 164.99 24.95 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.841 1.656 . . . . 0.0 113.321 172.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.5 162.4 21.04 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.015 1.769 . . . . 0.0 113.426 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -65.63 135.38 54.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.888 0.875 . . . . 0.0 110.975 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 142.65 64.88 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.817 -0.552 . . . . 0.0 112.097 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--N 1.35 0.624 0 C-N-CA 122.77 2.313 . . . . 0.0 111.162 179.015 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.5 m . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.66 163.9 36.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.694 2.929 . . . . 0.0 114.222 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -75.52 -6.35 49.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.115 2.166 . . . . 0.0 115.317 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -54.35 136.25 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 112.799 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.95 85.29 5.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.926 1.691 . . . . 0.0 110.583 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -140.97 68.09 28.03 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.387 1.075 . . . . 0.0 111.057 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.49 159.93 34.08 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.819 1.679 . . . . 0.0 111.817 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.81 158.12 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.771 2.029 . . . . 0.0 109.961 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -97.1 114.13 25.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.325 0.65 . . . . 0.0 109.618 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.67 163.0 47.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.77 0.7 . . . . 0.0 113.03 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 t -63.36 -19.75 64.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.83 -12.69 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 172.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.18 -4.48 58.73 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.745 2.117 . . . . 0.0 114.32 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -67.11 156.49 36.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.286 1.834 . . . . 0.0 111.615 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.7 m -115.07 132.63 56.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.769 2.028 . . . . 0.0 110.59 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.6 174.81 6.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.246 1.819 . . . . 0.0 111.418 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -49.63 76.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.384 1.074 . . . . 0.0 113.564 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -162.06 -175.97 4.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 113.896 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -62.64 -37.85 87.97 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.01 -46.05 85.89 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.793 1.237 . . . . 0.0 111.823 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.26 -46.53 65.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.34 -46.0 80.13 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.143 0.977 . . . . 0.0 113.023 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.45 -28.64 65.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.656 1.982 . . . . 0.0 114.019 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.8 t -97.72 -24.71 15.36 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.355 1.462 . . . . 0.0 111.926 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -69.54 -11.8 61.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.476 1.91 . . . . 0.0 113.503 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.99 56.03 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.433 1.016 . . . . 0.0 114.782 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.41 151.49 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.992 1.317 . . . . 0.0 110.879 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.14 138.3 31.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 108.955 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.88 137.67 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.976 0.807 . . . . 0.0 109.53 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -96.98 -34.1 11.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 112.433 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -157.27 168.33 27.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.07 0.948 . . . . 0.0 112.682 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.25 149.27 25.6 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.403 1.881 . . . . 0.0 111.675 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.56 161.85 28.36 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.908 1.242 . . . . 0.0 112.28 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -63.59 149.89 45.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.574 -0.957 . . . . 0.0 112.236 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.98 149.44 50.46 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.132 0.573 . . . . 0.0 112.17 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 CA--C 1.539 0.764 0 C-N-CA 123.395 2.73 . . . . 0.0 112.566 177.886 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.27 167.86 24.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.023 3.149 . . . . 0.0 114.335 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.08 -9.85 58.95 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 pt -58.1 114.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.418 1.887 . . . . 0.0 113.813 -171.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.98 85.66 0.52 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 110.848 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.74 72.6 55.7 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 125.91 1.684 . . . . 0.0 109.888 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.79 160.64 35.94 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.189 1.926 . . . . 0.0 112.085 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.19 157.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.857 2.063 . . . . 0.0 110.48 -170.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.71 114.04 27.94 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.605 0.762 . . . . 0.0 111.693 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.29 163.08 51.44 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.88 1.229 . . . . 0.0 114.406 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 t -61.89 -28.55 69.59 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.216 . . . . 0.0 113.551 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.39 -10.79 59.83 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.285 1.034 . . . . 0.0 113.313 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.05 -5.51 61.43 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.84 2.162 . . . . 0.0 113.884 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -70.3 157.03 38.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.429 1.892 . . . . 0.0 111.798 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 m -115.17 137.59 51.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.039 2.136 . . . . 0.0 110.525 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 173.04 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.984 1.714 . . . . 0.0 111.439 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.15 86.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.546 1.138 . . . . 0.0 114.018 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -160.12 -174.7 4.67 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.801 1.64 . . . . 0.0 112.494 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.2 p -59.98 -41.39 91.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.79 -47.42 80.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.3 1.44 . . . . 0.0 111.405 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 tp -71.93 -43.71 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.56 76.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 112.27 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -59.82 -41.79 92.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.895 1.678 . . . . 0.0 111.952 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.4 t -74.25 -25.09 59.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.947 0.899 . . . . 0.0 112.504 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -11.07 59.8 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.044 1.738 . . . . 0.0 114.179 172.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.14 44.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.694 1.14 . . . . 0.0 115.105 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.5 154.6 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.04 1.736 . . . . 0.0 111.133 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -98.77 144.59 27.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.386 1.074 . . . . 0.0 109.444 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 pt -91.82 134.91 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.651 0.659 . . . . 0.0 111.025 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.08 -34.98 22.12 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 112.227 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -160.62 173.65 15.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.496 1.118 . . . . 0.0 112.458 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.68 161.44 23.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.058 1.743 . . . . 0.0 112.839 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.81 156.97 15.08 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.325 1.441 . . . . 0.0 112.262 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -64.01 142.32 58.45 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.607 -0.937 . . . . 0.0 111.5 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.12 150.66 71.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.539 0.73 0 C-N-CA 123.096 2.531 . . . . 0.0 112.079 177.019 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.88 163.88 34.62 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.745 2.963 . . . . 0.0 113.596 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.05 -8.52 57.58 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -53.36 111.84 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.59 1.956 . . . . 0.0 113.285 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.97 84.3 0.97 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.712 1.605 . . . . 0.0 111.332 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -141.45 74.05 24.26 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.205 1.402 . . . . 0.0 109.748 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.98 165.38 21.66 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.82 2.347 . . . . 0.0 112.84 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -145.6 153.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -98.19 113.0 24.77 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.009 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.59 164.82 37.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.403 1.002 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -60.61 -29.71 69.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.41 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -79.01 -13.5 59.75 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.847 1.259 . . . . 0.0 113.488 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.51 -3.17 59.3 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 126.281 1.896 . . . . 0.0 114.049 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -66.16 156.28 34.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.722 1.609 . . . . 0.0 111.464 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 m -114.0 138.4 50.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.54 1.936 . . . . 0.0 110.111 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.89 174.1 9.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.691 1.596 . . . . 0.0 111.25 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.43 -49.03 77.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 113.443 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -159.7 -174.29 4.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.462 1.505 . . . . 0.0 113.206 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.7 p -61.17 -38.0 84.94 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.04 -46.09 85.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.19 1.396 . . . . 0.0 111.79 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.64 -41.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 O-C-N 122.066 -0.397 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.36 -47.77 82.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.731 1.212 . . . . 0.0 112.405 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -59.06 -42.51 90.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 111.82 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.6 -27.87 61.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.917 0.887 . . . . 0.0 112.598 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -7.33 22.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.724 1.61 . . . . 0.0 114.113 175.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 18.84 48.99 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.875 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.3 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.779 1.631 . . . . 0.0 111.093 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.3 p -82.74 168.32 17.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.586 0.754 . . . . 0.0 111.488 168.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.58 137.49 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.102 1.361 . . . . 0.0 110.064 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -92.54 -33.55 14.41 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.698 1.199 . . . . 0.0 112.039 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 m -150.93 162.41 40.86 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.708 1.603 . . . . 0.0 112.26 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.87 162.91 27.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.43 1.092 . . . . 0.0 112.329 165.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 167.63 31.21 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.313 1.435 . . . . 0.0 113.002 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 p -66.13 149.09 50.83 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.51 -0.994 . . . . 0.0 111.562 169.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 145.17 32.04 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.002 0.521 . . . . 0.0 112.194 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 C-N-CA 122.916 2.411 . . . . 0.0 112.359 177.914 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.9 m . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 110.979 -0.008 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.12 164.09 29.85 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.341 2.694 . . . . 0.0 112.962 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -81.22 -5.78 58.13 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.01 131.2 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.222 1.809 . . . . 0.0 110.749 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.15 78.4 8.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.158 1.783 . . . . 0.0 110.318 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -130.06 69.64 81.88 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.899 1.28 . . . . 0.0 109.667 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.19 161.74 38.98 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.15 1.9 . . . . 0.0 112.44 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.7 157.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 127.007 2.123 . . . . 0.0 110.627 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -102.53 114.81 29.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.783 0.833 . . . . 0.0 111.674 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 162.33 54.6 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.15 0.881 . . . . 0.0 113.943 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -61.74 -26.05 67.82 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.4 1.48 . . . . 0.0 114.228 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.1 -19.44 54.15 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.67 1.188 . . . . 0.0 112.989 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.16 -7.15 32.61 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 127.381 2.419 . . . . 0.0 114.166 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -74.38 158.01 34.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.61 1.564 . . . . 0.0 112.199 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.3 m -114.74 125.85 54.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.658 2.383 . . . . 0.0 110.653 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.17 174.6 6.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.884 1.674 . . . . 0.0 111.65 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.46 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.455 1.102 . . . . 0.0 113.751 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -163.18 -175.92 4.55 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.658 1.983 . . . . 0.0 112.665 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -57.87 -39.28 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.77 -46.7 81.31 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.062 1.345 . . . . 0.0 111.829 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -75.06 -41.6 45.29 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 O-C-N 122.225 -0.297 . . . . 0.0 110.284 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.87 78.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.445 1.098 . . . . 0.0 112.234 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -59.42 -39.92 85.03 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.032 1.733 . . . . 0.0 112.436 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.9 -34.63 73.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -8.92 17.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.889 1.676 . . . . 0.0 114.545 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.84 50.58 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.975 1.274 . . . . 0.0 114.814 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.04 156.65 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.912 2.085 . . . . 0.0 110.823 -172.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -106.96 139.02 42.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 109.606 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.0 pt -85.56 136.02 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.753 -0.592 . . . . 0.0 111.175 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -90.74 -31.66 16.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.818 1.247 . . . . 0.0 112.537 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 m -158.85 164.55 35.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.886 1.675 . . . . 0.0 111.928 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -80.45 160.64 25.24 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 111.811 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.2 159.88 23.71 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.205 1.383 . . . . 0.0 112.425 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -63.58 143.0 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.59 -0.947 . . . . 0.0 111.598 171.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 149.09 61.51 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 122.05 -0.406 . . . . 0.0 111.89 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 123.049 2.499 . . . . 0.0 112.104 176.399 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.4 161.44 45.56 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.575 2.85 . . . . 0.0 113.446 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -74.82 -8.3 56.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.837 1.655 . . . . 0.0 114.73 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -49.47 128.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.683 1.993 . . . . 0.0 113.378 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.8 mt -84.85 77.19 10.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 110.178 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -142.4 73.42 20.87 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 124.151 0.98 . . . . 0.0 110.69 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.23 164.19 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.12 1.88 . . . . 0.0 112.551 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.15 169.17 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.932 2.093 . . . . 0.0 110.383 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -113.7 110.07 19.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.415 0.686 . . . . 0.0 110.577 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.45 155.14 52.9 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.927 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -57.4 -23.37 48.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.802 1.641 . . . . 0.0 114.44 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.32 -24.3 64.82 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.314 1.446 . . . . 0.0 113.086 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.15 -8.03 35.55 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 127.502 2.477 . . . . 0.0 114.01 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -78.68 158.75 28.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.535 1.934 . . . . 0.0 111.458 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.4 t -116.84 149.57 39.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.662 1.585 . . . . 0.0 112.699 172.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.86 177.19 8.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.974 2.11 . . . . 0.0 110.814 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -158.77 -177.35 6.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.939 1.696 . . . . 0.0 112.712 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 p -58.13 -36.51 73.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.7 t -63.29 -42.56 99.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.721 1.608 . . . . 0.0 112.248 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.88 -44.87 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.675 -0.641 . . . . 0.0 110.106 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.44 98.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.784 1.234 . . . . 0.0 113.215 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.37 -42.28 98.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.419 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.8 t -76.11 -21.29 56.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.845 1.258 . . . . 0.0 112.412 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -10.04 39.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.84 2.056 . . . . 0.0 113.901 165.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.12 15.03 37.2 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.178 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.43 148.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.847 1.324 . . . . 0.0 111.865 -173.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 132.42 40.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.181 1.793 . . . . 0.0 111.1 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.43 109.62 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.036 0.935 . . . . 0.0 109.999 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -91.72 -35.99 13.84 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.943 0.897 . . . . 0.0 113.062 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -159.94 168.25 26.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.571 1.149 . . . . 0.0 112.276 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.82 163.88 12.02 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.18 1.392 . . . . 0.0 113.645 177.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 160.48 23.08 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.481 1.515 . . . . 0.0 112.11 -168.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.0 m -62.61 135.38 57.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.997 -0.708 . . . . 0.0 110.685 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 146.92 98.7 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 121.961 -0.462 . . . . 0.0 111.212 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.54 0.797 0 C-N-CA 123.75 2.966 . . . . 0.0 112.217 -176.282 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 111.106 0.039 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.24 155.12 56.58 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.264 2.643 . . . . 0.0 112.272 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -77.72 -6.48 54.09 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.3 tp -45.74 125.46 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.968 2.107 . . . . 0.0 113.459 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -76.9 83.87 3.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.288 1.835 . . . . 0.0 109.814 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -145.5 65.36 11.38 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 111.834 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.43 161.45 34.76 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.232 2.621 . . . . 0.0 112.437 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 157.42 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.716 2.006 . . . . 0.0 111.024 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -91.18 117.19 29.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.146 0.979 . . . . 0.0 110.32 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.5 166.03 42.95 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.437 1.018 . . . . 0.0 114.348 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -56.41 -26.82 54.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 114.412 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.4 -4.68 37.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.733 1.613 . . . . 0.0 113.771 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.19 62.4 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.741 1.638 . . . . 0.0 114.489 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.24 159.04 18.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.926 1.69 . . . . 0.0 111.179 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -124.43 122.35 37.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.687 1.995 . . . . 0.0 110.252 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.97 175.02 5.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.134 1.774 . . . . 0.0 111.196 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.52 87.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -157.23 -175.53 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.9 m -77.84 8.75 4.18 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -104.8 -46.42 4.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.652 1.581 . . . . 0.0 110.714 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.4 -41.06 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.826 0.851 . . . . 0.0 110.233 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.76 72.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.876 1.27 . . . . 0.0 111.495 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.263 1.825 . . . . 0.0 112.561 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.85 -32.77 65.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.507 0.723 . . . . 0.0 112.319 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -10.57 35.04 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.472 1.509 . . . . 0.0 114.206 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 13.71 57.53 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.039 1.304 . . . . 0.0 114.951 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.27 132.52 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.808 2.043 . . . . 0.0 110.626 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 p -75.48 164.57 26.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.727 0.811 . . . . 0.0 111.623 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 pp -102.79 135.48 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.402 1.081 . . . . 0.0 109.381 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -89.17 -35.63 16.13 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.312 1.445 . . . . 0.0 112.488 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -160.12 170.12 21.89 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 112.715 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.06 153.35 32.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.67 1.588 . . . . 0.0 112.904 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.18 156.89 13.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.996 1.284 . . . . 0.0 112.837 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -58.23 136.55 57.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.941 0.897 . . . . 0.0 111.108 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 147.67 82.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 121.837 -0.539 . . . . 0.0 111.29 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.539 0.725 0 C-N-CA 122.766 2.311 . . . . 0.0 111.994 -178.791 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.8 m . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 111.471 0.175 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -80.02 167.5 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.481 2.787 . . . . 0.0 113.488 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -79.63 -7.3 58.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.575 1.55 . . . . 0.0 114.958 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.4 128.42 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 111.261 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.2 mt -80.33 77.97 7.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.484 1.913 . . . . 0.0 110.268 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -133.7 69.19 76.17 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.704 1.202 . . . . 0.0 109.624 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.99 162.89 30.58 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.893 1.729 . . . . 0.0 112.644 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.44 145.13 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.59 1.956 . . . . 0.0 110.037 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -89.67 118.58 29.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.432 0.693 . . . . 0.0 110.803 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.89 161.91 52.56 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.139 0.876 . . . . 0.0 114.326 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.3 t -59.59 -29.67 68.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.811 1.244 . . . . 0.0 113.664 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -74.9 -20.08 59.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.489 1.116 . . . . 0.0 113.013 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.94 -8.75 31.66 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 126.741 2.115 . . . . 0.0 114.238 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -73.39 161.31 30.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.865 1.666 . . . . 0.0 111.505 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 t -110.52 151.75 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.168 1.387 . . . . 0.0 111.838 165.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.34 175.33 9.37 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.203 1.801 . . . . 0.0 111.167 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.38 69.51 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.535 1.134 . . . . 0.0 114.041 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -160.93 -175.39 4.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.276 1.83 . . . . 0.0 112.753 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -57.86 -40.97 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.89 -47.34 77.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.061 1.344 . . . . 0.0 111.869 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.35 -43.95 63.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.21 -49.24 76.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.474 1.11 . . . . 0.0 112.253 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.3 -42.96 87.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.884 1.674 . . . . 0.0 112.2 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.2 t -73.53 -27.54 61.41 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.071 0.549 . . . . 0.0 112.425 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -11.52 60.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.971 1.708 . . . . 0.0 114.114 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 17.33 57.66 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.545 1.069 . . . . 0.0 115.238 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.44 149.01 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.962 1.705 . . . . 0.0 111.38 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -77.12 156.02 31.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.411 0.684 . . . . 0.0 110.598 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.33 126.76 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.257 1.023 . . . . 0.0 109.681 170.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -91.16 -30.06 16.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.278 1.831 . . . . 0.0 112.201 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -162.01 173.37 14.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.515 1.926 . . . . 0.0 111.124 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -84.35 164.02 19.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 0.0 113.233 172.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.95 166.69 25.77 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.509 1.528 . . . . 0.0 112.69 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -67.39 137.61 56.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.645 -0.915 . . . . 0.0 110.83 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 147.84 91.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 122.052 -0.405 . . . . 0.0 111.777 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 CA--C 1.54 0.78 0 C-N-CA 123.175 2.583 . . . . 0.0 112.438 178.599 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.32 162.52 41.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.731 2.954 . . . . 0.0 113.732 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -77.46 -5.42 49.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.474 1.91 . . . . 0.0 114.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -50.7 131.45 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.227 1.811 . . . . 0.0 112.893 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.59 71.36 7.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.126 1.77 . . . . 0.0 110.47 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.04 68.69 80.43 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.005 1.322 . . . . 0.0 111.084 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.02 161.18 34.36 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.383 2.056 . . . . 0.0 112.756 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.12 152.91 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.11 2.164 . . . . 0.0 110.323 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.08 116.39 30.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.568 0.747 . . . . 0.0 111.152 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.56 164.6 50.82 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.711 1.148 . . . . 0.0 114.284 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t -57.42 -30.8 65.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.831 1.252 . . . . 0.0 113.373 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.76 -12.29 59.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.116 1.366 . . . . 0.0 113.936 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.79 -2.23 61.98 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 126.028 1.775 . . . . 0.0 114.215 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -68.46 157.83 35.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.928 1.691 . . . . 0.0 110.957 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.8 m -112.32 141.42 46.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.104 1.761 . . . . 0.0 110.695 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.98 172.16 12.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.131 1.772 . . . . 0.0 110.961 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -160.14 -175.2 4.94 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.444 1.897 . . . . 0.0 112.42 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.5 p -59.65 -38.65 82.01 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.8 t -57.68 -47.51 82.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 111.587 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.37 -42.06 65.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 O-C-N 122.131 -0.356 . . . . 0.0 110.153 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.57 72.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.106 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -59.26 -41.36 88.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.479 1.512 . . . . 0.0 111.956 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.78 -24.76 58.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.746 0.818 . . . . 0.0 112.497 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -10.58 58.33 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.054 1.742 . . . . 0.0 114.089 170.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.78 15.33 59.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.646 1.117 . . . . 0.0 115.088 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.56 151.23 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.157 1.783 . . . . 0.0 111.182 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 m -84.69 157.09 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.624 0.77 . . . . 0.0 110.038 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.51 140.09 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.556 0.742 . . . . 0.0 110.31 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -92.39 -31.07 15.46 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.659 1.184 . . . . 0.0 111.48 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 99.2 p -160.32 169.02 24.01 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.537 1.535 . . . . 0.0 112.421 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.37 164.38 21.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.338 1.055 . . . . 0.0 112.762 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.23 164.2 29.79 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.504 1.526 . . . . 0.0 112.705 -173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 t -65.5 146.73 54.49 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.57 -0.959 . . . . 0.0 111.024 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.42 146.54 37.91 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.537 . . . . 0.0 111.856 176.159 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 165.55 31.26 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.65 2.9 . . . . 0.0 113.695 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -77.51 -8.26 57.51 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 pt -57.33 113.23 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.358 1.863 . . . . 0.0 113.006 -173.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.67 84.61 0.89 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.586 1.554 . . . . 0.0 111.018 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -142.93 75.67 17.51 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.364 1.465 . . . . 0.0 109.422 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.34 165.19 20.59 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.858 2.372 . . . . 0.0 112.8 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.56 159.79 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.482 1.913 . . . . 0.0 110.058 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.0 t -105.99 119.51 39.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.671 . . . . 0.0 111.944 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.01 164.95 53.96 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.732 1.158 . . . . 0.0 114.143 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -59.29 -26.8 65.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.39 1.476 . . . . 0.0 113.534 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -73.38 -17.05 61.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.158 1.383 . . . . 0.0 113.294 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.5 -2.0 67.13 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.238 1.875 . . . . 0.0 113.785 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -70.04 156.38 39.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 111.22 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.1 m -114.84 138.04 51.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.581 1.952 . . . . 0.0 110.621 172.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.04 173.1 10.75 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.726 1.61 . . . . 0.0 111.236 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.85 85.44 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.395 1.078 . . . . 0.0 113.343 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.426 ' H ' HG23 ' A' ' 26' ' ' ILE . 43.8 p-10 -159.32 -176.36 5.76 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.019 1.328 . . . . 0.0 113.548 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -58.66 -38.6 78.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -60.31 -44.8 95.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.368 1.067 . . . . 0.0 112.63 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 23' ' ' ASN . 4.8 tt -73.53 -39.17 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.13 75.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.631 1.172 . . . . 0.0 112.458 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -63.9 -34.76 78.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.495 1.118 . . . . 0.0 113.414 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.3 t -85.05 -21.35 29.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.727 1.211 . . . . 0.0 111.982 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -67.12 -7.26 21.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.799 1.639 . . . . 0.0 113.775 162.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 21.16 53.53 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.392 0.996 . . . . 0.0 114.874 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 143.01 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.049 1.34 . . . . 0.0 111.28 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.34 135.49 34.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.762 0.825 . . . . 0.0 110.248 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.7 pt -81.26 138.01 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.74 0.7 . . . . 0.0 111.053 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -94.17 -31.47 14.13 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.293 1.437 . . . . 0.0 112.69 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -160.52 174.17 14.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.956 1.302 . . . . 0.0 112.078 174.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.09 161.64 16.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.921 1.688 . . . . 0.0 111.865 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.41 166.97 24.34 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.613 1.577 . . . . 0.0 113.241 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 m -65.63 137.38 57.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.187 0.595 . . . . 0.0 110.545 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 145.23 83.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.364 0.666 . . . . 0.0 111.817 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 CA--C 1.538 0.716 0 C-N-CA 124.239 3.292 . . . . 0.0 111.738 179.062 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 164.12 32.52 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.748 2.966 . . . . 0.0 113.875 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -76.97 -10.27 59.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.386 1.874 . . . . 0.0 115.37 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 pt -51.55 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.297 2.239 . . . . 0.0 113.107 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.27 90.61 0.5 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.279 1.832 . . . . 0.0 111.124 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.49 68.2 16.85 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.837 1.255 . . . . 0.0 111.049 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -63.62 159.07 42.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.285 1.99 . . . . 0.0 112.284 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.59 158.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.159 2.183 . . . . 0.0 110.463 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.17 115.25 29.4 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.602 0.761 . . . . 0.0 110.957 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.38 160.09 53.98 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.494 0.569 . . . . 0.0 113.737 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.3 m -59.9 -24.15 64.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.23 -14.38 59.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.938 1.295 . . . . 0.0 113.197 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.24 -4.66 55.25 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.005 2.241 . . . . 0.0 114.154 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -75.26 157.45 34.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.462 1.905 . . . . 0.0 111.87 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.1 m -111.66 138.04 48.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.006 2.123 . . . . 0.0 110.566 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.33 174.57 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.886 1.674 . . . . 0.0 111.7 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.78 80.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.73 1.212 . . . . 0.0 113.662 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -160.82 -174.98 4.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.194 1.398 . . . . 0.0 112.935 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.1 p -59.57 -40.04 86.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.0 t -57.28 -46.24 83.3 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.029 1.331 . . . . 0.0 111.654 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -73.64 -42.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 O-C-N 122.155 -0.34 . . . . 0.0 110.18 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.5 74.96 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.545 1.138 . . . . 0.0 112.384 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -58.55 -39.72 81.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.019 1.728 . . . . 0.0 112.433 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.4 t -74.8 -29.27 61.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.797 0.839 . . . . 0.0 112.688 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -9.38 36.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.698 1.599 . . . . 0.0 114.38 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.56 19.53 51.67 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.643 1.116 . . . . 0.0 114.805 175.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.41 147.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.188 1.795 . . . . 0.0 110.358 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 m -80.67 163.04 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.982 -0.449 . . . . 0.0 110.164 172.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.87 131.59 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 109.371 171.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -89.56 -32.61 17.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.042 0.937 . . . . 0.0 112.093 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -159.62 171.24 19.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.159 1.384 . . . . 0.0 112.229 172.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.73 160.28 24.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.269 1.828 . . . . 0.0 112.936 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 159.16 15.97 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.143 1.354 . . . . 0.0 112.251 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.9 p -62.65 143.74 57.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.521 -0.988 . . . . 0.0 111.808 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.33 146.17 57.31 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.001 -0.437 . . . . 0.0 111.606 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.538 0.693 0 C-N-CA 122.787 2.325 . . . . 0.0 111.962 179.479 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 111.155 0.057 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.1 165.78 30.45 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 114.197 -174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -75.25 -8.77 57.52 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.561 1.944 . . . . 0.0 115.742 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.4 153.97 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.923 2.089 . . . . 0.0 112.675 -172.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.37 81.89 1.62 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.143 1.377 . . . . 0.0 110.579 -170.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -139.63 73.42 35.06 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.36 1.464 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.1 162.99 24.16 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.988 1.792 . . . . 0.0 112.591 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.07 152.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.588 1.955 . . . . 0.0 109.962 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.6 t -103.03 122.18 44.1 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.804 0.842 . . . . 0.0 110.761 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.93 166.54 54.43 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.502 1.049 . . . . 0.0 113.536 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 p -59.47 -22.67 61.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.42 -23.93 42.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.032 1.333 . . . . 0.0 113.395 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.49 -5.17 33.13 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.481 1.991 . . . . 0.0 114.325 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -74.66 157.24 35.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.507 1.523 . . . . 0.0 111.643 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.6 m -113.26 136.73 52.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.904 1.682 . . . . 0.0 112.115 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.68 171.78 10.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.78 1.632 . . . . 0.0 111.707 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.35 93.12 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -157.81 -175.45 5.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.636 1.574 . . . . 0.0 112.559 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.0 p -59.37 -43.22 92.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.005 0.922 . . . . 0.0 113.423 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.2 t -55.12 -46.73 75.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.619 1.567 . . . . 0.0 111.569 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -72.97 -44.13 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.5 80.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.217 1.007 . . . . 0.0 112.033 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -60.03 -40.67 90.14 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.824 1.65 . . . . 0.0 112.199 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.0 t -72.4 -28.38 62.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.088 0.555 . . . . 0.0 112.386 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -9.51 41.02 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.128 1.771 . . . . 0.0 114.103 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 16.83 52.4 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.625 1.107 . . . . 0.0 114.752 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.52 156.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.464 1.906 . . . . 0.0 111.257 -174.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -92.62 155.99 17.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.941 0.896 . . . . 0.0 109.935 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.98 130.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -85.52 -35.38 21.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.749 1.22 . . . . 0.0 112.343 173.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -156.12 169.47 24.42 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 0.0 112.374 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.47 160.03 22.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.15 1.78 . . . . 0.0 112.64 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.75 170.31 28.7 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.039 1.304 . . . . 0.0 112.933 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.8 m -67.42 138.05 56.38 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.772 -0.84 . . . . 0.0 111.024 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 152.14 92.5 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.889 -0.507 . . . . 0.0 112.038 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 C-N-CA 123.619 2.879 . . . . 0.0 112.619 176.337 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 111.233 0.086 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.74 160.85 30.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.9 2.4 . . . . 0.0 113.614 -173.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -75.07 -9.54 58.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.525 1.93 . . . . 0.0 114.409 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mt -60.11 131.84 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.347 1.859 . . . . 0.0 111.09 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 63.89 5.34 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.498 2.319 . . . . 0.0 112.022 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -122.91 71.24 41.39 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.347 1.459 . . . . 0.0 110.222 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.03 164.66 24.15 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.723 2.282 . . . . 0.0 112.6 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -145.4 151.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.714 2.006 . . . . 0.0 110.39 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.6 t -92.42 117.14 29.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.443 0.697 . . . . 0.0 110.389 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.5 166.0 39.33 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.657 1.122 . . . . 0.0 114.566 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -57.96 -33.87 69.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.571 1.148 . . . . 0.0 112.878 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.09 -19.12 57.45 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.095 1.358 . . . . 0.0 113.441 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.2 55.27 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 126.545 2.022 . . . . 0.0 114.171 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -68.23 160.09 29.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.011 1.724 . . . . 0.0 111.525 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.1 m -116.97 138.88 51.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.201 1.801 . . . . 0.0 111.415 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.25 176.3 8.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.4 1.88 . . . . 0.0 111.651 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.11 61.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.904 1.281 . . . . 0.0 114.359 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -162.72 178.14 8.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.206 1.802 . . . . 0.0 112.689 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.9 p -68.5 27.4 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.491 2.316 . . . . 0.0 117.032 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.8 t -119.85 -45.04 2.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.649 2.379 . . . . 0.0 110.394 174.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.06 -40.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 O-C-N 121.783 -0.573 . . . . 0.0 110.212 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.05 -53.21 59.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.93 1.292 . . . . 0.0 111.202 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -58.63 -36.62 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.958 1.303 . . . . 0.0 112.872 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 t -77.55 -29.54 52.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.754 0.822 . . . . 0.0 112.17 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -21.52 62.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.96 1.704 . . . . 0.0 113.56 167.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.45 10.61 33.15 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.563 1.554 . . . . 0.0 115.351 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.286 1.835 . . . . 0.0 110.798 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p -81.09 170.63 15.95 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.776 0.83 . . . . 0.0 111.027 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.99 149.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.798 1.239 . . . . 0.0 110.715 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -110.19 -26.89 9.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.401 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -161.89 170.28 19.72 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.597 1.159 . . . . 0.0 112.938 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.41 155.62 36.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.412 1.885 . . . . 0.0 111.97 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.16 164.92 28.7 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.575 1.56 . . . . 0.0 113.529 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 m -63.2 136.23 57.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.717 -0.872 . . . . 0.0 110.971 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.88 148.52 82.04 Favored Pre-proline 0 CA--C 1.548 0.903 0 O-C-N 121.82 -0.55 . . . . 0.0 111.9 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.539 0.732 0 C-N-CA 123.094 2.529 . . . . 0.0 112.248 176.961 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.6 163.39 36.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.544 2.829 . . . . 0.0 113.196 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -84.52 -4.24 58.84 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 tt -48.68 131.56 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.085 2.154 . . . . 0.0 113.332 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.76 79.03 7.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.579 . . . . 0.0 110.576 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -143.32 71.48 17.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.835 0.854 . . . . 0.0 110.429 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.55 160.62 45.07 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.013 1.809 . . . . 0.0 112.089 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.52 155.19 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 110.198 -172.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -98.25 112.91 24.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.167 0.587 . . . . 0.0 111.112 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.07 164.42 51.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.433 0.539 . . . . 0.0 113.005 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -64.26 -18.89 65.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.35 -22.85 60.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.593 1.157 . . . . 0.0 113.242 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.33 42.2 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 127.043 2.259 . . . . 0.0 114.124 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -83.55 159.8 21.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.196 1.798 . . . . 0.0 111.244 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.8 t -113.89 147.95 37.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.451 1.501 . . . . 0.0 112.767 173.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.79 178.02 7.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.248 2.219 . . . . 0.0 110.688 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.55 74.09 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -157.2 -176.87 6.21 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.908 1.683 . . . . 0.0 113.366 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.9 p -73.73 14.0 0.43 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 116.009 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -107.12 -48.08 3.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.53 1.932 . . . . 0.0 111.179 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 tp -65.57 -41.4 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -42.5 98.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.204 1.002 . . . . 0.0 112.196 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -64.25 -37.89 89.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.308 1.443 . . . . 0.0 112.597 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -71.8 -29.15 64.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.481 0.712 . . . . 0.0 112.01 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -10.44 57.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.428 1.891 . . . . 0.0 114.816 174.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.69 14.89 38.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.648 1.118 . . . . 0.0 115.326 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 159.22 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.9 1.68 . . . . 0.0 111.178 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 p -100.61 158.15 16.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.411 1.085 . . . . 0.0 111.814 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.5 mm -93.34 109.72 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.958 1.303 . . . . 0.0 109.944 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -76.01 -46.0 31.7 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.041 1.336 . . . . 0.0 112.264 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 t -153.73 164.28 38.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.817 0.847 . . . . 0.0 112.907 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -84.63 155.19 22.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.421 1.488 . . . . 0.0 112.799 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.09 151.01 13.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.715 1.15 . . . . 0.0 111.596 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -61.63 135.44 57.63 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.697 -0.884 . . . . 0.0 111.609 173.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.41 150.56 97.8 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.927 0.491 . . . . 0.0 111.557 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.54 0.805 0 C-N-CA 123.339 2.692 . . . . 0.0 112.633 179.497 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.26 162.92 19.95 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.539 2.826 . . . . 0.0 113.227 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -84.38 -7.94 59.15 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 pt -54.7 133.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.093 1.757 . . . . 0.0 112.946 -171.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -76.08 76.79 2.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.511 1.524 . . . . 0.0 111.21 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -132.85 66.97 77.5 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 126.194 1.797 . . . . 0.0 111.337 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -61.69 157.74 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.926 1.751 . . . . 0.0 111.945 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -143.77 154.96 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.012 2.125 . . . . 0.0 110.262 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -90.69 112.62 24.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.155 0.582 . . . . 0.0 109.8 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.87 159.17 46.55 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.681 0.657 . . . . 0.0 113.496 170.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 p -63.16 -22.41 66.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.34 1.456 . . . . 0.0 114.506 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -84.57 -10.27 57.55 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.527 1.131 . . . . 0.0 113.842 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.66 60.77 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 126.579 2.038 . . . . 0.0 113.908 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -66.31 157.62 31.21 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.841 1.656 . . . . 0.0 111.444 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.1 m -121.97 135.77 54.88 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.396 1.878 . . . . 0.0 110.519 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.32 177.61 6.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.33 1.852 . . . . 0.0 111.662 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.37 77.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -148.83 -179.69 7.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.221 1.408 . . . . 0.0 111.846 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.6 p -66.41 -43.97 84.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.475 1.11 . . . . 0.0 113.002 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 t -61.55 -41.67 97.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.95 1.3 . . . . 0.0 112.217 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 tp -67.39 -42.95 87.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.93 63.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.106 1.362 . . . . 0.0 111.431 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -56.73 -41.14 76.97 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.461 1.104 . . . . 0.0 112.54 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.84 -26.49 59.74 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -8.79 41.65 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.855 1.662 . . . . 0.0 114.175 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.27 15.69 46.72 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.914 1.245 . . . . 0.0 114.736 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.86 142.74 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.122 1.769 . . . . 0.0 110.779 -174.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -84.12 152.68 24.17 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.984 -0.447 . . . . 0.0 109.94 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.47 149.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 167.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -119.18 -22.34 7.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.259 1.424 . . . . 0.0 112.853 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.7 p -160.95 167.75 25.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.243 1.417 . . . . 0.0 112.616 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.33 154.23 25.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.72 1.208 . . . . 0.0 112.264 173.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.11 165.97 36.99 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.362 1.458 . . . . 0.0 113.185 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.7 t -60.15 149.66 32.12 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.731 -0.864 . . . . 0.0 111.576 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.49 141.24 22.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.564 0.746 . . . . 0.0 112.186 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 CA--C 1.537 0.672 0 C-N-CA 123.074 2.516 . . . . 0.0 112.32 -176.484 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.8 m . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.45 162.56 35.79 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.755 2.97 . . . . 0.0 113.229 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -78.57 -9.17 59.26 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -50.52 113.9 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.942 2.097 . . . . 0.0 113.021 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -70.8 91.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.796 1.238 . . . . 0.0 110.508 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 69.77 14.46 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.179 0.991 . . . . 0.0 110.5 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.58 161.34 28.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.361 2.041 . . . . 0.0 112.214 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.89 155.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.401 2.28 . . . . 0.0 109.719 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -99.57 114.74 27.95 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.907 0.883 . . . . 0.0 109.584 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.96 166.54 40.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.547 1.07 . . . . 0.0 114.127 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.27 -30.2 59.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.997 1.319 . . . . 0.0 113.708 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.35 -18.39 49.2 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.927 1.291 . . . . 0.0 113.777 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.74 -3.87 49.65 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.358 1.932 . . . . 0.0 114.328 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -70.61 157.92 37.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 111.953 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -111.63 141.54 45.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 111.536 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.13 173.59 10.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.527 1.931 . . . . 0.0 111.053 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.92 82.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.041 . . . . 0.0 113.741 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -162.07 -176.38 5.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.343 1.457 . . . . 0.0 113.125 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -60.84 -35.61 77.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -62.52 -39.17 92.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.049 1.34 . . . . 0.0 112.444 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 tp -79.7 -42.32 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 O-C-N 121.773 -0.579 . . . . 0.0 110.49 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.1 70.0 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.287 1.035 . . . . 0.0 112.37 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -57.58 -41.66 81.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.546 1.138 . . . . 0.0 112.846 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.46 -24.08 50.33 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.816 1.246 . . . . 0.0 112.629 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -11.47 60.66 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.29 1.836 . . . . 0.0 113.797 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 17.92 39.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.014 1.292 . . . . 0.0 115.22 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.11 146.09 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.221 1.808 . . . . 0.0 111.134 -172.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -82.13 147.59 28.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.27 1.028 . . . . 0.0 110.918 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.83 131.8 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -89.79 -40.4 12.49 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.273 1.429 . . . . 0.0 111.98 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -145.37 160.33 41.7 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.167 1.387 . . . . 0.0 112.349 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.37 154.14 35.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.932 1.293 . . . . 0.0 112.167 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.19 162.39 28.63 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.152 1.358 . . . . 0.0 112.942 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.5 t -64.14 147.19 52.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.654 -0.909 . . . . 0.0 111.329 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.66 143.1 33.29 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.798 0.839 . . . . 0.0 112.08 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.813 -179.727 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.8 m . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 120.312 0.101 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.9 163.3 35.75 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.479 2.786 . . . . 0.0 113.571 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -79.93 -8.34 59.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.116 1.766 . . . . 0.0 114.93 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 135.43 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.636 1.975 . . . . 0.0 113.077 -171.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.69 81.11 8.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.367 1.867 . . . . 0.0 111.79 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.29 70.0 77.54 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.094 1.358 . . . . 0.0 110.638 172.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.19 161.69 29.42 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.547 2.164 . . . . 0.0 112.817 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.6 m -147.16 153.62 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.915 2.086 . . . . 0.0 110.64 -172.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -99.29 111.61 23.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.831 0.852 . . . . 0.0 111.871 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.88 162.56 48.32 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.615 1.102 . . . . 0.0 113.967 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 m -59.54 -25.45 64.53 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -78.74 -15.86 57.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.373 1.069 . . . . 0.0 113.267 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 -1.45 59.68 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 126.61 2.052 . . . . 0.0 113.974 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -72.58 158.2 36.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.897 1.679 . . . . 0.0 111.116 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.0 m -116.85 140.6 49.25 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.695 1.998 . . . . 0.0 110.595 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.16 175.83 8.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.981 1.712 . . . . 0.0 111.418 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.67 72.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.508 1.123 . . . . 0.0 113.818 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.92 -174.52 4.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.377 1.871 . . . . 0.0 112.491 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 p -58.62 -39.87 81.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.67 -47.31 82.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.451 1.5 . . . . 0.0 111.654 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.46 -42.56 64.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.06 74.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.543 1.137 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -56.12 -43.37 78.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.64 1.976 . . . . 0.0 112.162 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -76.18 -24.98 54.78 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -9.73 49.02 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.94 1.696 . . . . 0.0 114.073 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.6 15.55 54.65 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.893 1.235 . . . . 0.0 114.906 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.6 162.19 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.497 1.919 . . . . 0.0 111.468 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 132.3 56.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.249 1.42 . . . . 0.0 109.376 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 pt -78.99 140.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.998 -0.439 . . . . 0.0 111.245 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -93.12 -35.25 13.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.444 1.098 . . . . 0.0 112.285 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -149.38 161.16 42.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.629 1.172 . . . . 0.0 112.303 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.57 160.31 25.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 169.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.3 166.0 40.21 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.48 1.514 . . . . 0.0 113.132 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.9 t -63.11 150.42 42.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.926 -0.749 . . . . 0.0 111.282 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.49 137.02 19.27 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.328 1.051 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 112.765 -178.274 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 120.304 0.097 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.72 158.16 57.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.16 2.573 . . . . 0.0 113.016 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.83 -5.44 43.54 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.419 1.888 . . . . 0.0 114.73 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 tt -51.24 131.89 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.886 2.074 . . . . 0.0 113.539 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 tt -82.12 78.63 8.78 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.116 1.766 . . . . 0.0 109.531 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -143.25 68.39 17.43 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 111.567 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.22 168.69 12.07 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.741 2.961 . . . . 0.0 113.615 -172.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.06 158.58 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.485 1.914 . . . . 0.0 111.023 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -98.71 113.17 25.13 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.889 0.875 . . . . 0.0 109.758 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 153.7 51.45 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 113.414 173.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -59.72 -26.41 65.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.112 0.965 . . . . 0.0 113.204 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.06 -19.3 61.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.225 1.41 . . . . 0.0 113.337 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.41 -8.15 40.62 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.859 2.171 . . . . 0.0 114.507 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -75.77 160.15 30.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.486 1.915 . . . . 0.0 111.701 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -111.58 143.31 42.65 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.668 1.987 . . . . 0.0 110.77 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.34 175.21 9.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.559 1.943 . . . . 0.0 110.979 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -47.76 79.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.201 1.001 . . . . 0.0 113.591 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -156.55 -173.31 4.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 112.433 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 p -60.81 -37.14 80.96 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -60.53 -46.91 88.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.429 1.492 . . . . 0.0 112.474 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 tp -69.76 -39.71 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 122.359 1.076 . . . . 0.0 110.339 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.77 77.84 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.932 1.693 . . . . 0.0 112.472 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -58.09 -34.56 70.32 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.574 1.55 . . . . 0.0 112.682 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.3 t -79.54 -30.73 41.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.432 0.693 . . . . 0.0 111.653 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -66.49 -5.32 10.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.128 1.771 . . . . 0.0 113.942 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 9.66 68.2 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.586 1.565 . . . . 0.0 115.19 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.0 152.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.909 1.283 . . . . 0.0 111.896 -171.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.4 m -85.23 -19.27 31.9 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -168.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.2 mm 53.49 88.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 130.74 3.616 . . . . 0.0 112.73 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -75.07 -32.96 61.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.778 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -160.54 168.79 24.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 0.0 112.714 172.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -93.18 163.43 13.63 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.813 1.645 . . . . 0.0 112.319 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.05 165.42 26.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.607 1.575 . . . . 0.0 112.63 -171.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -64.82 147.22 53.64 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.436 -1.038 . . . . 0.0 111.273 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.73 143.67 36.03 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.579 0.752 . . . . 0.0 111.902 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 123.547 2.831 . . . . 0.0 112.971 -176.592 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.83 161.45 46.04 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.554 2.836 . . . . 0.0 113.366 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.8 -7.0 52.08 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 tt -51.61 127.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.321 1.848 . . . . 0.0 113.458 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -80.75 97.34 7.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -156.69 72.85 4.8 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 123.486 0.714 . . . . 0.0 111.945 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.99 166.98 16.94 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.238 1.959 . . . . 0.0 113.012 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.38 147.77 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 127.091 2.156 . . . . 0.0 110.113 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.05 115.93 26.96 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.54 165.66 46.99 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.069 0.842 . . . . 0.0 114.083 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 t -62.06 -27.45 68.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 113.154 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.95 -24.2 58.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.918 1.287 . . . . 0.0 113.226 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.92 -8.41 39.18 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 126.785 2.136 . . . . 0.0 114.333 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -66.95 160.76 25.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.764 1.626 . . . . 0.0 111.088 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.5 t -109.5 156.5 20.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.706 1.202 . . . . 0.0 112.022 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.28 169.54 17.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.702 2.001 . . . . 0.0 110.272 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.28 81.41 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -159.13 -176.85 6.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.428 1.491 . . . . 0.0 112.461 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 p -58.87 -34.86 72.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.92 -43.22 96.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 112.65 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -38.96 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.704 -0.622 . . . . 0.0 110.255 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -51.36 69.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.951 1.301 . . . . 0.0 112.519 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -61.11 -32.5 72.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -88.19 -19.56 26.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.244 1.417 . . . . 0.0 112.384 -173.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.07 -6.27 32.63 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.926 2.09 . . . . 0.0 114.448 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.16 60.12 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.641 1.115 . . . . 0.0 114.736 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.27 168.14 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.054 2.542 . . . . 0.0 110.622 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -119.38 167.43 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.871 1.268 . . . . 0.0 110.642 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.91 138.15 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.027 1.331 . . . . 0.0 110.462 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -100.94 -31.57 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.846 1.659 . . . . 0.0 113.097 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 164.01 39.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.622 1.169 . . . . 0.0 112.022 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.29 152.11 23.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.66 1.584 . . . . 0.0 112.693 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.46 167.39 28.66 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.938 1.256 . . . . 0.0 112.48 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.8 t -63.67 148.72 48.29 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.718 -0.872 . . . . 0.0 111.387 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.28 145.42 60.0 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 111.402 174.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.539 0.739 0 C-N-CA 122.68 2.254 . . . . 0.0 111.573 176.531 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -81.48 57.9 3.46 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 119.849 -1.782 . . . . 0.0 112.013 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 t -67.03 142.33 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.219 1.407 . . . . 0.0 110.56 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.38 139.22 58.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.533 0.733 . . . . 0.0 112.2 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.99 92.72 1.31 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.572 1.149 . . . . 0.0 111.228 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.5 m -121.61 159.3 51.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 126.661 1.984 . . . . 0.0 111.151 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.8 165.24 28.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.418 2.745 . . . . 0.0 112.919 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -75.79 -8.09 56.01 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -56.02 131.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.55 1.94 . . . . 0.0 111.183 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -84.26 79.01 9.68 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 109.69 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -127.41 63.09 57.39 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 125.376 1.471 . . . . 0.0 110.963 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.86 161.99 33.99 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.859 2.373 . . . . 0.0 112.663 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.84 154.58 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.889 2.075 . . . . 0.0 110.454 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.26 113.78 25.06 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.415 0.686 . . . . 0.0 109.728 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.66 160.38 53.0 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.128 0.394 . . . . 0.0 113.313 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -64.76 -23.3 67.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.59 -19.14 58.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.097 1.359 . . . . 0.0 113.17 171.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.52 -7.92 47.03 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.16 2.315 . . . . 0.0 113.789 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -67.23 156.85 35.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.915 1.686 . . . . 0.0 111.964 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.4 m -113.64 136.28 53.0 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.021 2.128 . . . . 0.0 110.184 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.22 174.21 9.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.181 1.792 . . . . 0.0 111.133 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.67 72.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.391 1.076 . . . . 0.0 113.853 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -162.33 -176.7 5.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.314 1.446 . . . . 0.0 112.764 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -57.02 -39.95 75.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -55.46 -45.92 76.87 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.942 1.297 . . . . 0.0 111.843 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 tp -75.99 -43.0 39.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.212 -0.305 . . . . 0.0 110.479 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.35 -48.85 75.94 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.571 1.148 . . . . 0.0 112.526 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.953 1.701 . . . . 0.0 111.987 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.23 -30.79 67.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.995 0.918 . . . . 0.0 112.331 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -7.29 17.98 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.662 1.585 . . . . 0.0 114.191 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.08 18.92 52.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.813 1.197 . . . . 0.0 114.847 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.67 158.49 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.629 1.572 . . . . 0.0 110.908 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 t -96.52 166.05 11.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 0.0 110.574 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -102.66 142.37 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.215 1.406 . . . . 0.0 110.149 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -97.47 -31.34 12.4 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.347 1.459 . . . . 0.0 111.633 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.2 p -162.37 169.61 20.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.706 1.602 . . . . 0.0 112.474 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.61 160.44 29.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.903 1.281 . . . . 0.0 112.597 168.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.05 166.25 25.16 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.347 1.451 . . . . 0.0 112.811 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 p -64.06 146.7 53.71 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.443 -1.034 . . . . 0.0 111.94 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.14 146.66 40.78 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 122.931 0.492 . . . . 0.0 111.508 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.33 152.23 66.26 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.645 2.23 . . . . 0.0 112.032 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 t -75.14 -13.62 60.48 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.42 72.78 0.89 Allowed Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.309 1.909 . . . . 0.0 112.644 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.687 1.595 . . . . 0.0 113.217 175.868 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 160.86 29.98 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.508 -0.745 . . . . 0.0 111.234 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.68 2.24 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.525 1.53 . . . . 0.0 112.396 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.0 t -147.11 143.92 28.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.486 1.514 . . . . 0.0 111.725 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.76 94.07 3.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.731 1.212 . . . . 0.0 111.67 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.0 m -128.25 159.19 68.52 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.395 1.878 . . . . 0.0 111.556 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.53 166.89 26.56 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.513 2.808 . . . . 0.0 113.386 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -80.28 -6.65 58.26 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.6 133.35 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.455 1.902 . . . . 0.0 111.361 -172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 79.98 8.64 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.33 1.852 . . . . 0.0 110.469 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -129.83 66.88 78.51 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 125.269 1.428 . . . . 0.0 110.907 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.35 162.2 31.4 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.985 2.457 . . . . 0.0 113.065 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -144.83 155.83 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.505 1.922 . . . . 0.0 110.881 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t -94.98 111.09 22.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.916 0.887 . . . . 0.0 111.18 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.51 163.71 51.33 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.053 0.835 . . . . 0.0 114.307 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.4 t -63.62 -25.63 68.31 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.4 -17.12 60.85 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.072 1.349 . . . . 0.0 113.121 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.99 -5.68 63.69 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.872 2.177 . . . . 0.0 113.711 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -68.21 157.53 35.26 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.369 1.868 . . . . 0.0 111.775 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.6 m -113.76 137.94 50.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.48 1.912 . . . . 0.0 110.702 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.34 176.03 8.27 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.124 1.77 . . . . 0.0 111.395 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.3 -51.02 71.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.73 1.212 . . . . 0.0 113.814 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -159.78 -174.95 4.86 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.581 1.553 . . . . 0.0 112.569 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -58.4 -39.69 80.39 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.4 t -57.02 -48.45 78.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.284 1.434 . . . . 0.0 111.237 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 tp -71.12 -43.32 75.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -51.5 68.45 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.532 1.133 . . . . 0.0 112.347 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -61.14 -41.4 96.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.987 1.715 . . . . 0.0 111.835 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.1 t -74.15 -24.06 59.36 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.487 0.715 . . . . 0.0 112.413 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -10.89 59.07 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.903 1.681 . . . . 0.0 113.94 169.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.59 15.4 56.88 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.79 1.186 . . . . 0.0 115.184 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.06 148.65 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.666 1.586 . . . . 0.0 111.675 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -78.71 168.58 19.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.914 0.886 . . . . 0.0 111.231 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.68 134.85 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 110.532 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -69.61 -47.97 61.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.854 1.261 . . . . 0.0 110.768 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 t -165.81 177.67 7.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.225 1.41 . . . . 0.0 112.104 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.45 164.99 24.95 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.841 1.656 . . . . 0.0 113.321 172.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.5 162.4 21.04 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.015 1.769 . . . . 0.0 113.426 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -65.63 135.38 54.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.888 0.875 . . . . 0.0 110.975 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 142.65 64.88 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.817 -0.552 . . . . 0.0 112.097 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.17 137.43 52.0 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.77 2.313 . . . . 0.0 111.162 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.3 m 59.55 13.99 3.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.66 1.584 . . . . 0.0 113.584 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.15 0.1 89.09 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.656 1.598 . . . . 0.0 116.119 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mt . . . . . 0 C--O 1.253 1.264 0 C-N-CA 127.241 2.217 . . . . 0.0 109.937 178.536 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -129.22 106.15 8.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.327 1.851 . . . . 0.0 110.494 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t -105.58 146.83 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.852 1.661 . . . . 0.0 109.83 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 136.89 57.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.663 0.785 . . . . 0.0 112.192 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.4 96.86 1.52 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.192 0.997 . . . . 0.0 110.874 171.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.5 m -124.68 157.49 65.61 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.88 1.672 . . . . 0.0 112.264 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.66 163.9 36.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.694 2.929 . . . . 0.0 114.222 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -75.52 -6.35 49.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.115 2.166 . . . . 0.0 115.317 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -54.35 136.25 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 112.799 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.95 85.29 5.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.926 1.691 . . . . 0.0 110.583 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -140.97 68.09 28.03 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.387 1.075 . . . . 0.0 111.057 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.49 159.93 34.08 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.819 1.679 . . . . 0.0 111.817 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.81 158.12 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.771 2.029 . . . . 0.0 109.961 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -97.1 114.13 25.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.325 0.65 . . . . 0.0 109.618 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.67 163.0 47.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.77 0.7 . . . . 0.0 113.03 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 t -63.36 -19.75 64.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.83 -12.69 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 172.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.18 -4.48 58.73 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.745 2.117 . . . . 0.0 114.32 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -67.11 156.49 36.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.286 1.834 . . . . 0.0 111.615 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.7 m -115.07 132.63 56.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.769 2.028 . . . . 0.0 110.59 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.6 174.81 6.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.246 1.819 . . . . 0.0 111.418 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -49.63 76.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.384 1.074 . . . . 0.0 113.564 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -162.06 -175.97 4.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 113.896 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -62.64 -37.85 87.97 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.01 -46.05 85.89 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.793 1.237 . . . . 0.0 111.823 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.26 -46.53 65.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.34 -46.0 80.13 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.143 0.977 . . . . 0.0 113.023 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.45 -28.64 65.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.656 1.982 . . . . 0.0 114.019 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.8 t -97.72 -24.71 15.36 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.355 1.462 . . . . 0.0 111.926 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -69.54 -11.8 61.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.476 1.91 . . . . 0.0 113.503 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.99 56.03 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.433 1.016 . . . . 0.0 114.782 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.41 151.49 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.992 1.317 . . . . 0.0 110.879 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.14 138.3 31.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 108.955 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.88 137.67 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.976 0.807 . . . . 0.0 109.53 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -96.98 -34.1 11.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 112.433 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -157.27 168.33 27.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.07 0.948 . . . . 0.0 112.682 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.25 149.27 25.6 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.403 1.881 . . . . 0.0 111.675 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.56 161.85 28.36 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.908 1.242 . . . . 0.0 112.28 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -63.59 149.89 45.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.574 -0.957 . . . . 0.0 112.236 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.98 149.44 50.46 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.132 0.573 . . . . 0.0 112.17 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.5 162.6 39.65 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.395 2.73 . . . . 0.0 112.566 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 p -93.21 68.53 4.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.146 1.378 . . . . 0.0 111.959 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.65 124.79 1.69 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.335 1.445 . . . . 0.0 112.74 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.783 2.033 . . . . 0.0 112.032 174.512 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 119.788 -0.149 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.29 -178.66 6.26 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.797 1.639 . . . . 0.0 112.273 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.27 154.44 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.354 1.462 . . . . 0.0 112.011 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.1 m -72.03 93.28 1.37 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.928 1.691 . . . . 0.0 111.37 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.03 97.75 1.51 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.384 1.074 . . . . 0.0 111.307 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m -122.39 157.81 57.74 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.958 1.703 . . . . 0.0 112.423 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.27 167.86 24.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.023 3.149 . . . . 0.0 114.335 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.08 -9.85 58.95 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 pt -58.1 114.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.418 1.887 . . . . 0.0 113.813 -171.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.98 85.66 0.52 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 110.848 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.74 72.6 55.7 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 125.91 1.684 . . . . 0.0 109.888 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.79 160.64 35.94 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.189 1.926 . . . . 0.0 112.085 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.19 157.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.857 2.063 . . . . 0.0 110.48 -170.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.71 114.04 27.94 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.605 0.762 . . . . 0.0 111.693 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.29 163.08 51.44 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.88 1.229 . . . . 0.0 114.406 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 t -61.89 -28.55 69.59 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.216 . . . . 0.0 113.551 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.39 -10.79 59.83 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.285 1.034 . . . . 0.0 113.313 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.05 -5.51 61.43 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.84 2.162 . . . . 0.0 113.884 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -70.3 157.03 38.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.429 1.892 . . . . 0.0 111.798 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 m -115.17 137.59 51.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.039 2.136 . . . . 0.0 110.525 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 173.04 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.984 1.714 . . . . 0.0 111.439 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.15 86.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.546 1.138 . . . . 0.0 114.018 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -160.12 -174.7 4.67 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.801 1.64 . . . . 0.0 112.494 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.2 p -59.98 -41.39 91.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.79 -47.42 80.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.3 1.44 . . . . 0.0 111.405 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 tp -71.93 -43.71 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.56 76.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 112.27 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -59.82 -41.79 92.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.895 1.678 . . . . 0.0 111.952 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.4 t -74.25 -25.09 59.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.947 0.899 . . . . 0.0 112.504 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -11.07 59.8 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.044 1.738 . . . . 0.0 114.179 172.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.14 44.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.694 1.14 . . . . 0.0 115.105 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.5 154.6 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.04 1.736 . . . . 0.0 111.133 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -98.77 144.59 27.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.386 1.074 . . . . 0.0 109.444 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 pt -91.82 134.91 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.651 0.659 . . . . 0.0 111.025 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.08 -34.98 22.12 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 112.227 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -160.62 173.65 15.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.496 1.118 . . . . 0.0 112.458 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.68 161.44 23.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.058 1.743 . . . . 0.0 112.839 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.81 156.97 15.08 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.325 1.441 . . . . 0.0 112.262 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -64.01 142.32 58.45 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.607 -0.937 . . . . 0.0 111.5 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.12 150.66 71.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.63 151.15 57.99 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.096 2.531 . . . . 0.0 112.079 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 m -78.36 -10.81 59.83 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.093 1.357 . . . . 0.0 113.166 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.55 149.59 5.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 128.058 2.742 . . . . 0.0 110.997 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.596 1.558 . . . . 0.0 112.569 -177.146 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.6 pttm . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -76.12 102.1 5.59 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 121.39 1.905 . . . . 0.0 112.662 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.1 t -89.37 147.08 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.88 1.672 . . . . 0.0 110.999 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 137.97 56.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.279 1.032 . . . . 0.0 112.713 173.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.39 97.92 2.62 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.458 1.103 . . . . 0.0 111.416 170.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m -124.01 157.77 62.55 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.414 1.886 . . . . 0.0 111.732 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.88 163.88 34.62 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.745 2.963 . . . . 0.0 113.596 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.05 -8.52 57.58 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -53.36 111.84 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.59 1.956 . . . . 0.0 113.285 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.97 84.3 0.97 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.712 1.605 . . . . 0.0 111.332 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -141.45 74.05 24.26 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.205 1.402 . . . . 0.0 109.748 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.98 165.38 21.66 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.82 2.347 . . . . 0.0 112.84 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -145.6 153.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -98.19 113.0 24.77 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.009 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.59 164.82 37.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.403 1.002 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -60.61 -29.71 69.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.41 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -79.01 -13.5 59.75 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.847 1.259 . . . . 0.0 113.488 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.51 -3.17 59.3 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 126.281 1.896 . . . . 0.0 114.049 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -66.16 156.28 34.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.722 1.609 . . . . 0.0 111.464 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 m -114.0 138.4 50.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.54 1.936 . . . . 0.0 110.111 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.89 174.1 9.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.691 1.596 . . . . 0.0 111.25 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.43 -49.03 77.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 113.443 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -159.7 -174.29 4.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.462 1.505 . . . . 0.0 113.206 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.7 p -61.17 -38.0 84.94 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.04 -46.09 85.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.19 1.396 . . . . 0.0 111.79 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.64 -41.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 O-C-N 122.066 -0.397 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.36 -47.77 82.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.731 1.212 . . . . 0.0 112.405 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -59.06 -42.51 90.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 111.82 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.6 -27.87 61.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.917 0.887 . . . . 0.0 112.598 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -7.33 22.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.724 1.61 . . . . 0.0 114.113 175.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 18.84 48.99 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.875 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.3 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.779 1.631 . . . . 0.0 111.093 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.3 p -82.74 168.32 17.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.586 0.754 . . . . 0.0 111.488 168.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.58 137.49 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.102 1.361 . . . . 0.0 110.064 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -92.54 -33.55 14.41 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.698 1.199 . . . . 0.0 112.039 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 m -150.93 162.41 40.86 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.708 1.603 . . . . 0.0 112.26 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.87 162.91 27.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.43 1.092 . . . . 0.0 112.329 165.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 167.63 31.21 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.313 1.435 . . . . 0.0 113.002 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 p -66.13 149.09 50.83 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.51 -0.994 . . . . 0.0 111.562 169.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 145.17 32.04 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.002 0.521 . . . . 0.0 112.194 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.85 157.06 52.21 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.916 2.411 . . . . 0.0 112.359 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.8 p -83.02 -5.84 59.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.313 1.445 . . . . 0.0 114.491 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.77 86.43 0.1 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.301 1.429 . . . . 0.0 112.171 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.985 1.714 . . . . 0.0 113.289 175.718 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . 0.272 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -71.5 112.53 7.7 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.159 1.783 . . . . 0.0 111.166 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.85 151.64 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.73 1.212 . . . . 0.0 112.162 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.8 m -71.92 121.53 19.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.763 0.825 . . . . 0.0 111.677 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.08 99.84 0.54 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.867 1.267 . . . . 0.0 111.294 172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.9 m -124.26 159.04 58.96 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.605 1.962 . . . . 0.0 110.979 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.12 164.09 29.85 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.341 2.694 . . . . 0.0 112.962 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -81.22 -5.78 58.13 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.01 131.2 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.222 1.809 . . . . 0.0 110.749 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.15 78.4 8.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.158 1.783 . . . . 0.0 110.318 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -130.06 69.64 81.88 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.899 1.28 . . . . 0.0 109.667 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.19 161.74 38.98 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.15 1.9 . . . . 0.0 112.44 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.7 157.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 127.007 2.123 . . . . 0.0 110.627 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -102.53 114.81 29.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.783 0.833 . . . . 0.0 111.674 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 162.33 54.6 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.15 0.881 . . . . 0.0 113.943 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -61.74 -26.05 67.82 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.4 1.48 . . . . 0.0 114.228 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.1 -19.44 54.15 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.67 1.188 . . . . 0.0 112.989 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.16 -7.15 32.61 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 127.381 2.419 . . . . 0.0 114.166 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -74.38 158.01 34.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.61 1.564 . . . . 0.0 112.199 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.3 m -114.74 125.85 54.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.658 2.383 . . . . 0.0 110.653 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.17 174.6 6.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.884 1.674 . . . . 0.0 111.65 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.46 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.455 1.102 . . . . 0.0 113.751 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -163.18 -175.92 4.55 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.658 1.983 . . . . 0.0 112.665 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -57.87 -39.28 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.77 -46.7 81.31 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.062 1.345 . . . . 0.0 111.829 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -75.06 -41.6 45.29 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 O-C-N 122.225 -0.297 . . . . 0.0 110.284 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.87 78.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.445 1.098 . . . . 0.0 112.234 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -59.42 -39.92 85.03 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.032 1.733 . . . . 0.0 112.436 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.9 -34.63 73.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -8.92 17.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.889 1.676 . . . . 0.0 114.545 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.84 50.58 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.975 1.274 . . . . 0.0 114.814 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.04 156.65 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.912 2.085 . . . . 0.0 110.823 -172.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -106.96 139.02 42.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 109.606 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.0 pt -85.56 136.02 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.753 -0.592 . . . . 0.0 111.175 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -90.74 -31.66 16.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.818 1.247 . . . . 0.0 112.537 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 m -158.85 164.55 35.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.886 1.675 . . . . 0.0 111.928 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -80.45 160.64 25.24 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 111.811 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.2 159.88 23.71 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.205 1.383 . . . . 0.0 112.425 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -63.58 143.0 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.59 -0.947 . . . . 0.0 111.598 171.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 149.09 61.51 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 122.05 -0.406 . . . . 0.0 111.89 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.1 155.88 60.65 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.049 2.499 . . . . 0.0 112.104 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.01 -1.61 39.34 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.868 1.267 . . . . 0.0 113.325 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.14 92.2 1.72 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.409 1.481 . . . . 0.0 111.718 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.383 1.873 . . . . 0.0 110.675 -175.065 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -135.13 159.05 42.76 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.94 1.696 . . . . 0.0 112.378 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.1 -6.08 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 125.81 1.644 . . . . 0.0 112.288 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.7 m -85.43 101.52 12.68 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.351 2.26 . . . . 0.0 110.768 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.16 101.65 0.56 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.323 1.049 . . . . 0.0 111.685 175.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.4 m -129.75 157.84 75.44 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.401 1.88 . . . . 0.0 111.774 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.4 161.44 45.56 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.575 2.85 . . . . 0.0 113.446 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -74.82 -8.3 56.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.837 1.655 . . . . 0.0 114.73 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -49.47 128.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.683 1.993 . . . . 0.0 113.378 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.8 mt -84.85 77.19 10.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 110.178 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -142.4 73.42 20.87 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 124.151 0.98 . . . . 0.0 110.69 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.23 164.19 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.12 1.88 . . . . 0.0 112.551 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.15 169.17 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.932 2.093 . . . . 0.0 110.383 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -113.7 110.07 19.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.415 0.686 . . . . 0.0 110.577 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.45 155.14 52.9 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.927 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -57.4 -23.37 48.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.802 1.641 . . . . 0.0 114.44 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.32 -24.3 64.82 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.314 1.446 . . . . 0.0 113.086 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.15 -8.03 35.55 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 127.502 2.477 . . . . 0.0 114.01 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -78.68 158.75 28.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.535 1.934 . . . . 0.0 111.458 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.4 t -116.84 149.57 39.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.662 1.585 . . . . 0.0 112.699 172.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.86 177.19 8.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.974 2.11 . . . . 0.0 110.814 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -158.77 -177.35 6.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.939 1.696 . . . . 0.0 112.712 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 p -58.13 -36.51 73.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.7 t -63.29 -42.56 99.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.721 1.608 . . . . 0.0 112.248 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.88 -44.87 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.675 -0.641 . . . . 0.0 110.106 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.44 98.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.784 1.234 . . . . 0.0 113.215 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.37 -42.28 98.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.419 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.8 t -76.11 -21.29 56.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.845 1.258 . . . . 0.0 112.412 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -10.04 39.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.84 2.056 . . . . 0.0 113.901 165.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.12 15.03 37.2 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.178 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.43 148.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.847 1.324 . . . . 0.0 111.865 -173.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 132.42 40.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.181 1.793 . . . . 0.0 111.1 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.43 109.62 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.036 0.935 . . . . 0.0 109.999 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -91.72 -35.99 13.84 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.943 0.897 . . . . 0.0 113.062 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -159.94 168.25 26.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.571 1.149 . . . . 0.0 112.276 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.82 163.88 12.02 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.18 1.392 . . . . 0.0 113.645 177.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 160.48 23.08 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.481 1.515 . . . . 0.0 112.11 -168.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.0 m -62.61 135.38 57.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.997 -0.708 . . . . 0.0 110.685 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 146.92 98.7 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 121.961 -0.462 . . . . 0.0 111.212 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 103.89 1.27 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.75 2.966 . . . . 0.0 112.217 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.3 p -75.12 63.91 1.34 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.259 1.823 . . . . 0.0 112.984 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.69 4.63 5.11 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.274 1.892 . . . . 0.0 115.176 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.1 mm . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.494 1.918 . . . . 0.0 111.752 179.483 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.681 0.277 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.46 170.19 21.98 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.27 1.828 . . . . 0.0 111.664 170.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.81 5.27 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 125.737 1.615 . . . . 0.0 112.624 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -133.11 132.45 41.72 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.185 1.794 . . . . 0.0 112.158 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.41 96.92 1.96 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.041 1.336 . . . . 0.0 110.901 170.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.2 m -122.08 155.99 60.45 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.834 1.654 . . . . 0.0 111.106 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.24 155.12 56.58 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.264 2.643 . . . . 0.0 112.272 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -77.72 -6.48 54.09 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.3 tp -45.74 125.46 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.968 2.107 . . . . 0.0 113.459 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -76.9 83.87 3.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.288 1.835 . . . . 0.0 109.814 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -145.5 65.36 11.38 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 111.834 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.43 161.45 34.76 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.232 2.621 . . . . 0.0 112.437 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 157.42 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.716 2.006 . . . . 0.0 111.024 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -91.18 117.19 29.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.146 0.979 . . . . 0.0 110.32 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.5 166.03 42.95 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.437 1.018 . . . . 0.0 114.348 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -56.41 -26.82 54.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 114.412 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.4 -4.68 37.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.733 1.613 . . . . 0.0 113.771 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.19 62.4 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.741 1.638 . . . . 0.0 114.489 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.24 159.04 18.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.926 1.69 . . . . 0.0 111.179 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -124.43 122.35 37.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.687 1.995 . . . . 0.0 110.252 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.97 175.02 5.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.134 1.774 . . . . 0.0 111.196 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.52 87.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -157.23 -175.53 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.9 m -77.84 8.75 4.18 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -104.8 -46.42 4.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.652 1.581 . . . . 0.0 110.714 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.4 -41.06 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.826 0.851 . . . . 0.0 110.233 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.76 72.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.876 1.27 . . . . 0.0 111.495 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.263 1.825 . . . . 0.0 112.561 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.85 -32.77 65.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.507 0.723 . . . . 0.0 112.319 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -10.57 35.04 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.472 1.509 . . . . 0.0 114.206 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 13.71 57.53 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.039 1.304 . . . . 0.0 114.951 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.27 132.52 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.808 2.043 . . . . 0.0 110.626 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 p -75.48 164.57 26.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.727 0.811 . . . . 0.0 111.623 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 pp -102.79 135.48 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.402 1.081 . . . . 0.0 109.381 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -89.17 -35.63 16.13 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.312 1.445 . . . . 0.0 112.488 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -160.12 170.12 21.89 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 112.715 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.06 153.35 32.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.67 1.588 . . . . 0.0 112.904 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.18 156.89 13.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.996 1.284 . . . . 0.0 112.837 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -58.23 136.55 57.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.941 0.897 . . . . 0.0 111.108 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 147.67 82.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 121.837 -0.539 . . . . 0.0 111.29 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.46 146.08 54.89 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.766 2.311 . . . . 0.0 111.994 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.8 p -78.41 -5.81 53.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.261 1.424 . . . . 0.0 114.048 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.84 -18.74 0.49 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.885 1.707 . . . . 0.0 114.767 174.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 tt . . . . . 0 C--O 1.254 1.3 0 C-N-CA 126.924 2.09 . . . . 0.0 112.201 176.46 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 119.505 -0.283 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 47.24 44.59 15.94 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.54 1.936 . . . . 0.0 113.645 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -64.9 137.08 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.377 1.471 . . . . 0.0 110.62 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 32.2 m -79.67 149.36 31.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.016 0.926 . . . . 0.0 111.799 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.31 96.13 1.4 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.405 1.082 . . . . 0.0 111.82 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.8 m -128.04 159.53 66.32 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.674 1.99 . . . . 0.0 111.471 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -80.02 167.5 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.481 2.787 . . . . 0.0 113.488 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -79.63 -7.3 58.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.575 1.55 . . . . 0.0 114.958 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.4 128.42 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 111.261 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.2 mt -80.33 77.97 7.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.484 1.913 . . . . 0.0 110.268 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -133.7 69.19 76.17 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.704 1.202 . . . . 0.0 109.624 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.99 162.89 30.58 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.893 1.729 . . . . 0.0 112.644 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.44 145.13 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.59 1.956 . . . . 0.0 110.037 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -89.67 118.58 29.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.432 0.693 . . . . 0.0 110.803 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.89 161.91 52.56 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.139 0.876 . . . . 0.0 114.326 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.3 t -59.59 -29.67 68.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.811 1.244 . . . . 0.0 113.664 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -74.9 -20.08 59.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.489 1.116 . . . . 0.0 113.013 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.94 -8.75 31.66 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 126.741 2.115 . . . . 0.0 114.238 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -73.39 161.31 30.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.865 1.666 . . . . 0.0 111.505 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 t -110.52 151.75 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.168 1.387 . . . . 0.0 111.838 165.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.34 175.33 9.37 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.203 1.801 . . . . 0.0 111.167 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.38 69.51 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.535 1.134 . . . . 0.0 114.041 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -160.93 -175.39 4.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.276 1.83 . . . . 0.0 112.753 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -57.86 -40.97 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.89 -47.34 77.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.061 1.344 . . . . 0.0 111.869 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.35 -43.95 63.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.21 -49.24 76.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.474 1.11 . . . . 0.0 112.253 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.3 -42.96 87.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.884 1.674 . . . . 0.0 112.2 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.2 t -73.53 -27.54 61.41 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.071 0.549 . . . . 0.0 112.425 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -11.52 60.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.971 1.708 . . . . 0.0 114.114 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 17.33 57.66 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.545 1.069 . . . . 0.0 115.238 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.44 149.01 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.962 1.705 . . . . 0.0 111.38 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -77.12 156.02 31.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.411 0.684 . . . . 0.0 110.598 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.33 126.76 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.257 1.023 . . . . 0.0 109.681 170.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -91.16 -30.06 16.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.278 1.831 . . . . 0.0 112.201 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -162.01 173.37 14.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.515 1.926 . . . . 0.0 111.124 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -84.35 164.02 19.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 0.0 113.233 172.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.95 166.69 25.77 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.509 1.528 . . . . 0.0 112.69 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -67.39 137.61 56.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.645 -0.915 . . . . 0.0 110.83 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 147.84 91.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 122.052 -0.405 . . . . 0.0 111.777 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.92 160.84 45.09 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.175 2.583 . . . . 0.0 112.438 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 t -73.65 -14.92 61.25 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.78 79.48 0.14 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.793 1.664 . . . . 0.0 112.52 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.775 1.63 . . . . 0.0 111.683 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.238 0.066 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -110.33 168.45 9.44 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.146 1.779 . . . . 0.0 111.673 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.77 0.05 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 125.571 1.548 . . . . 0.0 112.259 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.15 145.72 29.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.724 1.61 . . . . 0.0 111.419 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.97 95.3 5.44 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.528 1.131 . . . . 0.0 111.175 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.59 157.35 73.38 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 125.862 1.665 . . . . 0.0 112.055 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.32 162.52 41.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.731 2.954 . . . . 0.0 113.732 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -77.46 -5.42 49.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.474 1.91 . . . . 0.0 114.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -50.7 131.45 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.227 1.811 . . . . 0.0 112.893 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.59 71.36 7.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.126 1.77 . . . . 0.0 110.47 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.04 68.69 80.43 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.005 1.322 . . . . 0.0 111.084 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.02 161.18 34.36 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.383 2.056 . . . . 0.0 112.756 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.12 152.91 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.11 2.164 . . . . 0.0 110.323 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.08 116.39 30.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.568 0.747 . . . . 0.0 111.152 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.56 164.6 50.82 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.711 1.148 . . . . 0.0 114.284 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t -57.42 -30.8 65.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.831 1.252 . . . . 0.0 113.373 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.76 -12.29 59.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.116 1.366 . . . . 0.0 113.936 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.79 -2.23 61.98 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 126.028 1.775 . . . . 0.0 114.215 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -68.46 157.83 35.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.928 1.691 . . . . 0.0 110.957 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.8 m -112.32 141.42 46.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.104 1.761 . . . . 0.0 110.695 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.98 172.16 12.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.131 1.772 . . . . 0.0 110.961 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -160.14 -175.2 4.94 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.444 1.897 . . . . 0.0 112.42 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.5 p -59.65 -38.65 82.01 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.8 t -57.68 -47.51 82.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 111.587 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.37 -42.06 65.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 O-C-N 122.131 -0.356 . . . . 0.0 110.153 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.57 72.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.106 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -59.26 -41.36 88.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.479 1.512 . . . . 0.0 111.956 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.78 -24.76 58.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.746 0.818 . . . . 0.0 112.497 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -10.58 58.33 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.054 1.742 . . . . 0.0 114.089 170.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.78 15.33 59.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.646 1.117 . . . . 0.0 115.088 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.56 151.23 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.157 1.783 . . . . 0.0 111.182 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 m -84.69 157.09 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.624 0.77 . . . . 0.0 110.038 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.51 140.09 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.556 0.742 . . . . 0.0 110.31 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -92.39 -31.07 15.46 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.659 1.184 . . . . 0.0 111.48 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 99.2 p -160.32 169.02 24.01 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.537 1.535 . . . . 0.0 112.421 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.37 164.38 21.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.338 1.055 . . . . 0.0 112.762 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.23 164.2 29.79 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.504 1.526 . . . . 0.0 112.705 -173.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 t -65.5 146.73 54.49 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.57 -0.959 . . . . 0.0 111.024 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.42 146.54 37.91 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.45 154.99 64.58 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.537 . . . . 0.0 111.856 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.5 m -121.29 -4.83 9.42 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.625 1.17 . . . . 0.0 112.997 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.87 61.23 0.02 OUTLIER Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.588 1.09 . . . . 0.0 113.613 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.349 0 C-N-CA 125.419 1.487 . . . . 0.0 111.443 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.93 126.07 21.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.806 1.642 . . . . 0.0 110.903 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 t -140.44 141.4 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.947 1.699 . . . . 0.0 109.92 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.5 m -78.3 148.12 33.97 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.714 0.806 . . . . 0.0 112.015 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.27 100.7 1.75 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.336 1.055 . . . . 0.0 111.235 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -129.34 158.33 73.46 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.23 1.812 . . . . 0.0 111.788 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 165.55 31.26 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.65 2.9 . . . . 0.0 113.695 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -77.51 -8.26 57.51 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 pt -57.33 113.23 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.358 1.863 . . . . 0.0 113.006 -173.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.67 84.61 0.89 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.586 1.554 . . . . 0.0 111.018 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -142.93 75.67 17.51 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.364 1.465 . . . . 0.0 109.422 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.34 165.19 20.59 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.858 2.372 . . . . 0.0 112.8 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.56 159.79 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.482 1.913 . . . . 0.0 110.058 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.0 t -105.99 119.51 39.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.671 . . . . 0.0 111.944 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.01 164.95 53.96 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.732 1.158 . . . . 0.0 114.143 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -59.29 -26.8 65.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.39 1.476 . . . . 0.0 113.534 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -73.38 -17.05 61.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.158 1.383 . . . . 0.0 113.294 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.5 -2.0 67.13 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.238 1.875 . . . . 0.0 113.785 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -70.04 156.38 39.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 111.22 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.1 m -114.84 138.04 51.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.581 1.952 . . . . 0.0 110.621 172.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.04 173.1 10.75 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.726 1.61 . . . . 0.0 111.236 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.85 85.44 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.395 1.078 . . . . 0.0 113.343 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.426 ' H ' HG23 ' A' ' 26' ' ' ILE . 43.8 p-10 -159.32 -176.36 5.76 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.019 1.328 . . . . 0.0 113.548 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -58.66 -38.6 78.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -60.31 -44.8 95.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.368 1.067 . . . . 0.0 112.63 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.426 HG23 ' H ' ' A' ' 23' ' ' ASN . 4.8 tt -73.53 -39.17 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.13 75.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.631 1.172 . . . . 0.0 112.458 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -63.9 -34.76 78.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.495 1.118 . . . . 0.0 113.414 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.3 t -85.05 -21.35 29.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.727 1.211 . . . . 0.0 111.982 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -67.12 -7.26 21.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.799 1.639 . . . . 0.0 113.775 162.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 21.16 53.53 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.392 0.996 . . . . 0.0 114.874 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 143.01 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.049 1.34 . . . . 0.0 111.28 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.34 135.49 34.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.762 0.825 . . . . 0.0 110.248 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.7 pt -81.26 138.01 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.74 0.7 . . . . 0.0 111.053 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -94.17 -31.47 14.13 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.293 1.437 . . . . 0.0 112.69 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -160.52 174.17 14.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.956 1.302 . . . . 0.0 112.078 174.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.09 161.64 16.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.921 1.688 . . . . 0.0 111.865 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.41 166.97 24.34 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.613 1.577 . . . . 0.0 113.241 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 m -65.63 137.38 57.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.187 0.595 . . . . 0.0 110.545 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 145.23 83.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.364 0.666 . . . . 0.0 111.817 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.27 119.85 6.57 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.239 3.292 . . . . 0.0 111.738 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 m -65.41 -17.82 64.83 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.641 1.577 . . . . 0.0 113.987 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.6 68.72 0.25 Allowed Glycine 0 N--CA 1.471 0.99 0 C-N-CA 125.519 1.533 . . . . 0.0 112.364 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt . . . . . 0 C--O 1.256 1.401 0 C-N-CA 126.022 1.729 . . . . 0.0 113.174 176.453 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.61 143.83 41.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.474 1.51 . . . . 0.0 111.785 173.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.85 169.71 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.061 1.744 . . . . 0.0 111.989 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.47 133.93 56.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.386 0.674 . . . . 0.0 111.975 172.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.34 97.69 0.99 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.628 1.171 . . . . 0.0 111.081 174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.9 m -125.05 157.83 65.48 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.992 1.717 . . . . 0.0 111.908 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 164.12 32.52 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.748 2.966 . . . . 0.0 113.875 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -76.97 -10.27 59.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.386 1.874 . . . . 0.0 115.37 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 pt -51.55 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.297 2.239 . . . . 0.0 113.107 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.27 90.61 0.5 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.279 1.832 . . . . 0.0 111.124 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.49 68.2 16.85 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.837 1.255 . . . . 0.0 111.049 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -63.62 159.07 42.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.285 1.99 . . . . 0.0 112.284 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.59 158.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.159 2.183 . . . . 0.0 110.463 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.17 115.25 29.4 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.602 0.761 . . . . 0.0 110.957 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.38 160.09 53.98 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.494 0.569 . . . . 0.0 113.737 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.3 m -59.9 -24.15 64.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.23 -14.38 59.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.938 1.295 . . . . 0.0 113.197 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.24 -4.66 55.25 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.005 2.241 . . . . 0.0 114.154 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -75.26 157.45 34.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.462 1.905 . . . . 0.0 111.87 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.1 m -111.66 138.04 48.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.006 2.123 . . . . 0.0 110.566 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.33 174.57 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.886 1.674 . . . . 0.0 111.7 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.78 80.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.73 1.212 . . . . 0.0 113.662 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -160.82 -174.98 4.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.194 1.398 . . . . 0.0 112.935 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.1 p -59.57 -40.04 86.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.0 t -57.28 -46.24 83.3 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.029 1.331 . . . . 0.0 111.654 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -73.64 -42.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 O-C-N 122.155 -0.34 . . . . 0.0 110.18 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.5 74.96 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.545 1.138 . . . . 0.0 112.384 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -58.55 -39.72 81.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.019 1.728 . . . . 0.0 112.433 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.4 t -74.8 -29.27 61.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.797 0.839 . . . . 0.0 112.688 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -9.38 36.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.698 1.599 . . . . 0.0 114.38 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.56 19.53 51.67 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.643 1.116 . . . . 0.0 114.805 175.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.41 147.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.188 1.795 . . . . 0.0 110.358 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 m -80.67 163.04 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.982 -0.449 . . . . 0.0 110.164 172.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.87 131.59 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 109.371 171.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -89.56 -32.61 17.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.042 0.937 . . . . 0.0 112.093 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -159.62 171.24 19.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.159 1.384 . . . . 0.0 112.229 172.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.73 160.28 24.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.269 1.828 . . . . 0.0 112.936 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 159.16 15.97 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.143 1.354 . . . . 0.0 112.251 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.9 p -62.65 143.74 57.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.521 -0.988 . . . . 0.0 111.808 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.33 146.17 57.31 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.001 -0.437 . . . . 0.0 111.606 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.64 146.46 49.05 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.787 2.325 . . . . 0.0 111.962 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.1 p -96.5 -0.58 48.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.707 1.603 . . . . 0.0 114.192 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.4 -54.69 0.03 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.175 0.893 . . . . 0.0 114.701 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 tt . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.982 1.713 . . . . 0.0 113.919 -179.621 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -140.59 152.44 45.47 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.443 1.497 . . . . 0.0 110.065 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -131.28 143.42 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.831 1.652 . . . . 0.0 109.235 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 m -68.08 137.65 55.15 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.305 0.642 . . . . 0.0 111.637 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.5 96.08 0.88 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.404 1.082 . . . . 0.0 111.652 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m -124.8 159.98 56.0 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.797 2.039 . . . . 0.0 111.155 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.1 165.78 30.45 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 114.197 -174.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -75.25 -8.77 57.52 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.561 1.944 . . . . 0.0 115.742 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.4 153.97 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.923 2.089 . . . . 0.0 112.675 -172.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.37 81.89 1.62 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.143 1.377 . . . . 0.0 110.579 -170.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -139.63 73.42 35.06 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.36 1.464 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.1 162.99 24.16 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.988 1.792 . . . . 0.0 112.591 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.07 152.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.588 1.955 . . . . 0.0 109.962 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.6 t -103.03 122.18 44.1 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.804 0.842 . . . . 0.0 110.761 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.93 166.54 54.43 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.502 1.049 . . . . 0.0 113.536 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 p -59.47 -22.67 61.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.42 -23.93 42.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.032 1.333 . . . . 0.0 113.395 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.49 -5.17 33.13 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.481 1.991 . . . . 0.0 114.325 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -74.66 157.24 35.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.507 1.523 . . . . 0.0 111.643 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.6 m -113.26 136.73 52.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.904 1.682 . . . . 0.0 112.115 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.68 171.78 10.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.78 1.632 . . . . 0.0 111.707 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.35 93.12 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -157.81 -175.45 5.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.636 1.574 . . . . 0.0 112.559 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.0 p -59.37 -43.22 92.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.005 0.922 . . . . 0.0 113.423 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.2 t -55.12 -46.73 75.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.619 1.567 . . . . 0.0 111.569 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -72.97 -44.13 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.5 80.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.217 1.007 . . . . 0.0 112.033 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -60.03 -40.67 90.14 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.824 1.65 . . . . 0.0 112.199 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.0 t -72.4 -28.38 62.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.088 0.555 . . . . 0.0 112.386 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -9.51 41.02 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.128 1.771 . . . . 0.0 114.103 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 16.83 52.4 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.625 1.107 . . . . 0.0 114.752 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.52 156.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.464 1.906 . . . . 0.0 111.257 -174.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -92.62 155.99 17.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.941 0.896 . . . . 0.0 109.935 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.98 130.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -85.52 -35.38 21.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.749 1.22 . . . . 0.0 112.343 173.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -156.12 169.47 24.42 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 0.0 112.374 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.47 160.03 22.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.15 1.78 . . . . 0.0 112.64 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.75 170.31 28.7 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.039 1.304 . . . . 0.0 112.933 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.8 m -67.42 138.05 56.38 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.772 -0.84 . . . . 0.0 111.024 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 152.14 92.5 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.889 -0.507 . . . . 0.0 112.038 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.2 170.69 19.24 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.619 2.879 . . . . 0.0 112.619 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.7 m -110.68 -1.08 16.9 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.847 1.259 . . . . 0.0 113.012 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.35 -76.9 1.32 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.978 1.275 . . . . 0.0 113.294 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.335 0 C-N-CA 125.969 1.708 . . . . 0.0 112.324 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.4 mttm . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.766 0.317 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -87.6 153.51 21.33 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 120.83 -1.169 . . . . 0.0 110.057 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.66 145.65 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.858 1.263 . . . . 0.0 109.174 170.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.5 t -66.35 142.13 57.73 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.628 0.771 . . . . 0.0 111.988 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.43 85.92 2.01 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.524 1.13 . . . . 0.0 112.123 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m -128.2 159.67 65.94 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 127.138 2.175 . . . . 0.0 111.233 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.74 160.85 30.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.9 2.4 . . . . 0.0 113.614 -173.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -75.07 -9.54 58.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.525 1.93 . . . . 0.0 114.409 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mt -60.11 131.84 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.347 1.859 . . . . 0.0 111.09 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 63.89 5.34 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.498 2.319 . . . . 0.0 112.022 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -122.91 71.24 41.39 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.347 1.459 . . . . 0.0 110.222 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.03 164.66 24.15 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.723 2.282 . . . . 0.0 112.6 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -145.4 151.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.714 2.006 . . . . 0.0 110.39 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.6 t -92.42 117.14 29.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.443 0.697 . . . . 0.0 110.389 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.5 166.0 39.33 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.657 1.122 . . . . 0.0 114.566 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -57.96 -33.87 69.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.571 1.148 . . . . 0.0 112.878 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.09 -19.12 57.45 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.095 1.358 . . . . 0.0 113.441 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.2 55.27 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 126.545 2.022 . . . . 0.0 114.171 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -68.23 160.09 29.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.011 1.724 . . . . 0.0 111.525 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.1 m -116.97 138.88 51.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.201 1.801 . . . . 0.0 111.415 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.25 176.3 8.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.4 1.88 . . . . 0.0 111.651 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.11 61.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.904 1.281 . . . . 0.0 114.359 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -162.72 178.14 8.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.206 1.802 . . . . 0.0 112.689 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.9 p -68.5 27.4 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.491 2.316 . . . . 0.0 117.032 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.8 t -119.85 -45.04 2.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.649 2.379 . . . . 0.0 110.394 174.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.06 -40.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 O-C-N 121.783 -0.573 . . . . 0.0 110.212 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.05 -53.21 59.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.93 1.292 . . . . 0.0 111.202 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -58.63 -36.62 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.958 1.303 . . . . 0.0 112.872 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 t -77.55 -29.54 52.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.754 0.822 . . . . 0.0 112.17 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -21.52 62.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.96 1.704 . . . . 0.0 113.56 167.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.45 10.61 33.15 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.563 1.554 . . . . 0.0 115.351 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.286 1.835 . . . . 0.0 110.798 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p -81.09 170.63 15.95 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.776 0.83 . . . . 0.0 111.027 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.99 149.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.798 1.239 . . . . 0.0 110.715 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -110.19 -26.89 9.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.401 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -161.89 170.28 19.72 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.597 1.159 . . . . 0.0 112.938 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.41 155.62 36.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.412 1.885 . . . . 0.0 111.97 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.16 164.92 28.7 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.575 1.56 . . . . 0.0 113.529 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 m -63.2 136.23 57.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.717 -0.872 . . . . 0.0 110.971 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.88 148.52 82.04 Favored Pre-proline 0 CA--C 1.548 0.903 0 O-C-N 121.82 -0.55 . . . . 0.0 111.9 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.71 162.24 41.74 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.094 2.529 . . . . 0.0 112.248 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.9 m -68.86 -18.52 64.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.011 1.324 . . . . 0.0 113.652 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.38 103.36 0.19 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.373 1.94 . . . . 0.0 111.73 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.254 1.33 0 C-N-CA 125.847 1.659 . . . . 0.0 113.166 176.856 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.747 0.308 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.4 172.81 14.82 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.022 1.729 . . . . 0.0 111.99 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.93 0.92 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 125.8 1.64 . . . . 0.0 111.671 172.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.3 m -76.23 93.89 3.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.949 2.1 . . . . 0.0 112.199 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.17 91.61 3.74 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.711 1.204 . . . . 0.0 111.269 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -124.23 156.65 66.34 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 126.012 1.725 . . . . 0.0 111.668 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.6 163.39 36.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.544 2.829 . . . . 0.0 113.196 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -84.52 -4.24 58.84 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 tt -48.68 131.56 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.085 2.154 . . . . 0.0 113.332 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.76 79.03 7.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.579 . . . . 0.0 110.576 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -143.32 71.48 17.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.835 0.854 . . . . 0.0 110.429 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.55 160.62 45.07 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.013 1.809 . . . . 0.0 112.089 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.52 155.19 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 110.198 -172.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -98.25 112.91 24.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.167 0.587 . . . . 0.0 111.112 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.07 164.42 51.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.433 0.539 . . . . 0.0 113.005 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -64.26 -18.89 65.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.35 -22.85 60.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.593 1.157 . . . . 0.0 113.242 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.33 42.2 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 127.043 2.259 . . . . 0.0 114.124 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -83.55 159.8 21.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.196 1.798 . . . . 0.0 111.244 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.8 t -113.89 147.95 37.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.451 1.501 . . . . 0.0 112.767 173.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.79 178.02 7.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.248 2.219 . . . . 0.0 110.688 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.55 74.09 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -157.2 -176.87 6.21 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.908 1.683 . . . . 0.0 113.366 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.9 p -73.73 14.0 0.43 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 116.009 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -107.12 -48.08 3.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.53 1.932 . . . . 0.0 111.179 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 tp -65.57 -41.4 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -176.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.59 -42.5 98.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.204 1.002 . . . . 0.0 112.196 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -64.25 -37.89 89.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.308 1.443 . . . . 0.0 112.597 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -71.8 -29.15 64.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.481 0.712 . . . . 0.0 112.01 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -10.44 57.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.428 1.891 . . . . 0.0 114.816 174.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.69 14.89 38.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.648 1.118 . . . . 0.0 115.326 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 159.22 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.9 1.68 . . . . 0.0 111.178 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 p -100.61 158.15 16.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.411 1.085 . . . . 0.0 111.814 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.5 mm -93.34 109.72 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.958 1.303 . . . . 0.0 109.944 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -76.01 -46.0 31.7 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.041 1.336 . . . . 0.0 112.264 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 t -153.73 164.28 38.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.817 0.847 . . . . 0.0 112.907 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -84.63 155.19 22.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.421 1.488 . . . . 0.0 112.799 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.09 151.01 13.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.715 1.15 . . . . 0.0 111.596 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -61.63 135.44 57.63 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.697 -0.884 . . . . 0.0 111.609 173.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.41 150.56 97.8 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.927 0.491 . . . . 0.0 111.557 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.53 161.32 46.45 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.339 2.692 . . . . 0.0 112.633 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.6 m -131.81 32.19 4.13 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.388 1.475 . . . . 0.0 111.592 -172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.32 43.96 5.12 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.805 1.193 . . . . 0.0 113.804 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--O 1.254 1.295 0 C-N-CA 126.478 1.911 . . . . 0.0 113.295 176.041 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 52.8 pttt . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -126.12 97.89 5.27 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.431 1.493 . . . . 0.0 110.695 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 m -60.4 152.04 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.36 1.464 . . . . 0.0 111.813 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.5 m -104.08 145.12 30.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.066 0.946 . . . . 0.0 111.326 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.64 73.91 3.33 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.471 1.109 . . . . 0.0 112.042 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m -109.98 155.35 41.8 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.534 1.933 . . . . 0.0 111.904 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.26 162.92 19.95 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.539 2.826 . . . . 0.0 113.227 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -84.38 -7.94 59.15 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 pt -54.7 133.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.093 1.757 . . . . 0.0 112.946 -171.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -76.08 76.79 2.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.511 1.524 . . . . 0.0 111.21 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -132.85 66.97 77.5 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 126.194 1.797 . . . . 0.0 111.337 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -61.69 157.74 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.926 1.751 . . . . 0.0 111.945 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -143.77 154.96 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.012 2.125 . . . . 0.0 110.262 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -90.69 112.62 24.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.155 0.582 . . . . 0.0 109.8 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.87 159.17 46.55 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.681 0.657 . . . . 0.0 113.496 170.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 p -63.16 -22.41 66.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.34 1.456 . . . . 0.0 114.506 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -84.57 -10.27 57.55 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.527 1.131 . . . . 0.0 113.842 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.66 60.77 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 126.579 2.038 . . . . 0.0 113.908 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -66.31 157.62 31.21 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.841 1.656 . . . . 0.0 111.444 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.1 m -121.97 135.77 54.88 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.396 1.878 . . . . 0.0 110.519 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.32 177.61 6.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.33 1.852 . . . . 0.0 111.662 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.37 77.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -148.83 -179.69 7.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.221 1.408 . . . . 0.0 111.846 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.6 p -66.41 -43.97 84.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.475 1.11 . . . . 0.0 113.002 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 t -61.55 -41.67 97.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.95 1.3 . . . . 0.0 112.217 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 tp -67.39 -42.95 87.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.93 63.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.106 1.362 . . . . 0.0 111.431 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -56.73 -41.14 76.97 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.461 1.104 . . . . 0.0 112.54 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.84 -26.49 59.74 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -8.79 41.65 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.855 1.662 . . . . 0.0 114.175 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.27 15.69 46.72 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.914 1.245 . . . . 0.0 114.736 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.86 142.74 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.122 1.769 . . . . 0.0 110.779 -174.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -84.12 152.68 24.17 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.984 -0.447 . . . . 0.0 109.94 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.47 149.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 167.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -119.18 -22.34 7.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.259 1.424 . . . . 0.0 112.853 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.7 p -160.95 167.75 25.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.243 1.417 . . . . 0.0 112.616 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.33 154.23 25.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.72 1.208 . . . . 0.0 112.264 173.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.11 165.97 36.99 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.362 1.458 . . . . 0.0 113.185 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.7 t -60.15 149.66 32.12 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.731 -0.864 . . . . 0.0 111.576 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.49 141.24 22.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.564 0.746 . . . . 0.0 112.186 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.09 133.03 25.74 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.074 2.516 . . . . 0.0 112.32 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.9 p -76.97 72.61 3.54 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.81 1.644 . . . . 0.0 111.955 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.92 82.58 0.08 OUTLIER Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.095 1.331 . . . . 0.0 112.324 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.916 2.086 . . . . 0.0 112.316 -179.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -106.12 73.14 0.97 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 120.817 1.644 . . . . 0.0 111.52 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.26 157.88 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.58 1.152 . . . . 0.0 111.271 171.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.7 m -91.31 146.64 23.65 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.624 0.77 . . . . 0.0 111.506 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.95 99.09 1.72 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.467 1.107 . . . . 0.0 111.615 177.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.8 m -131.25 158.52 75.0 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 126.069 1.748 . . . . 0.0 112.244 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.45 162.56 35.79 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.755 2.97 . . . . 0.0 113.229 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -78.57 -9.17 59.26 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -50.52 113.9 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.942 2.097 . . . . 0.0 113.021 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -70.8 91.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.796 1.238 . . . . 0.0 110.508 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 69.77 14.46 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.179 0.991 . . . . 0.0 110.5 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.58 161.34 28.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.361 2.041 . . . . 0.0 112.214 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.89 155.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.401 2.28 . . . . 0.0 109.719 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -99.57 114.74 27.95 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.907 0.883 . . . . 0.0 109.584 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.96 166.54 40.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.547 1.07 . . . . 0.0 114.127 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.27 -30.2 59.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.997 1.319 . . . . 0.0 113.708 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.35 -18.39 49.2 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.927 1.291 . . . . 0.0 113.777 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.74 -3.87 49.65 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.358 1.932 . . . . 0.0 114.328 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -70.61 157.92 37.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 111.953 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -111.63 141.54 45.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 111.536 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.13 173.59 10.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.527 1.931 . . . . 0.0 111.053 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.92 82.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.041 . . . . 0.0 113.741 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -162.07 -176.38 5.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.343 1.457 . . . . 0.0 113.125 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -60.84 -35.61 77.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -62.52 -39.17 92.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.049 1.34 . . . . 0.0 112.444 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 tp -79.7 -42.32 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 O-C-N 121.773 -0.579 . . . . 0.0 110.49 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.1 70.0 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.287 1.035 . . . . 0.0 112.37 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -57.58 -41.66 81.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.546 1.138 . . . . 0.0 112.846 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.46 -24.08 50.33 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.816 1.246 . . . . 0.0 112.629 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -11.47 60.66 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.29 1.836 . . . . 0.0 113.797 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 17.92 39.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.014 1.292 . . . . 0.0 115.22 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.11 146.09 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.221 1.808 . . . . 0.0 111.134 -172.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -82.13 147.59 28.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.27 1.028 . . . . 0.0 110.918 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.83 131.8 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -89.79 -40.4 12.49 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.273 1.429 . . . . 0.0 111.98 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -145.37 160.33 41.7 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.167 1.387 . . . . 0.0 112.349 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.37 154.14 35.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.932 1.293 . . . . 0.0 112.167 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.19 162.39 28.63 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.152 1.358 . . . . 0.0 112.942 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.5 t -64.14 147.19 52.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.654 -0.909 . . . . 0.0 111.329 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.66 143.1 33.29 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.798 0.839 . . . . 0.0 112.08 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.6 157.76 48.24 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.813 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.3 t -78.23 -13.95 59.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.505 1.122 . . . . 0.0 113.923 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.97 -13.34 3.86 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.534 2.016 . . . . 0.0 114.943 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 C--O 1.254 1.323 0 C-N-CA 127.149 2.18 . . . . 0.0 110.229 177.335 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -122.25 103.23 8.62 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.651 1.581 . . . . 0.0 110.389 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.12 136.89 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.335 1.454 . . . . 0.0 109.622 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.3 m -78.11 133.51 37.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.232 1.013 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.58 95.68 0.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.425 1.09 . . . . 0.0 111.758 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.8 m -125.8 158.61 64.79 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.866 2.066 . . . . 0.0 111.061 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.9 163.3 35.75 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.479 2.786 . . . . 0.0 113.571 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -79.93 -8.34 59.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.116 1.766 . . . . 0.0 114.93 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 135.43 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.636 1.975 . . . . 0.0 113.077 -171.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.69 81.11 8.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.367 1.867 . . . . 0.0 111.79 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.29 70.0 77.54 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.094 1.358 . . . . 0.0 110.638 172.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.19 161.69 29.42 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.547 2.164 . . . . 0.0 112.817 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.6 m -147.16 153.62 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.915 2.086 . . . . 0.0 110.64 -172.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -99.29 111.61 23.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.831 0.852 . . . . 0.0 111.871 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.88 162.56 48.32 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.615 1.102 . . . . 0.0 113.967 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 m -59.54 -25.45 64.53 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -78.74 -15.86 57.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.373 1.069 . . . . 0.0 113.267 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 -1.45 59.68 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 126.61 2.052 . . . . 0.0 113.974 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -72.58 158.2 36.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.897 1.679 . . . . 0.0 111.116 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.0 m -116.85 140.6 49.25 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.695 1.998 . . . . 0.0 110.595 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.16 175.83 8.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.981 1.712 . . . . 0.0 111.418 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.67 72.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.508 1.123 . . . . 0.0 113.818 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.92 -174.52 4.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.377 1.871 . . . . 0.0 112.491 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 p -58.62 -39.87 81.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.67 -47.31 82.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.451 1.5 . . . . 0.0 111.654 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.46 -42.56 64.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.06 74.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.543 1.137 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -56.12 -43.37 78.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.64 1.976 . . . . 0.0 112.162 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -76.18 -24.98 54.78 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -9.73 49.02 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.94 1.696 . . . . 0.0 114.073 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.6 15.55 54.65 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.893 1.235 . . . . 0.0 114.906 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.6 162.19 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.497 1.919 . . . . 0.0 111.468 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 132.3 56.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.249 1.42 . . . . 0.0 109.376 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 pt -78.99 140.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.998 -0.439 . . . . 0.0 111.245 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -93.12 -35.25 13.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.444 1.098 . . . . 0.0 112.285 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -149.38 161.16 42.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.629 1.172 . . . . 0.0 112.303 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.57 160.31 25.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 169.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.3 166.0 40.21 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.48 1.514 . . . . 0.0 113.132 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.9 t -63.11 150.42 42.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.926 -0.749 . . . . 0.0 111.282 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.49 137.02 19.27 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.328 1.051 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.54 155.37 54.95 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 112.765 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.9 p -80.67 -5.44 56.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.275 1.43 . . . . 0.0 114.351 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.3 -36.16 0.18 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.832 1.206 . . . . 0.0 114.77 173.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mt . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.553 1.941 . . . . 0.0 110.217 178.787 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 110.778 -0.082 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.74 169.53 12.75 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.671 1.189 . . . . 0.0 111.842 173.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.29 153.31 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 126.429 1.891 . . . . 0.0 110.085 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.07 151.06 38.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.258 1.423 . . . . 0.0 112.51 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.71 91.88 3.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.746 1.218 . . . . 0.0 111.046 173.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.4 m -125.77 158.39 65.45 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.512 1.925 . . . . 0.0 110.974 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.72 158.16 57.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.16 2.573 . . . . 0.0 113.016 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.83 -5.44 43.54 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.419 1.888 . . . . 0.0 114.73 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 tt -51.24 131.89 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.886 2.074 . . . . 0.0 113.539 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 tt -82.12 78.63 8.78 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.116 1.766 . . . . 0.0 109.531 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -143.25 68.39 17.43 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 111.567 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.22 168.69 12.07 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.741 2.961 . . . . 0.0 113.615 -172.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.06 158.58 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.485 1.914 . . . . 0.0 111.023 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -98.71 113.17 25.13 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.889 0.875 . . . . 0.0 109.758 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 153.7 51.45 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 113.414 173.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -59.72 -26.41 65.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.112 0.965 . . . . 0.0 113.204 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.06 -19.3 61.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.225 1.41 . . . . 0.0 113.337 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.41 -8.15 40.62 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.859 2.171 . . . . 0.0 114.507 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -75.77 160.15 30.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.486 1.915 . . . . 0.0 111.701 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -111.58 143.31 42.65 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.668 1.987 . . . . 0.0 110.77 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.34 175.21 9.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.559 1.943 . . . . 0.0 110.979 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -47.76 79.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.201 1.001 . . . . 0.0 113.591 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -156.55 -173.31 4.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 112.433 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 p -60.81 -37.14 80.96 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -60.53 -46.91 88.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.429 1.492 . . . . 0.0 112.474 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 tp -69.76 -39.71 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 122.359 1.076 . . . . 0.0 110.339 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.77 77.84 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.932 1.693 . . . . 0.0 112.472 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -58.09 -34.56 70.32 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.574 1.55 . . . . 0.0 112.682 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.3 t -79.54 -30.73 41.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.432 0.693 . . . . 0.0 111.653 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -66.49 -5.32 10.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.128 1.771 . . . . 0.0 113.942 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 9.66 68.2 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.586 1.565 . . . . 0.0 115.19 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.0 152.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.909 1.283 . . . . 0.0 111.896 -171.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.4 m -85.23 -19.27 31.9 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -168.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.2 mm 53.49 88.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 130.74 3.616 . . . . 0.0 112.73 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -75.07 -32.96 61.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.778 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -160.54 168.79 24.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 0.0 112.714 172.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -93.18 163.43 13.63 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.813 1.645 . . . . 0.0 112.319 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.05 165.42 26.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.607 1.575 . . . . 0.0 112.63 -171.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -64.82 147.22 53.64 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.436 -1.038 . . . . 0.0 111.273 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.73 143.67 36.03 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.579 0.752 . . . . 0.0 111.902 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.57 86.16 1.61 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.547 2.831 . . . . 0.0 112.971 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.7 p -83.74 -10.19 58.3 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.819 1.648 . . . . 0.0 113.979 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.56 81.36 1.75 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.1 1.81 . . . . 0.0 112.559 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.957 2.103 . . . . 0.0 112.59 -179.179 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.2 tptm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.12 163.97 31.29 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.386 1.875 . . . . 0.0 109.934 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.07 149.82 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.472 1.509 . . . . 0.0 111.293 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.9 m -66.41 124.7 23.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.142 0.977 . . . . 0.0 110.919 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.18 101.08 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.469 1.107 . . . . 0.0 111.508 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.3 m -126.69 157.44 71.2 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.31 1.844 . . . . 0.0 111.625 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.83 161.45 46.04 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.554 2.836 . . . . 0.0 113.366 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.8 -7.0 52.08 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 tt -51.61 127.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.321 1.848 . . . . 0.0 113.458 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -80.75 97.34 7.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -156.69 72.85 4.8 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 123.486 0.714 . . . . 0.0 111.945 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.99 166.98 16.94 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.238 1.959 . . . . 0.0 113.012 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.38 147.77 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 127.091 2.156 . . . . 0.0 110.113 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.05 115.93 26.96 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.54 165.66 46.99 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.069 0.842 . . . . 0.0 114.083 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 t -62.06 -27.45 68.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 113.154 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.95 -24.2 58.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.918 1.287 . . . . 0.0 113.226 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.92 -8.41 39.18 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 126.785 2.136 . . . . 0.0 114.333 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -66.95 160.76 25.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.764 1.626 . . . . 0.0 111.088 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.5 t -109.5 156.5 20.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.706 1.202 . . . . 0.0 112.022 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.28 169.54 17.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.702 2.001 . . . . 0.0 110.272 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.28 81.41 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -159.13 -176.85 6.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.428 1.491 . . . . 0.0 112.461 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 p -58.87 -34.86 72.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.92 -43.22 96.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 112.65 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -38.96 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.704 -0.622 . . . . 0.0 110.255 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -51.36 69.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.951 1.301 . . . . 0.0 112.519 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -61.11 -32.5 72.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -88.19 -19.56 26.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.244 1.417 . . . . 0.0 112.384 -173.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.07 -6.27 32.63 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.926 2.09 . . . . 0.0 114.448 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.16 60.12 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.641 1.115 . . . . 0.0 114.736 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.27 168.14 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.054 2.542 . . . . 0.0 110.622 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -119.38 167.43 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.871 1.268 . . . . 0.0 110.642 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.91 138.15 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.027 1.331 . . . . 0.0 110.462 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -100.94 -31.57 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.846 1.659 . . . . 0.0 113.097 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 164.01 39.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.622 1.169 . . . . 0.0 112.022 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.29 152.11 23.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.66 1.584 . . . . 0.0 112.693 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.46 167.39 28.66 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.938 1.256 . . . . 0.0 112.48 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.8 t -63.67 148.72 48.29 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.718 -0.872 . . . . 0.0 111.387 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.28 145.42 60.0 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 111.402 174.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.45 149.85 84.45 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.68 2.254 . . . . 0.0 111.573 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.9 m 55.38 30.13 14.35 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.215 1.406 . . . . 0.0 113.14 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.43 -65.73 2.77 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.523 1.535 . . . . 0.0 114.72 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.486 1.332 0 C-N-CA 129.765 3.226 . . . . 0.0 113.229 -174.511 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 120.256 0.074 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.8 165.24 28.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.418 2.745 . . . . 0.0 112.919 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -75.79 -8.09 56.01 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -56.02 131.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.55 1.94 . . . . 0.0 111.183 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -84.26 79.01 9.68 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 109.69 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -127.41 63.09 57.39 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 125.376 1.471 . . . . 0.0 110.963 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.86 161.99 33.99 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.859 2.373 . . . . 0.0 112.663 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.84 154.58 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.889 2.075 . . . . 0.0 110.454 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.26 113.78 25.06 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.415 0.686 . . . . 0.0 109.728 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.66 160.38 53.0 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.128 0.394 . . . . 0.0 113.313 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -64.76 -23.3 67.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.59 -19.14 58.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.097 1.359 . . . . 0.0 113.17 171.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.52 -7.92 47.03 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.16 2.315 . . . . 0.0 113.789 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -67.23 156.85 35.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.915 1.686 . . . . 0.0 111.964 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.4 m -113.64 136.28 53.0 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.021 2.128 . . . . 0.0 110.184 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.22 174.21 9.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.181 1.792 . . . . 0.0 111.133 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.67 72.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.391 1.076 . . . . 0.0 113.853 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -162.33 -176.7 5.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.314 1.446 . . . . 0.0 112.764 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -57.02 -39.95 75.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -55.46 -45.92 76.87 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.942 1.297 . . . . 0.0 111.843 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 tp -75.99 -43.0 39.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.212 -0.305 . . . . 0.0 110.479 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.35 -48.85 75.94 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.571 1.148 . . . . 0.0 112.526 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.953 1.701 . . . . 0.0 111.987 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.23 -30.79 67.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.995 0.918 . . . . 0.0 112.331 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -7.29 17.98 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.662 1.585 . . . . 0.0 114.191 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.08 18.92 52.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.813 1.197 . . . . 0.0 114.847 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.67 158.49 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.629 1.572 . . . . 0.0 110.908 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 t -96.52 166.05 11.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 0.0 110.574 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -102.66 142.37 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.215 1.406 . . . . 0.0 110.149 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -97.47 -31.34 12.4 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.347 1.459 . . . . 0.0 111.633 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.2 p -162.37 169.61 20.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.706 1.602 . . . . 0.0 112.474 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.61 160.44 29.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.903 1.281 . . . . 0.0 112.597 168.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.05 166.25 25.16 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.347 1.451 . . . . 0.0 112.811 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 p -64.06 146.7 53.71 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.443 -1.034 . . . . 0.0 111.94 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.14 146.66 40.78 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 122.931 0.492 . . . . 0.0 111.508 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 122.645 2.23 . . . . 0.0 112.032 178.197 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.53 166.89 26.56 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.513 2.808 . . . . 0.0 113.386 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -80.28 -6.65 58.26 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.6 133.35 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.455 1.902 . . . . 0.0 111.361 -172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 79.98 8.64 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.33 1.852 . . . . 0.0 110.469 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -129.83 66.88 78.51 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 125.269 1.428 . . . . 0.0 110.907 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.35 162.2 31.4 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.985 2.457 . . . . 0.0 113.065 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -144.83 155.83 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.505 1.922 . . . . 0.0 110.881 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t -94.98 111.09 22.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.916 0.887 . . . . 0.0 111.18 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.51 163.71 51.33 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.053 0.835 . . . . 0.0 114.307 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.4 t -63.62 -25.63 68.31 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.4 -17.12 60.85 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.072 1.349 . . . . 0.0 113.121 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.99 -5.68 63.69 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.872 2.177 . . . . 0.0 113.711 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -68.21 157.53 35.26 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.369 1.868 . . . . 0.0 111.775 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.6 m -113.76 137.94 50.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.48 1.912 . . . . 0.0 110.702 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.34 176.03 8.27 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.124 1.77 . . . . 0.0 111.395 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.3 -51.02 71.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.73 1.212 . . . . 0.0 113.814 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -159.78 -174.95 4.86 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.581 1.553 . . . . 0.0 112.569 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -58.4 -39.69 80.39 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.4 t -57.02 -48.45 78.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.284 1.434 . . . . 0.0 111.237 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 tp -71.12 -43.32 75.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -51.5 68.45 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.532 1.133 . . . . 0.0 112.347 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -61.14 -41.4 96.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.987 1.715 . . . . 0.0 111.835 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.1 t -74.15 -24.06 59.36 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.487 0.715 . . . . 0.0 112.413 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -10.89 59.07 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.903 1.681 . . . . 0.0 113.94 169.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.59 15.4 56.88 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.79 1.186 . . . . 0.0 115.184 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.06 148.65 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.666 1.586 . . . . 0.0 111.675 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -78.71 168.58 19.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.914 0.886 . . . . 0.0 111.231 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.68 134.85 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 110.532 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -69.61 -47.97 61.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.854 1.261 . . . . 0.0 110.768 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 t -165.81 177.67 7.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.225 1.41 . . . . 0.0 112.104 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.45 164.99 24.95 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.841 1.656 . . . . 0.0 113.321 172.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.5 162.4 21.04 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.015 1.769 . . . . 0.0 113.426 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -65.63 135.38 54.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.888 0.875 . . . . 0.0 110.975 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 142.65 64.88 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.817 -0.552 . . . . 0.0 112.097 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--N 1.35 0.624 0 C-N-CA 122.77 2.313 . . . . 0.0 111.162 179.015 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.5 m . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.66 163.9 36.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.694 2.929 . . . . 0.0 114.222 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -75.52 -6.35 49.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.115 2.166 . . . . 0.0 115.317 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -54.35 136.25 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 112.799 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.95 85.29 5.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.926 1.691 . . . . 0.0 110.583 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -140.97 68.09 28.03 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.387 1.075 . . . . 0.0 111.057 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.49 159.93 34.08 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.819 1.679 . . . . 0.0 111.817 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.81 158.12 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.771 2.029 . . . . 0.0 109.961 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -97.1 114.13 25.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.325 0.65 . . . . 0.0 109.618 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.67 163.0 47.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.77 0.7 . . . . 0.0 113.03 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 t -63.36 -19.75 64.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.83 -12.69 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 172.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.18 -4.48 58.73 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.745 2.117 . . . . 0.0 114.32 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -67.11 156.49 36.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.286 1.834 . . . . 0.0 111.615 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.7 m -115.07 132.63 56.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.769 2.028 . . . . 0.0 110.59 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.6 174.81 6.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.246 1.819 . . . . 0.0 111.418 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -49.63 76.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.384 1.074 . . . . 0.0 113.564 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -162.06 -175.97 4.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 113.896 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -62.64 -37.85 87.97 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.01 -46.05 85.89 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.793 1.237 . . . . 0.0 111.823 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.26 -46.53 65.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.34 -46.0 80.13 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.143 0.977 . . . . 0.0 113.023 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.45 -28.64 65.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.656 1.982 . . . . 0.0 114.019 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.8 t -97.72 -24.71 15.36 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.355 1.462 . . . . 0.0 111.926 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -69.54 -11.8 61.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.476 1.91 . . . . 0.0 113.503 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.99 56.03 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.433 1.016 . . . . 0.0 114.782 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.41 151.49 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.992 1.317 . . . . 0.0 110.879 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.14 138.3 31.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 108.955 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.88 137.67 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.976 0.807 . . . . 0.0 109.53 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -96.98 -34.1 11.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 112.433 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -157.27 168.33 27.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.07 0.948 . . . . 0.0 112.682 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.25 149.27 25.6 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.403 1.881 . . . . 0.0 111.675 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.56 161.85 28.36 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.908 1.242 . . . . 0.0 112.28 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -63.59 149.89 45.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.574 -0.957 . . . . 0.0 112.236 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.98 149.44 50.46 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.132 0.573 . . . . 0.0 112.17 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 CA--C 1.539 0.764 0 C-N-CA 123.395 2.73 . . . . 0.0 112.566 177.886 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.27 167.86 24.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.023 3.149 . . . . 0.0 114.335 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.08 -9.85 58.95 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 pt -58.1 114.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.418 1.887 . . . . 0.0 113.813 -171.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.98 85.66 0.52 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 110.848 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.74 72.6 55.7 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 125.91 1.684 . . . . 0.0 109.888 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.79 160.64 35.94 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.189 1.926 . . . . 0.0 112.085 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.19 157.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.857 2.063 . . . . 0.0 110.48 -170.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.71 114.04 27.94 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.605 0.762 . . . . 0.0 111.693 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.29 163.08 51.44 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.88 1.229 . . . . 0.0 114.406 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 t -61.89 -28.55 69.59 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.216 . . . . 0.0 113.551 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.39 -10.79 59.83 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.285 1.034 . . . . 0.0 113.313 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.05 -5.51 61.43 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.84 2.162 . . . . 0.0 113.884 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -70.3 157.03 38.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.429 1.892 . . . . 0.0 111.798 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 m -115.17 137.59 51.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.039 2.136 . . . . 0.0 110.525 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 173.04 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.984 1.714 . . . . 0.0 111.439 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.15 86.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.546 1.138 . . . . 0.0 114.018 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -160.12 -174.7 4.67 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.801 1.64 . . . . 0.0 112.494 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.2 p -59.98 -41.39 91.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.79 -47.42 80.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.3 1.44 . . . . 0.0 111.405 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 tp -71.93 -43.71 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.56 76.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 112.27 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -59.82 -41.79 92.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.895 1.678 . . . . 0.0 111.952 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.4 t -74.25 -25.09 59.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.947 0.899 . . . . 0.0 112.504 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -11.07 59.8 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.044 1.738 . . . . 0.0 114.179 172.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.14 44.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.694 1.14 . . . . 0.0 115.105 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.5 154.6 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.04 1.736 . . . . 0.0 111.133 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -98.77 144.59 27.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.386 1.074 . . . . 0.0 109.444 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 pt -91.82 134.91 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.651 0.659 . . . . 0.0 111.025 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.08 -34.98 22.12 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 112.227 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -160.62 173.65 15.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.496 1.118 . . . . 0.0 112.458 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.68 161.44 23.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.058 1.743 . . . . 0.0 112.839 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.81 156.97 15.08 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.325 1.441 . . . . 0.0 112.262 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -64.01 142.32 58.45 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.607 -0.937 . . . . 0.0 111.5 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.12 150.66 71.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.539 0.73 0 C-N-CA 123.096 2.531 . . . . 0.0 112.079 177.019 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.88 163.88 34.62 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.745 2.963 . . . . 0.0 113.596 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.05 -8.52 57.58 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -53.36 111.84 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.59 1.956 . . . . 0.0 113.285 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.97 84.3 0.97 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.712 1.605 . . . . 0.0 111.332 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -141.45 74.05 24.26 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.205 1.402 . . . . 0.0 109.748 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.98 165.38 21.66 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.82 2.347 . . . . 0.0 112.84 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -145.6 153.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -98.19 113.0 24.77 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.009 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.59 164.82 37.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.403 1.002 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -60.61 -29.71 69.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.41 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -79.01 -13.5 59.75 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.847 1.259 . . . . 0.0 113.488 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.51 -3.17 59.3 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 126.281 1.896 . . . . 0.0 114.049 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -66.16 156.28 34.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.722 1.609 . . . . 0.0 111.464 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 m -114.0 138.4 50.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.54 1.936 . . . . 0.0 110.111 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.89 174.1 9.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.691 1.596 . . . . 0.0 111.25 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.43 -49.03 77.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 113.443 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -159.7 -174.29 4.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.462 1.505 . . . . 0.0 113.206 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.7 p -61.17 -38.0 84.94 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.04 -46.09 85.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.19 1.396 . . . . 0.0 111.79 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.64 -41.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 O-C-N 122.066 -0.397 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.36 -47.77 82.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.731 1.212 . . . . 0.0 112.405 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -59.06 -42.51 90.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 111.82 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.6 -27.87 61.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.917 0.887 . . . . 0.0 112.598 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -7.33 22.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.724 1.61 . . . . 0.0 114.113 175.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 18.84 48.99 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.875 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.3 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.779 1.631 . . . . 0.0 111.093 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.3 p -82.74 168.32 17.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.586 0.754 . . . . 0.0 111.488 168.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.58 137.49 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.102 1.361 . . . . 0.0 110.064 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -92.54 -33.55 14.41 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.698 1.199 . . . . 0.0 112.039 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 m -150.93 162.41 40.86 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.708 1.603 . . . . 0.0 112.26 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.87 162.91 27.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.43 1.092 . . . . 0.0 112.329 165.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 167.63 31.21 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.313 1.435 . . . . 0.0 113.002 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 p -66.13 149.09 50.83 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.51 -0.994 . . . . 0.0 111.562 169.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 145.17 32.04 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.002 0.521 . . . . 0.0 112.194 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 C-N-CA 122.916 2.411 . . . . 0.0 112.359 177.914 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.9 m . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 110.979 -0.008 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.12 164.09 29.85 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.341 2.694 . . . . 0.0 112.962 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -81.22 -5.78 58.13 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.01 131.2 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.222 1.809 . . . . 0.0 110.749 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.15 78.4 8.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.158 1.783 . . . . 0.0 110.318 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -130.06 69.64 81.88 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.899 1.28 . . . . 0.0 109.667 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.19 161.74 38.98 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.15 1.9 . . . . 0.0 112.44 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.7 157.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 127.007 2.123 . . . . 0.0 110.627 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -102.53 114.81 29.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.783 0.833 . . . . 0.0 111.674 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 162.33 54.6 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.15 0.881 . . . . 0.0 113.943 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -61.74 -26.05 67.82 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.4 1.48 . . . . 0.0 114.228 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.1 -19.44 54.15 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.67 1.188 . . . . 0.0 112.989 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.16 -7.15 32.61 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 127.381 2.419 . . . . 0.0 114.166 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -74.38 158.01 34.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.61 1.564 . . . . 0.0 112.199 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.3 m -114.74 125.85 54.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.658 2.383 . . . . 0.0 110.653 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.17 174.6 6.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.884 1.674 . . . . 0.0 111.65 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.46 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.455 1.102 . . . . 0.0 113.751 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -163.18 -175.92 4.55 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.658 1.983 . . . . 0.0 112.665 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -57.87 -39.28 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.77 -46.7 81.31 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.062 1.345 . . . . 0.0 111.829 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -75.06 -41.6 45.29 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 O-C-N 122.225 -0.297 . . . . 0.0 110.284 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.87 78.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.445 1.098 . . . . 0.0 112.234 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -59.42 -39.92 85.03 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.032 1.733 . . . . 0.0 112.436 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.9 -34.63 73.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -8.92 17.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.889 1.676 . . . . 0.0 114.545 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.84 50.58 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.975 1.274 . . . . 0.0 114.814 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.04 156.65 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.912 2.085 . . . . 0.0 110.823 -172.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -106.96 139.02 42.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 109.606 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.0 pt -85.56 136.02 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.753 -0.592 . . . . 0.0 111.175 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -90.74 -31.66 16.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.818 1.247 . . . . 0.0 112.537 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 m -158.85 164.55 35.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.886 1.675 . . . . 0.0 111.928 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -80.45 160.64 25.24 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 111.811 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.2 159.88 23.71 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.205 1.383 . . . . 0.0 112.425 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -63.58 143.0 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.59 -0.947 . . . . 0.0 111.598 171.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 149.09 61.51 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 122.05 -0.406 . . . . 0.0 111.89 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 123.049 2.499 . . . . 0.0 112.104 176.399 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.4 161.44 45.56 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.575 2.85 . . . . 0.0 113.446 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -74.82 -8.3 56.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.837 1.655 . . . . 0.0 114.73 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -49.47 128.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.683 1.993 . . . . 0.0 113.378 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.8 mt -84.85 77.19 10.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 110.178 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -142.4 73.42 20.87 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 124.151 0.98 . . . . 0.0 110.69 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.23 164.19 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.12 1.88 . . . . 0.0 112.551 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.15 169.17 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.932 2.093 . . . . 0.0 110.383 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -113.7 110.07 19.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.415 0.686 . . . . 0.0 110.577 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.45 155.14 52.9 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.927 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -57.4 -23.37 48.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.802 1.641 . . . . 0.0 114.44 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.32 -24.3 64.82 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.314 1.446 . . . . 0.0 113.086 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.15 -8.03 35.55 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 127.502 2.477 . . . . 0.0 114.01 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -78.68 158.75 28.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.535 1.934 . . . . 0.0 111.458 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.4 t -116.84 149.57 39.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.662 1.585 . . . . 0.0 112.699 172.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.86 177.19 8.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.974 2.11 . . . . 0.0 110.814 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -158.77 -177.35 6.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.939 1.696 . . . . 0.0 112.712 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 p -58.13 -36.51 73.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.7 t -63.29 -42.56 99.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.721 1.608 . . . . 0.0 112.248 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.88 -44.87 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.675 -0.641 . . . . 0.0 110.106 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.44 98.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.784 1.234 . . . . 0.0 113.215 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.37 -42.28 98.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.419 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.8 t -76.11 -21.29 56.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.845 1.258 . . . . 0.0 112.412 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -10.04 39.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.84 2.056 . . . . 0.0 113.901 165.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.12 15.03 37.2 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.178 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.43 148.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.847 1.324 . . . . 0.0 111.865 -173.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 132.42 40.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.181 1.793 . . . . 0.0 111.1 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.43 109.62 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.036 0.935 . . . . 0.0 109.999 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -91.72 -35.99 13.84 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.943 0.897 . . . . 0.0 113.062 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -159.94 168.25 26.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.571 1.149 . . . . 0.0 112.276 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.82 163.88 12.02 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.18 1.392 . . . . 0.0 113.645 177.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 160.48 23.08 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.481 1.515 . . . . 0.0 112.11 -168.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.0 m -62.61 135.38 57.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.997 -0.708 . . . . 0.0 110.685 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 146.92 98.7 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 121.961 -0.462 . . . . 0.0 111.212 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.54 0.797 0 C-N-CA 123.75 2.966 . . . . 0.0 112.217 -176.282 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 111.106 0.039 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.24 155.12 56.58 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.264 2.643 . . . . 0.0 112.272 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -77.72 -6.48 54.09 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.3 tp -45.74 125.46 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.968 2.107 . . . . 0.0 113.459 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -76.9 83.87 3.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.288 1.835 . . . . 0.0 109.814 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -145.5 65.36 11.38 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 111.834 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.43 161.45 34.76 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.232 2.621 . . . . 0.0 112.437 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 157.42 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.716 2.006 . . . . 0.0 111.024 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -91.18 117.19 29.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.146 0.979 . . . . 0.0 110.32 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.5 166.03 42.95 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.437 1.018 . . . . 0.0 114.348 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -56.41 -26.82 54.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 114.412 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.4 -4.68 37.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.733 1.613 . . . . 0.0 113.771 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.19 62.4 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.741 1.638 . . . . 0.0 114.489 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.24 159.04 18.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.926 1.69 . . . . 0.0 111.179 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -124.43 122.35 37.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.687 1.995 . . . . 0.0 110.252 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.97 175.02 5.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.134 1.774 . . . . 0.0 111.196 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.52 87.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -157.23 -175.53 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.9 m -77.84 8.75 4.18 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -104.8 -46.42 4.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.652 1.581 . . . . 0.0 110.714 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.4 -41.06 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.826 0.851 . . . . 0.0 110.233 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.76 72.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.876 1.27 . . . . 0.0 111.495 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.263 1.825 . . . . 0.0 112.561 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.85 -32.77 65.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.507 0.723 . . . . 0.0 112.319 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -10.57 35.04 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.472 1.509 . . . . 0.0 114.206 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 13.71 57.53 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.039 1.304 . . . . 0.0 114.951 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.27 132.52 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.808 2.043 . . . . 0.0 110.626 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 p -75.48 164.57 26.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.727 0.811 . . . . 0.0 111.623 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 pp -102.79 135.48 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.402 1.081 . . . . 0.0 109.381 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -89.17 -35.63 16.13 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.312 1.445 . . . . 0.0 112.488 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -160.12 170.12 21.89 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 112.715 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.06 153.35 32.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.67 1.588 . . . . 0.0 112.904 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.18 156.89 13.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.996 1.284 . . . . 0.0 112.837 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -58.23 136.55 57.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.941 0.897 . . . . 0.0 111.108 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 147.67 82.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 121.837 -0.539 . . . . 0.0 111.29 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.539 0.725 0 C-N-CA 122.766 2.311 . . . . 0.0 111.994 -178.791 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.8 m . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 111.471 0.175 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -80.02 167.5 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.481 2.787 . . . . 0.0 113.488 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -79.63 -7.3 58.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.575 1.55 . . . . 0.0 114.958 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.4 128.42 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 111.261 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.2 mt -80.33 77.97 7.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.484 1.913 . . . . 0.0 110.268 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -133.7 69.19 76.17 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.704 1.202 . . . . 0.0 109.624 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.99 162.89 30.58 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.893 1.729 . . . . 0.0 112.644 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.44 145.13 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.59 1.956 . . . . 0.0 110.037 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -89.67 118.58 29.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.432 0.693 . . . . 0.0 110.803 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.89 161.91 52.56 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.139 0.876 . . . . 0.0 114.326 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.3 t -59.59 -29.67 68.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.811 1.244 . . . . 0.0 113.664 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -74.9 -20.08 59.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.489 1.116 . . . . 0.0 113.013 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.94 -8.75 31.66 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 126.741 2.115 . . . . 0.0 114.238 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -73.39 161.31 30.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.865 1.666 . . . . 0.0 111.505 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 t -110.52 151.75 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.168 1.387 . . . . 0.0 111.838 165.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.34 175.33 9.37 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.203 1.801 . . . . 0.0 111.167 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.38 69.51 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.535 1.134 . . . . 0.0 114.041 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -160.93 -175.39 4.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.276 1.83 . . . . 0.0 112.753 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -57.86 -40.97 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.89 -47.34 77.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.061 1.344 . . . . 0.0 111.869 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.35 -43.95 63.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.21 -49.24 76.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.474 1.11 . . . . 0.0 112.253 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.3 -42.96 87.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.884 1.674 . . . . 0.0 112.2 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.2 t -73.53 -27.54 61.41 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.071 0.549 . . . . 0.0 112.425 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -11.52 60.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.971 1.708 . . . . 0.0 114.114 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 17.33 57.66 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.545 1.069 . . . . 0.0 115.238 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.44 149.01 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.962 1.705 . . . . 0.0 111.38 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -77.12 156.02 31.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.411 0.684 . . . . 0.0 110.598 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.33 126.76 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.257 1.023 . . . . 0.0 109.681 170.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -91.16 -30.06 16.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.278 1.831 . . . . 0.0 112.201 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -162.01 173.37 14.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.515 1.926 . . . . 0.0 111.124 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -84.35 164.02 19.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 0.0 113.233 172.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.95 166.69 25.77 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.509 1.528 . . . . 0.0 112.69 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -67.39 137.61 56.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.645 -0.915 . . . . 0.0 110.83 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 147.84 91.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 122.052 -0.405 . . . . 0.0 111.777 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 CA--C 1.54 0.78 0 C-N-CA 123.175 2.583 . . . . 0.0 112.438 178.599 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.32 162.52 41.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.731 2.954 . . . . 0.0 113.732 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -77.46 -5.42 49.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.474 1.91 . . . . 0.0 114.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -50.7 131.45 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.227 1.811 . . . . 0.0 112.893 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.59 71.36 7.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.126 1.77 . . . . 0.0 110.47 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.04 68.69 80.43 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.005 1.322 . . . . 0.0 111.084 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.02 161.18 34.36 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.383 2.056 . . . . 0.0 112.756 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.12 152.91 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.11 2.164 . . . . 0.0 110.323 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.08 116.39 30.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.568 0.747 . . . . 0.0 111.152 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.56 164.6 50.82 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.711 1.148 . . . . 0.0 114.284 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t -57.42 -30.8 65.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.831 1.252 . . . . 0.0 113.373 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.76 -12.29 59.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.116 1.366 . . . . 0.0 113.936 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.79 -2.23 61.98 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 126.028 1.775 . . . . 0.0 114.215 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -68.46 157.83 35.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.928 1.691 . . . . 0.0 110.957 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.8 m -112.32 141.42 46.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.104 1.761 . . . . 0.0 110.695 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.98 172.16 12.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.131 1.772 . . . . 0.0 110.961 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -160.14 -175.2 4.94 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.444 1.897 . . . . 0.0 112.42 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.5 p -59.65 -38.65 82.01 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.8 t -57.68 -47.51 82.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 111.587 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.37 -42.06 65.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 O-C-N 122.131 -0.356 . . . . 0.0 110.153 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.57 72.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.106 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -59.26 -41.36 88.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.479 1.512 . . . . 0.0 111.956 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.78 -24.76 58.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.746 0.818 . . . . 0.0 112.497 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -10.58 58.33 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.054 1.742 . . . . 0.0 114.089 170.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.78 15.33 59.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.646 1.117 . . . . 0.0 115.088 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.56 151.23 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.157 1.783 . . . . 0.0 111.182 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 m -84.69 157.09 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.624 0.77 . . . . 0.0 110.038 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.51 140.09 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.556 0.742 . . . . 0.0 110.31 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -92.39 -31.07 15.46 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.659 1.184 . . . . 0.0 111.48 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 99.2 p -160.32 169.02 24.01 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.537 1.535 . . . . 0.0 112.421 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.37 164.38 21.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.338 1.055 . . . . 0.0 112.762 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.23 164.2 29.79 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.504 1.526 . . . . 0.0 112.705 -173.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 t -65.5 146.73 54.49 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.57 -0.959 . . . . 0.0 111.024 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.42 146.54 37.91 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.537 . . . . 0.0 111.856 176.159 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 165.55 31.26 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.65 2.9 . . . . 0.0 113.695 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -77.51 -8.26 57.51 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 pt -57.33 113.23 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.358 1.863 . . . . 0.0 113.006 -173.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.67 84.61 0.89 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.586 1.554 . . . . 0.0 111.018 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -142.93 75.67 17.51 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.364 1.465 . . . . 0.0 109.422 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.34 165.19 20.59 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.858 2.372 . . . . 0.0 112.8 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.56 159.79 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.482 1.913 . . . . 0.0 110.058 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.0 t -105.99 119.51 39.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.671 . . . . 0.0 111.944 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.01 164.95 53.96 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.732 1.158 . . . . 0.0 114.143 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -59.29 -26.8 65.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.39 1.476 . . . . 0.0 113.534 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -73.38 -17.05 61.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.158 1.383 . . . . 0.0 113.294 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.5 -2.0 67.13 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.238 1.875 . . . . 0.0 113.785 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -70.04 156.38 39.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 111.22 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.1 m -114.84 138.04 51.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.581 1.952 . . . . 0.0 110.621 172.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.04 173.1 10.75 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.726 1.61 . . . . 0.0 111.236 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.85 85.44 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.395 1.078 . . . . 0.0 113.343 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 26' ' ' ILE . 43.8 p-10 -159.32 -176.36 5.76 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.019 1.328 . . . . 0.0 113.548 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -58.66 -38.6 78.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -60.31 -44.8 95.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.368 1.067 . . . . 0.0 112.63 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 23' ' ' ASN . 4.8 tt -73.53 -39.17 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.13 75.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.631 1.172 . . . . 0.0 112.458 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -63.9 -34.76 78.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.495 1.118 . . . . 0.0 113.414 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.3 t -85.05 -21.35 29.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.727 1.211 . . . . 0.0 111.982 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -67.12 -7.26 21.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.799 1.639 . . . . 0.0 113.775 162.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 21.16 53.53 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.392 0.996 . . . . 0.0 114.874 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 143.01 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.049 1.34 . . . . 0.0 111.28 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.34 135.49 34.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.762 0.825 . . . . 0.0 110.248 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.7 pt -81.26 138.01 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.74 0.7 . . . . 0.0 111.053 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -94.17 -31.47 14.13 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.293 1.437 . . . . 0.0 112.69 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -160.52 174.17 14.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.956 1.302 . . . . 0.0 112.078 174.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.09 161.64 16.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.921 1.688 . . . . 0.0 111.865 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.41 166.97 24.34 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.613 1.577 . . . . 0.0 113.241 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 m -65.63 137.38 57.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.187 0.595 . . . . 0.0 110.545 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 145.23 83.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.364 0.666 . . . . 0.0 111.817 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 CA--C 1.538 0.716 0 C-N-CA 124.239 3.292 . . . . 0.0 111.738 179.062 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 164.12 32.52 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.748 2.966 . . . . 0.0 113.875 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -76.97 -10.27 59.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.386 1.874 . . . . 0.0 115.37 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 pt -51.55 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.297 2.239 . . . . 0.0 113.107 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.27 90.61 0.5 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.279 1.832 . . . . 0.0 111.124 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.49 68.2 16.85 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.837 1.255 . . . . 0.0 111.049 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -63.62 159.07 42.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.285 1.99 . . . . 0.0 112.284 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.59 158.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.159 2.183 . . . . 0.0 110.463 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.17 115.25 29.4 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.602 0.761 . . . . 0.0 110.957 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.38 160.09 53.98 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.494 0.569 . . . . 0.0 113.737 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.3 m -59.9 -24.15 64.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.23 -14.38 59.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.938 1.295 . . . . 0.0 113.197 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.24 -4.66 55.25 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.005 2.241 . . . . 0.0 114.154 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -75.26 157.45 34.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.462 1.905 . . . . 0.0 111.87 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.1 m -111.66 138.04 48.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.006 2.123 . . . . 0.0 110.566 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.33 174.57 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.886 1.674 . . . . 0.0 111.7 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.78 80.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.73 1.212 . . . . 0.0 113.662 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -160.82 -174.98 4.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.194 1.398 . . . . 0.0 112.935 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.1 p -59.57 -40.04 86.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.0 t -57.28 -46.24 83.3 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.029 1.331 . . . . 0.0 111.654 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -73.64 -42.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 O-C-N 122.155 -0.34 . . . . 0.0 110.18 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.5 74.96 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.545 1.138 . . . . 0.0 112.384 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -58.55 -39.72 81.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.019 1.728 . . . . 0.0 112.433 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.4 t -74.8 -29.27 61.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.797 0.839 . . . . 0.0 112.688 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -9.38 36.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.698 1.599 . . . . 0.0 114.38 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.56 19.53 51.67 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.643 1.116 . . . . 0.0 114.805 175.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.41 147.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.188 1.795 . . . . 0.0 110.358 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 m -80.67 163.04 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.982 -0.449 . . . . 0.0 110.164 172.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.87 131.59 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 109.371 171.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -89.56 -32.61 17.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.042 0.937 . . . . 0.0 112.093 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -159.62 171.24 19.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.159 1.384 . . . . 0.0 112.229 172.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.73 160.28 24.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.269 1.828 . . . . 0.0 112.936 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 159.16 15.97 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.143 1.354 . . . . 0.0 112.251 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.9 p -62.65 143.74 57.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.521 -0.988 . . . . 0.0 111.808 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.33 146.17 57.31 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.001 -0.437 . . . . 0.0 111.606 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.538 0.693 0 C-N-CA 122.787 2.325 . . . . 0.0 111.962 179.479 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 111.155 0.057 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.1 165.78 30.45 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 114.197 -174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -75.25 -8.77 57.52 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.561 1.944 . . . . 0.0 115.742 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.4 153.97 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.923 2.089 . . . . 0.0 112.675 -172.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.37 81.89 1.62 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.143 1.377 . . . . 0.0 110.579 -170.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -139.63 73.42 35.06 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.36 1.464 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.1 162.99 24.16 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.988 1.792 . . . . 0.0 112.591 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.07 152.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.588 1.955 . . . . 0.0 109.962 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.6 t -103.03 122.18 44.1 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.804 0.842 . . . . 0.0 110.761 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.93 166.54 54.43 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.502 1.049 . . . . 0.0 113.536 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 p -59.47 -22.67 61.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.42 -23.93 42.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.032 1.333 . . . . 0.0 113.395 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.49 -5.17 33.13 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.481 1.991 . . . . 0.0 114.325 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -74.66 157.24 35.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.507 1.523 . . . . 0.0 111.643 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.6 m -113.26 136.73 52.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.904 1.682 . . . . 0.0 112.115 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.68 171.78 10.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.78 1.632 . . . . 0.0 111.707 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.35 93.12 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -157.81 -175.45 5.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.636 1.574 . . . . 0.0 112.559 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.0 p -59.37 -43.22 92.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.005 0.922 . . . . 0.0 113.423 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.2 t -55.12 -46.73 75.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.619 1.567 . . . . 0.0 111.569 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -72.97 -44.13 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.5 80.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.217 1.007 . . . . 0.0 112.033 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -60.03 -40.67 90.14 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.824 1.65 . . . . 0.0 112.199 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.0 t -72.4 -28.38 62.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.088 0.555 . . . . 0.0 112.386 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -9.51 41.02 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.128 1.771 . . . . 0.0 114.103 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 16.83 52.4 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.625 1.107 . . . . 0.0 114.752 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.52 156.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.464 1.906 . . . . 0.0 111.257 -174.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -92.62 155.99 17.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.941 0.896 . . . . 0.0 109.935 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.98 130.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -85.52 -35.38 21.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.749 1.22 . . . . 0.0 112.343 173.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -156.12 169.47 24.42 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 0.0 112.374 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.47 160.03 22.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.15 1.78 . . . . 0.0 112.64 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.75 170.31 28.7 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.039 1.304 . . . . 0.0 112.933 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.8 m -67.42 138.05 56.38 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.772 -0.84 . . . . 0.0 111.024 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 152.14 92.5 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.889 -0.507 . . . . 0.0 112.038 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 C-N-CA 123.619 2.879 . . . . 0.0 112.619 176.337 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 111.233 0.086 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.74 160.85 30.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.9 2.4 . . . . 0.0 113.614 -173.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -75.07 -9.54 58.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.525 1.93 . . . . 0.0 114.409 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mt -60.11 131.84 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.347 1.859 . . . . 0.0 111.09 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 63.89 5.34 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.498 2.319 . . . . 0.0 112.022 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -122.91 71.24 41.39 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.347 1.459 . . . . 0.0 110.222 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.03 164.66 24.15 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.723 2.282 . . . . 0.0 112.6 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -145.4 151.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.714 2.006 . . . . 0.0 110.39 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.6 t -92.42 117.14 29.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.443 0.697 . . . . 0.0 110.389 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.5 166.0 39.33 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.657 1.122 . . . . 0.0 114.566 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -57.96 -33.87 69.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.571 1.148 . . . . 0.0 112.878 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.09 -19.12 57.45 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.095 1.358 . . . . 0.0 113.441 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.2 55.27 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 126.545 2.022 . . . . 0.0 114.171 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -68.23 160.09 29.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.011 1.724 . . . . 0.0 111.525 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.1 m -116.97 138.88 51.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.201 1.801 . . . . 0.0 111.415 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.25 176.3 8.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.4 1.88 . . . . 0.0 111.651 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.11 61.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.904 1.281 . . . . 0.0 114.359 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -162.72 178.14 8.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.206 1.802 . . . . 0.0 112.689 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.9 p -68.5 27.4 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.491 2.316 . . . . 0.0 117.032 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.8 t -119.85 -45.04 2.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.649 2.379 . . . . 0.0 110.394 174.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.06 -40.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 O-C-N 121.783 -0.573 . . . . 0.0 110.212 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.05 -53.21 59.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.93 1.292 . . . . 0.0 111.202 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -58.63 -36.62 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.958 1.303 . . . . 0.0 112.872 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 t -77.55 -29.54 52.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.754 0.822 . . . . 0.0 112.17 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -21.52 62.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.96 1.704 . . . . 0.0 113.56 167.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.45 10.61 33.15 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.563 1.554 . . . . 0.0 115.351 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.286 1.835 . . . . 0.0 110.798 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p -81.09 170.63 15.95 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.776 0.83 . . . . 0.0 111.027 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.99 149.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.798 1.239 . . . . 0.0 110.715 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -110.19 -26.89 9.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.401 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -161.89 170.28 19.72 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.597 1.159 . . . . 0.0 112.938 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.41 155.62 36.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.412 1.885 . . . . 0.0 111.97 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.16 164.92 28.7 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.575 1.56 . . . . 0.0 113.529 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 m -63.2 136.23 57.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.717 -0.872 . . . . 0.0 110.971 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.88 148.52 82.04 Favored Pre-proline 0 CA--C 1.548 0.903 0 O-C-N 121.82 -0.55 . . . . 0.0 111.9 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.539 0.732 0 C-N-CA 123.094 2.529 . . . . 0.0 112.248 176.961 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.6 163.39 36.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.544 2.829 . . . . 0.0 113.196 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -84.52 -4.24 58.84 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 tt -48.68 131.56 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.085 2.154 . . . . 0.0 113.332 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.76 79.03 7.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.579 . . . . 0.0 110.576 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -143.32 71.48 17.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.835 0.854 . . . . 0.0 110.429 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.55 160.62 45.07 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.013 1.809 . . . . 0.0 112.089 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.52 155.19 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 110.198 -172.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -98.25 112.91 24.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.167 0.587 . . . . 0.0 111.112 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.07 164.42 51.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.433 0.539 . . . . 0.0 113.005 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -64.26 -18.89 65.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.35 -22.85 60.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.593 1.157 . . . . 0.0 113.242 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.33 42.2 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 127.043 2.259 . . . . 0.0 114.124 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -83.55 159.8 21.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.196 1.798 . . . . 0.0 111.244 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.8 t -113.89 147.95 37.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.451 1.501 . . . . 0.0 112.767 173.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.79 178.02 7.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.248 2.219 . . . . 0.0 110.688 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.55 74.09 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -157.2 -176.87 6.21 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.908 1.683 . . . . 0.0 113.366 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.9 p -73.73 14.0 0.43 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 116.009 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -107.12 -48.08 3.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.53 1.932 . . . . 0.0 111.179 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 tp -65.57 -41.4 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -61.59 -42.5 98.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.204 1.002 . . . . 0.0 112.196 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -64.25 -37.89 89.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.308 1.443 . . . . 0.0 112.597 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -71.8 -29.15 64.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.481 0.712 . . . . 0.0 112.01 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -10.44 57.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.428 1.891 . . . . 0.0 114.816 174.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.69 14.89 38.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.648 1.118 . . . . 0.0 115.326 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 159.22 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.9 1.68 . . . . 0.0 111.178 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 p -100.61 158.15 16.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.411 1.085 . . . . 0.0 111.814 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 27' ' ' ALA . 37.5 mm -93.34 109.72 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.958 1.303 . . . . 0.0 109.944 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -76.01 -46.0 31.7 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.041 1.336 . . . . 0.0 112.264 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 t -153.73 164.28 38.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.817 0.847 . . . . 0.0 112.907 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -84.63 155.19 22.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.421 1.488 . . . . 0.0 112.799 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.09 151.01 13.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.715 1.15 . . . . 0.0 111.596 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -61.63 135.44 57.63 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.697 -0.884 . . . . 0.0 111.609 173.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.41 150.56 97.8 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.927 0.491 . . . . 0.0 111.557 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.54 0.805 0 C-N-CA 123.339 2.692 . . . . 0.0 112.633 179.497 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.26 162.92 19.95 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.539 2.826 . . . . 0.0 113.227 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -84.38 -7.94 59.15 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 pt -54.7 133.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.093 1.757 . . . . 0.0 112.946 -171.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -76.08 76.79 2.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.511 1.524 . . . . 0.0 111.21 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -132.85 66.97 77.5 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 126.194 1.797 . . . . 0.0 111.337 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -61.69 157.74 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.926 1.751 . . . . 0.0 111.945 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -143.77 154.96 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.012 2.125 . . . . 0.0 110.262 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -90.69 112.62 24.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.155 0.582 . . . . 0.0 109.8 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.87 159.17 46.55 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.681 0.657 . . . . 0.0 113.496 170.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 p -63.16 -22.41 66.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.34 1.456 . . . . 0.0 114.506 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -84.57 -10.27 57.55 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.527 1.131 . . . . 0.0 113.842 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.66 60.77 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 126.579 2.038 . . . . 0.0 113.908 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -66.31 157.62 31.21 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.841 1.656 . . . . 0.0 111.444 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.1 m -121.97 135.77 54.88 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.396 1.878 . . . . 0.0 110.519 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.32 177.61 6.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.33 1.852 . . . . 0.0 111.662 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.37 77.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -148.83 -179.69 7.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.221 1.408 . . . . 0.0 111.846 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.6 p -66.41 -43.97 84.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.475 1.11 . . . . 0.0 113.002 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 t -61.55 -41.67 97.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.95 1.3 . . . . 0.0 112.217 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 tp -67.39 -42.95 87.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.93 63.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.106 1.362 . . . . 0.0 111.431 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -56.73 -41.14 76.97 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.461 1.104 . . . . 0.0 112.54 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.84 -26.49 59.74 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -8.79 41.65 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.855 1.662 . . . . 0.0 114.175 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.27 15.69 46.72 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.914 1.245 . . . . 0.0 114.736 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.86 142.74 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.122 1.769 . . . . 0.0 110.779 -174.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -84.12 152.68 24.17 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.984 -0.447 . . . . 0.0 109.94 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.47 149.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 167.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -119.18 -22.34 7.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.259 1.424 . . . . 0.0 112.853 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.7 p -160.95 167.75 25.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.243 1.417 . . . . 0.0 112.616 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.33 154.23 25.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.72 1.208 . . . . 0.0 112.264 173.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.11 165.97 36.99 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.362 1.458 . . . . 0.0 113.185 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.7 t -60.15 149.66 32.12 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.731 -0.864 . . . . 0.0 111.576 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.49 141.24 22.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.564 0.746 . . . . 0.0 112.186 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 CA--C 1.537 0.672 0 C-N-CA 123.074 2.516 . . . . 0.0 112.32 -176.484 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.8 m . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.45 162.56 35.79 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.755 2.97 . . . . 0.0 113.229 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -78.57 -9.17 59.26 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -50.52 113.9 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.942 2.097 . . . . 0.0 113.021 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -70.8 91.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.796 1.238 . . . . 0.0 110.508 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 69.77 14.46 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.179 0.991 . . . . 0.0 110.5 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.58 161.34 28.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.361 2.041 . . . . 0.0 112.214 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.89 155.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.401 2.28 . . . . 0.0 109.719 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -99.57 114.74 27.95 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.907 0.883 . . . . 0.0 109.584 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.96 166.54 40.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.547 1.07 . . . . 0.0 114.127 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.27 -30.2 59.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.997 1.319 . . . . 0.0 113.708 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.35 -18.39 49.2 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.927 1.291 . . . . 0.0 113.777 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.74 -3.87 49.65 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.358 1.932 . . . . 0.0 114.328 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -70.61 157.92 37.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 111.953 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -111.63 141.54 45.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 111.536 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.13 173.59 10.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.527 1.931 . . . . 0.0 111.053 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.92 82.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.041 . . . . 0.0 113.741 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -162.07 -176.38 5.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.343 1.457 . . . . 0.0 113.125 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -60.84 -35.61 77.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -62.52 -39.17 92.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.049 1.34 . . . . 0.0 112.444 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 tp -79.7 -42.32 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 O-C-N 121.773 -0.579 . . . . 0.0 110.49 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.1 70.0 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.287 1.035 . . . . 0.0 112.37 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -57.58 -41.66 81.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.546 1.138 . . . . 0.0 112.846 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.46 -24.08 50.33 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.816 1.246 . . . . 0.0 112.629 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -11.47 60.66 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.29 1.836 . . . . 0.0 113.797 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 17.92 39.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.014 1.292 . . . . 0.0 115.22 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.11 146.09 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.221 1.808 . . . . 0.0 111.134 -172.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -82.13 147.59 28.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.27 1.028 . . . . 0.0 110.918 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.83 131.8 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -89.79 -40.4 12.49 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.273 1.429 . . . . 0.0 111.98 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -145.37 160.33 41.7 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.167 1.387 . . . . 0.0 112.349 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.37 154.14 35.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.932 1.293 . . . . 0.0 112.167 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.19 162.39 28.63 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.152 1.358 . . . . 0.0 112.942 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.5 t -64.14 147.19 52.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.654 -0.909 . . . . 0.0 111.329 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.66 143.1 33.29 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.798 0.839 . . . . 0.0 112.08 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.813 -179.727 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.8 m . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 120.312 0.101 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.9 163.3 35.75 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.479 2.786 . . . . 0.0 113.571 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -79.93 -8.34 59.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.116 1.766 . . . . 0.0 114.93 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 135.43 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.636 1.975 . . . . 0.0 113.077 -171.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.69 81.11 8.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.367 1.867 . . . . 0.0 111.79 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.29 70.0 77.54 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.094 1.358 . . . . 0.0 110.638 172.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.19 161.69 29.42 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.547 2.164 . . . . 0.0 112.817 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.6 m -147.16 153.62 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.915 2.086 . . . . 0.0 110.64 -172.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -99.29 111.61 23.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.831 0.852 . . . . 0.0 111.871 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.88 162.56 48.32 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.615 1.102 . . . . 0.0 113.967 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 m -59.54 -25.45 64.53 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -78.74 -15.86 57.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.373 1.069 . . . . 0.0 113.267 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 -1.45 59.68 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 126.61 2.052 . . . . 0.0 113.974 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -72.58 158.2 36.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.897 1.679 . . . . 0.0 111.116 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.0 m -116.85 140.6 49.25 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.695 1.998 . . . . 0.0 110.595 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.16 175.83 8.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.981 1.712 . . . . 0.0 111.418 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.67 72.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.508 1.123 . . . . 0.0 113.818 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.92 -174.52 4.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.377 1.871 . . . . 0.0 112.491 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 p -58.62 -39.87 81.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.67 -47.31 82.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.451 1.5 . . . . 0.0 111.654 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.46 -42.56 64.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.06 74.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.543 1.137 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -56.12 -43.37 78.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.64 1.976 . . . . 0.0 112.162 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -76.18 -24.98 54.78 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -9.73 49.02 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.94 1.696 . . . . 0.0 114.073 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.6 15.55 54.65 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.893 1.235 . . . . 0.0 114.906 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.6 162.19 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.497 1.919 . . . . 0.0 111.468 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 132.3 56.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.249 1.42 . . . . 0.0 109.376 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 pt -78.99 140.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.998 -0.439 . . . . 0.0 111.245 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -93.12 -35.25 13.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.444 1.098 . . . . 0.0 112.285 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -149.38 161.16 42.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.629 1.172 . . . . 0.0 112.303 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.57 160.31 25.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 169.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.3 166.0 40.21 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.48 1.514 . . . . 0.0 113.132 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.9 t -63.11 150.42 42.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.926 -0.749 . . . . 0.0 111.282 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.49 137.02 19.27 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.328 1.051 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 112.765 -178.274 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 120.304 0.097 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.72 158.16 57.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.16 2.573 . . . . 0.0 113.016 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.83 -5.44 43.54 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.419 1.888 . . . . 0.0 114.73 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 tt -51.24 131.89 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.886 2.074 . . . . 0.0 113.539 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 tt -82.12 78.63 8.78 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.116 1.766 . . . . 0.0 109.531 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -143.25 68.39 17.43 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 111.567 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.22 168.69 12.07 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.741 2.961 . . . . 0.0 113.615 -172.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.06 158.58 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.485 1.914 . . . . 0.0 111.023 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -98.71 113.17 25.13 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.889 0.875 . . . . 0.0 109.758 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 153.7 51.45 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 113.414 173.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -59.72 -26.41 65.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.112 0.965 . . . . 0.0 113.204 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.06 -19.3 61.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.225 1.41 . . . . 0.0 113.337 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.41 -8.15 40.62 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.859 2.171 . . . . 0.0 114.507 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -75.77 160.15 30.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.486 1.915 . . . . 0.0 111.701 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -111.58 143.31 42.65 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.668 1.987 . . . . 0.0 110.77 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.34 175.21 9.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.559 1.943 . . . . 0.0 110.979 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -47.76 79.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.201 1.001 . . . . 0.0 113.591 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -156.55 -173.31 4.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 112.433 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 p -60.81 -37.14 80.96 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -60.53 -46.91 88.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.429 1.492 . . . . 0.0 112.474 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 tp -69.76 -39.71 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 122.359 1.076 . . . . 0.0 110.339 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.77 77.84 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.932 1.693 . . . . 0.0 112.472 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -58.09 -34.56 70.32 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.574 1.55 . . . . 0.0 112.682 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.3 t -79.54 -30.73 41.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.432 0.693 . . . . 0.0 111.653 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -66.49 -5.32 10.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.128 1.771 . . . . 0.0 113.942 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 9.66 68.2 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.586 1.565 . . . . 0.0 115.19 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.0 152.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.909 1.283 . . . . 0.0 111.896 -171.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.4 m -85.23 -19.27 31.9 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -168.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.2 mm 53.49 88.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 130.74 3.616 . . . . 0.0 112.73 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -75.07 -32.96 61.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.778 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -160.54 168.79 24.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 0.0 112.714 172.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -93.18 163.43 13.63 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.813 1.645 . . . . 0.0 112.319 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.05 165.42 26.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.607 1.575 . . . . 0.0 112.63 -171.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -64.82 147.22 53.64 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.436 -1.038 . . . . 0.0 111.273 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.73 143.67 36.03 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.579 0.752 . . . . 0.0 111.902 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 123.547 2.831 . . . . 0.0 112.971 -176.592 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.83 161.45 46.04 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.554 2.836 . . . . 0.0 113.366 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.8 -7.0 52.08 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 tt -51.61 127.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.321 1.848 . . . . 0.0 113.458 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -80.75 97.34 7.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -156.69 72.85 4.8 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 123.486 0.714 . . . . 0.0 111.945 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.99 166.98 16.94 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.238 1.959 . . . . 0.0 113.012 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.38 147.77 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 127.091 2.156 . . . . 0.0 110.113 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.05 115.93 26.96 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.54 165.66 46.99 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.069 0.842 . . . . 0.0 114.083 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 t -62.06 -27.45 68.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 113.154 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.95 -24.2 58.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.918 1.287 . . . . 0.0 113.226 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.92 -8.41 39.18 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 126.785 2.136 . . . . 0.0 114.333 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -66.95 160.76 25.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.764 1.626 . . . . 0.0 111.088 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.5 t -109.5 156.5 20.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.706 1.202 . . . . 0.0 112.022 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.28 169.54 17.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.702 2.001 . . . . 0.0 110.272 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.28 81.41 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -159.13 -176.85 6.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.428 1.491 . . . . 0.0 112.461 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 p -58.87 -34.86 72.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.92 -43.22 96.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 112.65 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -38.96 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.704 -0.622 . . . . 0.0 110.255 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -51.36 69.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.951 1.301 . . . . 0.0 112.519 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -61.11 -32.5 72.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -88.19 -19.56 26.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.244 1.417 . . . . 0.0 112.384 -173.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.07 -6.27 32.63 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.926 2.09 . . . . 0.0 114.448 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.16 60.12 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.641 1.115 . . . . 0.0 114.736 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.27 168.14 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.054 2.542 . . . . 0.0 110.622 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -119.38 167.43 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.871 1.268 . . . . 0.0 110.642 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.91 138.15 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.027 1.331 . . . . 0.0 110.462 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -100.94 -31.57 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.846 1.659 . . . . 0.0 113.097 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 164.01 39.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.622 1.169 . . . . 0.0 112.022 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.29 152.11 23.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.66 1.584 . . . . 0.0 112.693 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.46 167.39 28.66 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.938 1.256 . . . . 0.0 112.48 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.8 t -63.67 148.72 48.29 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.718 -0.872 . . . . 0.0 111.387 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.28 145.42 60.0 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 111.402 174.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.539 0.739 0 C-N-CA 122.68 2.254 . . . . 0.0 111.573 176.531 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -81.48 57.9 3.46 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 119.849 -1.782 . . . . 0.0 112.013 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 t -67.03 142.33 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.219 1.407 . . . . 0.0 110.56 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.38 139.22 58.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.533 0.733 . . . . 0.0 112.2 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.99 92.72 1.31 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.572 1.149 . . . . 0.0 111.228 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.5 m -121.61 159.3 51.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 126.661 1.984 . . . . 0.0 111.151 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.8 165.24 28.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.418 2.745 . . . . 0.0 112.919 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -75.79 -8.09 56.01 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -56.02 131.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.55 1.94 . . . . 0.0 111.183 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -84.26 79.01 9.68 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 109.69 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -127.41 63.09 57.39 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 125.376 1.471 . . . . 0.0 110.963 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.86 161.99 33.99 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.859 2.373 . . . . 0.0 112.663 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.84 154.58 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.889 2.075 . . . . 0.0 110.454 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.26 113.78 25.06 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.415 0.686 . . . . 0.0 109.728 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.66 160.38 53.0 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.128 0.394 . . . . 0.0 113.313 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -64.76 -23.3 67.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.59 -19.14 58.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.097 1.359 . . . . 0.0 113.17 171.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.52 -7.92 47.03 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.16 2.315 . . . . 0.0 113.789 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -67.23 156.85 35.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.915 1.686 . . . . 0.0 111.964 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.4 m -113.64 136.28 53.0 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.021 2.128 . . . . 0.0 110.184 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.22 174.21 9.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.181 1.792 . . . . 0.0 111.133 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.67 72.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.391 1.076 . . . . 0.0 113.853 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -162.33 -176.7 5.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.314 1.446 . . . . 0.0 112.764 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -57.02 -39.95 75.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -55.46 -45.92 76.87 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.942 1.297 . . . . 0.0 111.843 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 tp -75.99 -43.0 39.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.212 -0.305 . . . . 0.0 110.479 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.35 -48.85 75.94 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.571 1.148 . . . . 0.0 112.526 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.953 1.701 . . . . 0.0 111.987 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.23 -30.79 67.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.995 0.918 . . . . 0.0 112.331 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -7.29 17.98 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.662 1.585 . . . . 0.0 114.191 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.08 18.92 52.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.813 1.197 . . . . 0.0 114.847 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.67 158.49 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.629 1.572 . . . . 0.0 110.908 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 t -96.52 166.05 11.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 0.0 110.574 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -102.66 142.37 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.215 1.406 . . . . 0.0 110.149 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -97.47 -31.34 12.4 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.347 1.459 . . . . 0.0 111.633 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.2 p -162.37 169.61 20.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.706 1.602 . . . . 0.0 112.474 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.61 160.44 29.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.903 1.281 . . . . 0.0 112.597 168.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.05 166.25 25.16 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.347 1.451 . . . . 0.0 112.811 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 p -64.06 146.7 53.71 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.443 -1.034 . . . . 0.0 111.94 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.14 146.66 40.78 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 122.931 0.492 . . . . 0.0 111.508 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.33 152.23 66.26 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.645 2.23 . . . . 0.0 112.032 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 t -75.14 -13.62 60.48 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.42 72.78 0.89 Allowed Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.309 1.909 . . . . 0.0 112.644 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.687 1.595 . . . . 0.0 113.217 175.868 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 160.86 29.98 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.508 -0.745 . . . . 0.0 111.234 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.68 2.24 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.525 1.53 . . . . 0.0 112.396 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.0 t -147.11 143.92 28.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.486 1.514 . . . . 0.0 111.725 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.76 94.07 3.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.731 1.212 . . . . 0.0 111.67 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.0 m -128.25 159.19 68.52 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.395 1.878 . . . . 0.0 111.556 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.53 166.89 26.56 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.513 2.808 . . . . 0.0 113.386 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -80.28 -6.65 58.26 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.6 133.35 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.455 1.902 . . . . 0.0 111.361 -172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 79.98 8.64 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.33 1.852 . . . . 0.0 110.469 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -129.83 66.88 78.51 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 125.269 1.428 . . . . 0.0 110.907 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.35 162.2 31.4 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.985 2.457 . . . . 0.0 113.065 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -144.83 155.83 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.505 1.922 . . . . 0.0 110.881 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t -94.98 111.09 22.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.916 0.887 . . . . 0.0 111.18 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.51 163.71 51.33 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.053 0.835 . . . . 0.0 114.307 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.4 t -63.62 -25.63 68.31 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.4 -17.12 60.85 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.072 1.349 . . . . 0.0 113.121 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.99 -5.68 63.69 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.872 2.177 . . . . 0.0 113.711 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -68.21 157.53 35.26 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.369 1.868 . . . . 0.0 111.775 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.6 m -113.76 137.94 50.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.48 1.912 . . . . 0.0 110.702 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.34 176.03 8.27 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.124 1.77 . . . . 0.0 111.395 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.3 -51.02 71.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.73 1.212 . . . . 0.0 113.814 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -159.78 -174.95 4.86 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.581 1.553 . . . . 0.0 112.569 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -58.4 -39.69 80.39 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.4 t -57.02 -48.45 78.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.284 1.434 . . . . 0.0 111.237 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 tp -71.12 -43.32 75.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -51.5 68.45 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.532 1.133 . . . . 0.0 112.347 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -61.14 -41.4 96.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.987 1.715 . . . . 0.0 111.835 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.1 t -74.15 -24.06 59.36 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.487 0.715 . . . . 0.0 112.413 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -10.89 59.07 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.903 1.681 . . . . 0.0 113.94 169.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.59 15.4 56.88 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.79 1.186 . . . . 0.0 115.184 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.06 148.65 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.666 1.586 . . . . 0.0 111.675 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -78.71 168.58 19.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.914 0.886 . . . . 0.0 111.231 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.68 134.85 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 110.532 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -69.61 -47.97 61.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.854 1.261 . . . . 0.0 110.768 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 t -165.81 177.67 7.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.225 1.41 . . . . 0.0 112.104 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.45 164.99 24.95 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.841 1.656 . . . . 0.0 113.321 172.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.5 162.4 21.04 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.015 1.769 . . . . 0.0 113.426 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -65.63 135.38 54.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.888 0.875 . . . . 0.0 110.975 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 142.65 64.88 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.817 -0.552 . . . . 0.0 112.097 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.17 137.43 52.0 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.77 2.313 . . . . 0.0 111.162 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.3 m 59.55 13.99 3.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.66 1.584 . . . . 0.0 113.584 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.15 0.1 89.09 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.656 1.598 . . . . 0.0 116.119 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mt . . . . . 0 C--O 1.253 1.264 0 C-N-CA 127.241 2.217 . . . . 0.0 109.937 178.536 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -129.22 106.15 8.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.327 1.851 . . . . 0.0 110.494 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t -105.58 146.83 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.852 1.661 . . . . 0.0 109.83 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 136.89 57.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.663 0.785 . . . . 0.0 112.192 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.4 96.86 1.52 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.192 0.997 . . . . 0.0 110.874 171.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.5 m -124.68 157.49 65.61 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.88 1.672 . . . . 0.0 112.264 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.66 163.9 36.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.694 2.929 . . . . 0.0 114.222 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -75.52 -6.35 49.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.115 2.166 . . . . 0.0 115.317 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -54.35 136.25 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 112.799 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.95 85.29 5.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.926 1.691 . . . . 0.0 110.583 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -140.97 68.09 28.03 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.387 1.075 . . . . 0.0 111.057 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.49 159.93 34.08 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.819 1.679 . . . . 0.0 111.817 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.81 158.12 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.771 2.029 . . . . 0.0 109.961 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -97.1 114.13 25.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.325 0.65 . . . . 0.0 109.618 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.67 163.0 47.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.77 0.7 . . . . 0.0 113.03 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 t -63.36 -19.75 64.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.83 -12.69 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 172.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.18 -4.48 58.73 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.745 2.117 . . . . 0.0 114.32 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -67.11 156.49 36.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.286 1.834 . . . . 0.0 111.615 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.7 m -115.07 132.63 56.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.769 2.028 . . . . 0.0 110.59 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.6 174.81 6.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.246 1.819 . . . . 0.0 111.418 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -49.63 76.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.384 1.074 . . . . 0.0 113.564 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -162.06 -175.97 4.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 113.896 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -62.64 -37.85 87.97 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.01 -46.05 85.89 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.793 1.237 . . . . 0.0 111.823 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.26 -46.53 65.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.34 -46.0 80.13 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.143 0.977 . . . . 0.0 113.023 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.45 -28.64 65.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.656 1.982 . . . . 0.0 114.019 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.8 t -97.72 -24.71 15.36 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.355 1.462 . . . . 0.0 111.926 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -69.54 -11.8 61.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.476 1.91 . . . . 0.0 113.503 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.99 56.03 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.433 1.016 . . . . 0.0 114.782 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.41 151.49 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.992 1.317 . . . . 0.0 110.879 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.14 138.3 31.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 108.955 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.88 137.67 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.976 0.807 . . . . 0.0 109.53 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -96.98 -34.1 11.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 112.433 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -157.27 168.33 27.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.07 0.948 . . . . 0.0 112.682 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.25 149.27 25.6 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.403 1.881 . . . . 0.0 111.675 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.56 161.85 28.36 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.908 1.242 . . . . 0.0 112.28 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -63.59 149.89 45.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.574 -0.957 . . . . 0.0 112.236 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.98 149.44 50.46 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.132 0.573 . . . . 0.0 112.17 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.5 162.6 39.65 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.395 2.73 . . . . 0.0 112.566 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 p -93.21 68.53 4.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.146 1.378 . . . . 0.0 111.959 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.65 124.79 1.69 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.335 1.445 . . . . 0.0 112.74 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.783 2.033 . . . . 0.0 112.032 174.512 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 119.788 -0.149 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.29 -178.66 6.26 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.797 1.639 . . . . 0.0 112.273 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.27 154.44 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.354 1.462 . . . . 0.0 112.011 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.1 m -72.03 93.28 1.37 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.928 1.691 . . . . 0.0 111.37 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.03 97.75 1.51 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.384 1.074 . . . . 0.0 111.307 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m -122.39 157.81 57.74 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.958 1.703 . . . . 0.0 112.423 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.27 167.86 24.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.023 3.149 . . . . 0.0 114.335 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.08 -9.85 58.95 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 pt -58.1 114.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.418 1.887 . . . . 0.0 113.813 -171.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.98 85.66 0.52 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 110.848 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.74 72.6 55.7 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 125.91 1.684 . . . . 0.0 109.888 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.79 160.64 35.94 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.189 1.926 . . . . 0.0 112.085 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.19 157.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.857 2.063 . . . . 0.0 110.48 -170.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.71 114.04 27.94 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.605 0.762 . . . . 0.0 111.693 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.29 163.08 51.44 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.88 1.229 . . . . 0.0 114.406 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 t -61.89 -28.55 69.59 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.216 . . . . 0.0 113.551 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.39 -10.79 59.83 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.285 1.034 . . . . 0.0 113.313 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.05 -5.51 61.43 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.84 2.162 . . . . 0.0 113.884 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -70.3 157.03 38.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.429 1.892 . . . . 0.0 111.798 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 m -115.17 137.59 51.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.039 2.136 . . . . 0.0 110.525 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 173.04 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.984 1.714 . . . . 0.0 111.439 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.15 86.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.546 1.138 . . . . 0.0 114.018 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -160.12 -174.7 4.67 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.801 1.64 . . . . 0.0 112.494 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.2 p -59.98 -41.39 91.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.79 -47.42 80.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.3 1.44 . . . . 0.0 111.405 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 tp -71.93 -43.71 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.56 76.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 112.27 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -59.82 -41.79 92.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.895 1.678 . . . . 0.0 111.952 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.4 t -74.25 -25.09 59.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.947 0.899 . . . . 0.0 112.504 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -11.07 59.8 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.044 1.738 . . . . 0.0 114.179 172.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.14 44.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.694 1.14 . . . . 0.0 115.105 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.5 154.6 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.04 1.736 . . . . 0.0 111.133 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -98.77 144.59 27.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.386 1.074 . . . . 0.0 109.444 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 pt -91.82 134.91 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.651 0.659 . . . . 0.0 111.025 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.08 -34.98 22.12 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 112.227 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -160.62 173.65 15.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.496 1.118 . . . . 0.0 112.458 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.68 161.44 23.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.058 1.743 . . . . 0.0 112.839 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.81 156.97 15.08 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.325 1.441 . . . . 0.0 112.262 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -64.01 142.32 58.45 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.607 -0.937 . . . . 0.0 111.5 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.12 150.66 71.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.63 151.15 57.99 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.096 2.531 . . . . 0.0 112.079 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 m -78.36 -10.81 59.83 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.093 1.357 . . . . 0.0 113.166 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.55 149.59 5.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 128.058 2.742 . . . . 0.0 110.997 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.596 1.558 . . . . 0.0 112.569 -177.146 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.6 pttm . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -76.12 102.1 5.59 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 121.39 1.905 . . . . 0.0 112.662 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.1 t -89.37 147.08 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.88 1.672 . . . . 0.0 110.999 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 137.97 56.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.279 1.032 . . . . 0.0 112.713 173.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.39 97.92 2.62 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.458 1.103 . . . . 0.0 111.416 170.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m -124.01 157.77 62.55 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.414 1.886 . . . . 0.0 111.732 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.88 163.88 34.62 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.745 2.963 . . . . 0.0 113.596 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.05 -8.52 57.58 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -53.36 111.84 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.59 1.956 . . . . 0.0 113.285 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.97 84.3 0.97 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.712 1.605 . . . . 0.0 111.332 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -141.45 74.05 24.26 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.205 1.402 . . . . 0.0 109.748 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.98 165.38 21.66 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.82 2.347 . . . . 0.0 112.84 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -145.6 153.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -98.19 113.0 24.77 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.009 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.59 164.82 37.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.403 1.002 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -60.61 -29.71 69.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.41 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -79.01 -13.5 59.75 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.847 1.259 . . . . 0.0 113.488 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.51 -3.17 59.3 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 126.281 1.896 . . . . 0.0 114.049 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -66.16 156.28 34.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.722 1.609 . . . . 0.0 111.464 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 m -114.0 138.4 50.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.54 1.936 . . . . 0.0 110.111 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.89 174.1 9.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.691 1.596 . . . . 0.0 111.25 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.43 -49.03 77.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 113.443 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -159.7 -174.29 4.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.462 1.505 . . . . 0.0 113.206 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.7 p -61.17 -38.0 84.94 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.04 -46.09 85.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.19 1.396 . . . . 0.0 111.79 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.64 -41.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 O-C-N 122.066 -0.397 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.36 -47.77 82.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.731 1.212 . . . . 0.0 112.405 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -59.06 -42.51 90.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 111.82 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.6 -27.87 61.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.917 0.887 . . . . 0.0 112.598 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -7.33 22.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.724 1.61 . . . . 0.0 114.113 175.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 18.84 48.99 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.875 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.3 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.779 1.631 . . . . 0.0 111.093 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.3 p -82.74 168.32 17.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.586 0.754 . . . . 0.0 111.488 168.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.58 137.49 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.102 1.361 . . . . 0.0 110.064 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -92.54 -33.55 14.41 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.698 1.199 . . . . 0.0 112.039 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 m -150.93 162.41 40.86 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.708 1.603 . . . . 0.0 112.26 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.87 162.91 27.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.43 1.092 . . . . 0.0 112.329 165.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 167.63 31.21 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.313 1.435 . . . . 0.0 113.002 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 p -66.13 149.09 50.83 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.51 -0.994 . . . . 0.0 111.562 169.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 145.17 32.04 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.002 0.521 . . . . 0.0 112.194 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.85 157.06 52.21 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.916 2.411 . . . . 0.0 112.359 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.8 p -83.02 -5.84 59.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.313 1.445 . . . . 0.0 114.491 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.77 86.43 0.1 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.301 1.429 . . . . 0.0 112.171 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.985 1.714 . . . . 0.0 113.289 175.718 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . 0.272 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -71.5 112.53 7.7 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.159 1.783 . . . . 0.0 111.166 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.85 151.64 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.73 1.212 . . . . 0.0 112.162 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.8 m -71.92 121.53 19.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.763 0.825 . . . . 0.0 111.677 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.08 99.84 0.54 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.867 1.267 . . . . 0.0 111.294 172.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.9 m -124.26 159.04 58.96 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.605 1.962 . . . . 0.0 110.979 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.12 164.09 29.85 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.341 2.694 . . . . 0.0 112.962 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -81.22 -5.78 58.13 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.01 131.2 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.222 1.809 . . . . 0.0 110.749 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.15 78.4 8.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.158 1.783 . . . . 0.0 110.318 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -130.06 69.64 81.88 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.899 1.28 . . . . 0.0 109.667 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.19 161.74 38.98 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.15 1.9 . . . . 0.0 112.44 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.7 157.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 127.007 2.123 . . . . 0.0 110.627 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -102.53 114.81 29.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.783 0.833 . . . . 0.0 111.674 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 162.33 54.6 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.15 0.881 . . . . 0.0 113.943 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -61.74 -26.05 67.82 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.4 1.48 . . . . 0.0 114.228 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.1 -19.44 54.15 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.67 1.188 . . . . 0.0 112.989 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.16 -7.15 32.61 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 127.381 2.419 . . . . 0.0 114.166 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -74.38 158.01 34.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.61 1.564 . . . . 0.0 112.199 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.3 m -114.74 125.85 54.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.658 2.383 . . . . 0.0 110.653 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.17 174.6 6.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.884 1.674 . . . . 0.0 111.65 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.46 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.455 1.102 . . . . 0.0 113.751 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -163.18 -175.92 4.55 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.658 1.983 . . . . 0.0 112.665 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -57.87 -39.28 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.77 -46.7 81.31 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.062 1.345 . . . . 0.0 111.829 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -75.06 -41.6 45.29 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 O-C-N 122.225 -0.297 . . . . 0.0 110.284 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.87 78.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.445 1.098 . . . . 0.0 112.234 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -59.42 -39.92 85.03 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.032 1.733 . . . . 0.0 112.436 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.9 -34.63 73.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -8.92 17.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.889 1.676 . . . . 0.0 114.545 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.84 50.58 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.975 1.274 . . . . 0.0 114.814 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.04 156.65 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.912 2.085 . . . . 0.0 110.823 -172.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -106.96 139.02 42.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 109.606 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.0 pt -85.56 136.02 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.753 -0.592 . . . . 0.0 111.175 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -90.74 -31.66 16.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.818 1.247 . . . . 0.0 112.537 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 m -158.85 164.55 35.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.886 1.675 . . . . 0.0 111.928 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -80.45 160.64 25.24 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 111.811 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.2 159.88 23.71 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.205 1.383 . . . . 0.0 112.425 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -63.58 143.0 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.59 -0.947 . . . . 0.0 111.598 171.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 149.09 61.51 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 122.05 -0.406 . . . . 0.0 111.89 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.1 155.88 60.65 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.049 2.499 . . . . 0.0 112.104 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.01 -1.61 39.34 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.868 1.267 . . . . 0.0 113.325 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.14 92.2 1.72 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.409 1.481 . . . . 0.0 111.718 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.383 1.873 . . . . 0.0 110.675 -175.065 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -135.13 159.05 42.76 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.94 1.696 . . . . 0.0 112.378 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.1 -6.08 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 125.81 1.644 . . . . 0.0 112.288 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.7 m -85.43 101.52 12.68 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.351 2.26 . . . . 0.0 110.768 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.16 101.65 0.56 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.323 1.049 . . . . 0.0 111.685 175.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.4 m -129.75 157.84 75.44 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.401 1.88 . . . . 0.0 111.774 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.4 161.44 45.56 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.575 2.85 . . . . 0.0 113.446 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -74.82 -8.3 56.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.837 1.655 . . . . 0.0 114.73 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -49.47 128.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.683 1.993 . . . . 0.0 113.378 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.8 mt -84.85 77.19 10.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 110.178 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -142.4 73.42 20.87 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 124.151 0.98 . . . . 0.0 110.69 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.23 164.19 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.12 1.88 . . . . 0.0 112.551 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.15 169.17 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.932 2.093 . . . . 0.0 110.383 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -113.7 110.07 19.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.415 0.686 . . . . 0.0 110.577 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.45 155.14 52.9 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.927 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -57.4 -23.37 48.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.802 1.641 . . . . 0.0 114.44 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.32 -24.3 64.82 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.314 1.446 . . . . 0.0 113.086 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.15 -8.03 35.55 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 127.502 2.477 . . . . 0.0 114.01 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -78.68 158.75 28.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.535 1.934 . . . . 0.0 111.458 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.4 t -116.84 149.57 39.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.662 1.585 . . . . 0.0 112.699 172.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.86 177.19 8.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.974 2.11 . . . . 0.0 110.814 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -158.77 -177.35 6.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.939 1.696 . . . . 0.0 112.712 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 p -58.13 -36.51 73.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.7 t -63.29 -42.56 99.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.721 1.608 . . . . 0.0 112.248 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.88 -44.87 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.675 -0.641 . . . . 0.0 110.106 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.44 98.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.784 1.234 . . . . 0.0 113.215 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.37 -42.28 98.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.419 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.8 t -76.11 -21.29 56.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.845 1.258 . . . . 0.0 112.412 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -10.04 39.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.84 2.056 . . . . 0.0 113.901 165.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.12 15.03 37.2 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.178 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.43 148.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.847 1.324 . . . . 0.0 111.865 -173.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 132.42 40.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.181 1.793 . . . . 0.0 111.1 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.43 109.62 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.036 0.935 . . . . 0.0 109.999 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -91.72 -35.99 13.84 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.943 0.897 . . . . 0.0 113.062 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -159.94 168.25 26.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.571 1.149 . . . . 0.0 112.276 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.82 163.88 12.02 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.18 1.392 . . . . 0.0 113.645 177.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 160.48 23.08 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.481 1.515 . . . . 0.0 112.11 -168.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.0 m -62.61 135.38 57.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.997 -0.708 . . . . 0.0 110.685 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 146.92 98.7 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 121.961 -0.462 . . . . 0.0 111.212 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 103.89 1.27 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.75 2.966 . . . . 0.0 112.217 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.3 p -75.12 63.91 1.34 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.259 1.823 . . . . 0.0 112.984 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.69 4.63 5.11 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.274 1.892 . . . . 0.0 115.176 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.1 mm . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.494 1.918 . . . . 0.0 111.752 179.483 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.681 0.277 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.46 170.19 21.98 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.27 1.828 . . . . 0.0 111.664 170.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.81 5.27 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 125.737 1.615 . . . . 0.0 112.624 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -133.11 132.45 41.72 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.185 1.794 . . . . 0.0 112.158 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.41 96.92 1.96 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.041 1.336 . . . . 0.0 110.901 170.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.2 m -122.08 155.99 60.45 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.834 1.654 . . . . 0.0 111.106 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.24 155.12 56.58 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.264 2.643 . . . . 0.0 112.272 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -77.72 -6.48 54.09 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.3 tp -45.74 125.46 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.968 2.107 . . . . 0.0 113.459 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -76.9 83.87 3.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.288 1.835 . . . . 0.0 109.814 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -145.5 65.36 11.38 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 111.834 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.43 161.45 34.76 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.232 2.621 . . . . 0.0 112.437 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 157.42 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.716 2.006 . . . . 0.0 111.024 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -91.18 117.19 29.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.146 0.979 . . . . 0.0 110.32 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.5 166.03 42.95 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.437 1.018 . . . . 0.0 114.348 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -56.41 -26.82 54.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 114.412 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.4 -4.68 37.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.733 1.613 . . . . 0.0 113.771 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.19 62.4 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.741 1.638 . . . . 0.0 114.489 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.24 159.04 18.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.926 1.69 . . . . 0.0 111.179 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -124.43 122.35 37.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.687 1.995 . . . . 0.0 110.252 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.97 175.02 5.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.134 1.774 . . . . 0.0 111.196 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.52 87.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -157.23 -175.53 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.9 m -77.84 8.75 4.18 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -104.8 -46.42 4.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.652 1.581 . . . . 0.0 110.714 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.4 -41.06 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.826 0.851 . . . . 0.0 110.233 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.76 72.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.876 1.27 . . . . 0.0 111.495 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.263 1.825 . . . . 0.0 112.561 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.85 -32.77 65.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.507 0.723 . . . . 0.0 112.319 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -10.57 35.04 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.472 1.509 . . . . 0.0 114.206 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 13.71 57.53 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.039 1.304 . . . . 0.0 114.951 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.27 132.52 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.808 2.043 . . . . 0.0 110.626 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 p -75.48 164.57 26.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.727 0.811 . . . . 0.0 111.623 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 pp -102.79 135.48 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.402 1.081 . . . . 0.0 109.381 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -89.17 -35.63 16.13 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.312 1.445 . . . . 0.0 112.488 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -160.12 170.12 21.89 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 112.715 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.06 153.35 32.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.67 1.588 . . . . 0.0 112.904 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.18 156.89 13.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.996 1.284 . . . . 0.0 112.837 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -58.23 136.55 57.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.941 0.897 . . . . 0.0 111.108 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 147.67 82.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 121.837 -0.539 . . . . 0.0 111.29 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.46 146.08 54.89 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.766 2.311 . . . . 0.0 111.994 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.8 p -78.41 -5.81 53.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.261 1.424 . . . . 0.0 114.048 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.84 -18.74 0.49 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.885 1.707 . . . . 0.0 114.767 174.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 tt . . . . . 0 C--O 1.254 1.3 0 C-N-CA 126.924 2.09 . . . . 0.0 112.201 176.46 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 119.505 -0.283 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 47.24 44.59 15.94 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.54 1.936 . . . . 0.0 113.645 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -64.9 137.08 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.377 1.471 . . . . 0.0 110.62 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 32.2 m -79.67 149.36 31.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.016 0.926 . . . . 0.0 111.799 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.31 96.13 1.4 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.405 1.082 . . . . 0.0 111.82 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.8 m -128.04 159.53 66.32 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.674 1.99 . . . . 0.0 111.471 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -80.02 167.5 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.481 2.787 . . . . 0.0 113.488 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -79.63 -7.3 58.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.575 1.55 . . . . 0.0 114.958 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.4 128.42 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 111.261 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.2 mt -80.33 77.97 7.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.484 1.913 . . . . 0.0 110.268 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -133.7 69.19 76.17 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.704 1.202 . . . . 0.0 109.624 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.99 162.89 30.58 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.893 1.729 . . . . 0.0 112.644 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.44 145.13 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.59 1.956 . . . . 0.0 110.037 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -89.67 118.58 29.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.432 0.693 . . . . 0.0 110.803 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.89 161.91 52.56 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.139 0.876 . . . . 0.0 114.326 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.3 t -59.59 -29.67 68.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.811 1.244 . . . . 0.0 113.664 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -74.9 -20.08 59.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.489 1.116 . . . . 0.0 113.013 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.94 -8.75 31.66 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 126.741 2.115 . . . . 0.0 114.238 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -73.39 161.31 30.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.865 1.666 . . . . 0.0 111.505 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 t -110.52 151.75 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.168 1.387 . . . . 0.0 111.838 165.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.34 175.33 9.37 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.203 1.801 . . . . 0.0 111.167 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.38 69.51 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.535 1.134 . . . . 0.0 114.041 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -160.93 -175.39 4.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.276 1.83 . . . . 0.0 112.753 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -57.86 -40.97 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.89 -47.34 77.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.061 1.344 . . . . 0.0 111.869 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.35 -43.95 63.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.21 -49.24 76.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.474 1.11 . . . . 0.0 112.253 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.3 -42.96 87.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.884 1.674 . . . . 0.0 112.2 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.2 t -73.53 -27.54 61.41 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.071 0.549 . . . . 0.0 112.425 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -11.52 60.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.971 1.708 . . . . 0.0 114.114 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 17.33 57.66 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.545 1.069 . . . . 0.0 115.238 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.44 149.01 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.962 1.705 . . . . 0.0 111.38 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -77.12 156.02 31.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.411 0.684 . . . . 0.0 110.598 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.33 126.76 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.257 1.023 . . . . 0.0 109.681 170.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -91.16 -30.06 16.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.278 1.831 . . . . 0.0 112.201 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -162.01 173.37 14.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.515 1.926 . . . . 0.0 111.124 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -84.35 164.02 19.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 0.0 113.233 172.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.95 166.69 25.77 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.509 1.528 . . . . 0.0 112.69 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -67.39 137.61 56.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.645 -0.915 . . . . 0.0 110.83 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 147.84 91.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 122.052 -0.405 . . . . 0.0 111.777 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.92 160.84 45.09 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.175 2.583 . . . . 0.0 112.438 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 t -73.65 -14.92 61.25 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.78 79.48 0.14 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.793 1.664 . . . . 0.0 112.52 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.775 1.63 . . . . 0.0 111.683 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.238 0.066 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -110.33 168.45 9.44 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.146 1.779 . . . . 0.0 111.673 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.77 0.05 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 125.571 1.548 . . . . 0.0 112.259 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.15 145.72 29.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.724 1.61 . . . . 0.0 111.419 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.97 95.3 5.44 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.528 1.131 . . . . 0.0 111.175 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.59 157.35 73.38 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 125.862 1.665 . . . . 0.0 112.055 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.32 162.52 41.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.731 2.954 . . . . 0.0 113.732 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -77.46 -5.42 49.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.474 1.91 . . . . 0.0 114.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -50.7 131.45 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.227 1.811 . . . . 0.0 112.893 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.59 71.36 7.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.126 1.77 . . . . 0.0 110.47 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.04 68.69 80.43 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.005 1.322 . . . . 0.0 111.084 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.02 161.18 34.36 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.383 2.056 . . . . 0.0 112.756 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.12 152.91 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.11 2.164 . . . . 0.0 110.323 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.08 116.39 30.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.568 0.747 . . . . 0.0 111.152 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.56 164.6 50.82 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.711 1.148 . . . . 0.0 114.284 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t -57.42 -30.8 65.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.831 1.252 . . . . 0.0 113.373 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.76 -12.29 59.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.116 1.366 . . . . 0.0 113.936 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.79 -2.23 61.98 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 126.028 1.775 . . . . 0.0 114.215 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -68.46 157.83 35.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.928 1.691 . . . . 0.0 110.957 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.8 m -112.32 141.42 46.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.104 1.761 . . . . 0.0 110.695 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.98 172.16 12.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.131 1.772 . . . . 0.0 110.961 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -160.14 -175.2 4.94 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.444 1.897 . . . . 0.0 112.42 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.5 p -59.65 -38.65 82.01 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.8 t -57.68 -47.51 82.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 111.587 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.37 -42.06 65.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 O-C-N 122.131 -0.356 . . . . 0.0 110.153 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.57 72.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.106 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -59.26 -41.36 88.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.479 1.512 . . . . 0.0 111.956 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.78 -24.76 58.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.746 0.818 . . . . 0.0 112.497 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -10.58 58.33 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.054 1.742 . . . . 0.0 114.089 170.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.78 15.33 59.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.646 1.117 . . . . 0.0 115.088 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.56 151.23 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.157 1.783 . . . . 0.0 111.182 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 m -84.69 157.09 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.624 0.77 . . . . 0.0 110.038 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.51 140.09 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.556 0.742 . . . . 0.0 110.31 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -92.39 -31.07 15.46 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.659 1.184 . . . . 0.0 111.48 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 99.2 p -160.32 169.02 24.01 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.537 1.535 . . . . 0.0 112.421 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.37 164.38 21.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.338 1.055 . . . . 0.0 112.762 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.23 164.2 29.79 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.504 1.526 . . . . 0.0 112.705 -173.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 t -65.5 146.73 54.49 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.57 -0.959 . . . . 0.0 111.024 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.42 146.54 37.91 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.45 154.99 64.58 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.537 . . . . 0.0 111.856 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.5 m -121.29 -4.83 9.42 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.625 1.17 . . . . 0.0 112.997 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.87 61.23 0.02 OUTLIER Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.588 1.09 . . . . 0.0 113.613 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.349 0 C-N-CA 125.419 1.487 . . . . 0.0 111.443 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.93 126.07 21.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.806 1.642 . . . . 0.0 110.903 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 t -140.44 141.4 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.947 1.699 . . . . 0.0 109.92 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.5 m -78.3 148.12 33.97 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.714 0.806 . . . . 0.0 112.015 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.27 100.7 1.75 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.336 1.055 . . . . 0.0 111.235 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -129.34 158.33 73.46 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.23 1.812 . . . . 0.0 111.788 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 165.55 31.26 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.65 2.9 . . . . 0.0 113.695 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -77.51 -8.26 57.51 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 pt -57.33 113.23 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.358 1.863 . . . . 0.0 113.006 -173.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.67 84.61 0.89 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.586 1.554 . . . . 0.0 111.018 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -142.93 75.67 17.51 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.364 1.465 . . . . 0.0 109.422 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.34 165.19 20.59 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.858 2.372 . . . . 0.0 112.8 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.56 159.79 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.482 1.913 . . . . 0.0 110.058 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.0 t -105.99 119.51 39.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.671 . . . . 0.0 111.944 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.01 164.95 53.96 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.732 1.158 . . . . 0.0 114.143 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -59.29 -26.8 65.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.39 1.476 . . . . 0.0 113.534 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -73.38 -17.05 61.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.158 1.383 . . . . 0.0 113.294 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.5 -2.0 67.13 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.238 1.875 . . . . 0.0 113.785 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -70.04 156.38 39.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 111.22 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.1 m -114.84 138.04 51.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.581 1.952 . . . . 0.0 110.621 172.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.04 173.1 10.75 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.726 1.61 . . . . 0.0 111.236 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.85 85.44 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.395 1.078 . . . . 0.0 113.343 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 26' ' ' ILE . 43.8 p-10 -159.32 -176.36 5.76 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.019 1.328 . . . . 0.0 113.548 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -58.66 -38.6 78.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -60.31 -44.8 95.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.368 1.067 . . . . 0.0 112.63 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 23' ' ' ASN . 4.8 tt -73.53 -39.17 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.13 75.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.631 1.172 . . . . 0.0 112.458 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -63.9 -34.76 78.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.495 1.118 . . . . 0.0 113.414 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.3 t -85.05 -21.35 29.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.727 1.211 . . . . 0.0 111.982 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -67.12 -7.26 21.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.799 1.639 . . . . 0.0 113.775 162.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 21.16 53.53 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.392 0.996 . . . . 0.0 114.874 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 143.01 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.049 1.34 . . . . 0.0 111.28 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.34 135.49 34.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.762 0.825 . . . . 0.0 110.248 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.7 pt -81.26 138.01 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.74 0.7 . . . . 0.0 111.053 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -94.17 -31.47 14.13 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.293 1.437 . . . . 0.0 112.69 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -160.52 174.17 14.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.956 1.302 . . . . 0.0 112.078 174.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.09 161.64 16.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.921 1.688 . . . . 0.0 111.865 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.41 166.97 24.34 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.613 1.577 . . . . 0.0 113.241 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 m -65.63 137.38 57.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.187 0.595 . . . . 0.0 110.545 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 145.23 83.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.364 0.666 . . . . 0.0 111.817 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.27 119.85 6.57 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.239 3.292 . . . . 0.0 111.738 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 m -65.41 -17.82 64.83 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.641 1.577 . . . . 0.0 113.987 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.6 68.72 0.25 Allowed Glycine 0 N--CA 1.471 0.99 0 C-N-CA 125.519 1.533 . . . . 0.0 112.364 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt . . . . . 0 C--O 1.256 1.401 0 C-N-CA 126.022 1.729 . . . . 0.0 113.174 176.453 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.61 143.83 41.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.474 1.51 . . . . 0.0 111.785 173.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.85 169.71 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.061 1.744 . . . . 0.0 111.989 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.47 133.93 56.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.386 0.674 . . . . 0.0 111.975 172.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.34 97.69 0.99 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.628 1.171 . . . . 0.0 111.081 174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.9 m -125.05 157.83 65.48 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.992 1.717 . . . . 0.0 111.908 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 164.12 32.52 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.748 2.966 . . . . 0.0 113.875 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -76.97 -10.27 59.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.386 1.874 . . . . 0.0 115.37 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 pt -51.55 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.297 2.239 . . . . 0.0 113.107 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.27 90.61 0.5 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.279 1.832 . . . . 0.0 111.124 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.49 68.2 16.85 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.837 1.255 . . . . 0.0 111.049 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -63.62 159.07 42.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.285 1.99 . . . . 0.0 112.284 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.59 158.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.159 2.183 . . . . 0.0 110.463 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.17 115.25 29.4 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.602 0.761 . . . . 0.0 110.957 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.38 160.09 53.98 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.494 0.569 . . . . 0.0 113.737 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.3 m -59.9 -24.15 64.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.23 -14.38 59.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.938 1.295 . . . . 0.0 113.197 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.24 -4.66 55.25 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.005 2.241 . . . . 0.0 114.154 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -75.26 157.45 34.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.462 1.905 . . . . 0.0 111.87 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.1 m -111.66 138.04 48.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.006 2.123 . . . . 0.0 110.566 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.33 174.57 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.886 1.674 . . . . 0.0 111.7 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.78 80.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.73 1.212 . . . . 0.0 113.662 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -160.82 -174.98 4.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.194 1.398 . . . . 0.0 112.935 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.1 p -59.57 -40.04 86.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.0 t -57.28 -46.24 83.3 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.029 1.331 . . . . 0.0 111.654 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -73.64 -42.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 O-C-N 122.155 -0.34 . . . . 0.0 110.18 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.5 74.96 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.545 1.138 . . . . 0.0 112.384 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -58.55 -39.72 81.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.019 1.728 . . . . 0.0 112.433 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.4 t -74.8 -29.27 61.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.797 0.839 . . . . 0.0 112.688 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -9.38 36.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.698 1.599 . . . . 0.0 114.38 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.56 19.53 51.67 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.643 1.116 . . . . 0.0 114.805 175.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.41 147.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.188 1.795 . . . . 0.0 110.358 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 m -80.67 163.04 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.982 -0.449 . . . . 0.0 110.164 172.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.87 131.59 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 109.371 171.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -89.56 -32.61 17.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.042 0.937 . . . . 0.0 112.093 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -159.62 171.24 19.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.159 1.384 . . . . 0.0 112.229 172.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.73 160.28 24.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.269 1.828 . . . . 0.0 112.936 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 159.16 15.97 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.143 1.354 . . . . 0.0 112.251 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.9 p -62.65 143.74 57.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.521 -0.988 . . . . 0.0 111.808 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.33 146.17 57.31 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.001 -0.437 . . . . 0.0 111.606 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.64 146.46 49.05 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.787 2.325 . . . . 0.0 111.962 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.1 p -96.5 -0.58 48.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.707 1.603 . . . . 0.0 114.192 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.4 -54.69 0.03 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.175 0.893 . . . . 0.0 114.701 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 tt . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.982 1.713 . . . . 0.0 113.919 -179.621 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -140.59 152.44 45.47 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.443 1.497 . . . . 0.0 110.065 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -131.28 143.42 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.831 1.652 . . . . 0.0 109.235 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 m -68.08 137.65 55.15 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.305 0.642 . . . . 0.0 111.637 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.5 96.08 0.88 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.404 1.082 . . . . 0.0 111.652 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m -124.8 159.98 56.0 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.797 2.039 . . . . 0.0 111.155 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.1 165.78 30.45 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 114.197 -174.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -75.25 -8.77 57.52 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.561 1.944 . . . . 0.0 115.742 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.4 153.97 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.923 2.089 . . . . 0.0 112.675 -172.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.37 81.89 1.62 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.143 1.377 . . . . 0.0 110.579 -170.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -139.63 73.42 35.06 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.36 1.464 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.1 162.99 24.16 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.988 1.792 . . . . 0.0 112.591 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.07 152.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.588 1.955 . . . . 0.0 109.962 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.6 t -103.03 122.18 44.1 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.804 0.842 . . . . 0.0 110.761 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.93 166.54 54.43 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.502 1.049 . . . . 0.0 113.536 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 p -59.47 -22.67 61.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.42 -23.93 42.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.032 1.333 . . . . 0.0 113.395 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.49 -5.17 33.13 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.481 1.991 . . . . 0.0 114.325 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -74.66 157.24 35.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.507 1.523 . . . . 0.0 111.643 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.6 m -113.26 136.73 52.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.904 1.682 . . . . 0.0 112.115 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.68 171.78 10.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.78 1.632 . . . . 0.0 111.707 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.35 93.12 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -157.81 -175.45 5.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.636 1.574 . . . . 0.0 112.559 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.0 p -59.37 -43.22 92.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.005 0.922 . . . . 0.0 113.423 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.2 t -55.12 -46.73 75.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.619 1.567 . . . . 0.0 111.569 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -72.97 -44.13 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.5 80.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.217 1.007 . . . . 0.0 112.033 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -60.03 -40.67 90.14 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.824 1.65 . . . . 0.0 112.199 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.0 t -72.4 -28.38 62.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.088 0.555 . . . . 0.0 112.386 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -9.51 41.02 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.128 1.771 . . . . 0.0 114.103 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 16.83 52.4 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.625 1.107 . . . . 0.0 114.752 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.52 156.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.464 1.906 . . . . 0.0 111.257 -174.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -92.62 155.99 17.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.941 0.896 . . . . 0.0 109.935 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.98 130.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -85.52 -35.38 21.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.749 1.22 . . . . 0.0 112.343 173.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -156.12 169.47 24.42 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 0.0 112.374 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.47 160.03 22.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.15 1.78 . . . . 0.0 112.64 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.75 170.31 28.7 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.039 1.304 . . . . 0.0 112.933 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.8 m -67.42 138.05 56.38 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.772 -0.84 . . . . 0.0 111.024 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 152.14 92.5 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.889 -0.507 . . . . 0.0 112.038 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.2 170.69 19.24 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.619 2.879 . . . . 0.0 112.619 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.7 m -110.68 -1.08 16.9 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.847 1.259 . . . . 0.0 113.012 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.35 -76.9 1.32 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.978 1.275 . . . . 0.0 113.294 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.335 0 C-N-CA 125.969 1.708 . . . . 0.0 112.324 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.4 mttm . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.766 0.317 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -87.6 153.51 21.33 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 120.83 -1.169 . . . . 0.0 110.057 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.66 145.65 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.858 1.263 . . . . 0.0 109.174 170.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.5 t -66.35 142.13 57.73 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.628 0.771 . . . . 0.0 111.988 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.43 85.92 2.01 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.524 1.13 . . . . 0.0 112.123 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m -128.2 159.67 65.94 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 127.138 2.175 . . . . 0.0 111.233 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.74 160.85 30.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.9 2.4 . . . . 0.0 113.614 -173.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -75.07 -9.54 58.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.525 1.93 . . . . 0.0 114.409 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mt -60.11 131.84 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.347 1.859 . . . . 0.0 111.09 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 63.89 5.34 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.498 2.319 . . . . 0.0 112.022 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -122.91 71.24 41.39 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.347 1.459 . . . . 0.0 110.222 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.03 164.66 24.15 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.723 2.282 . . . . 0.0 112.6 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -145.4 151.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.714 2.006 . . . . 0.0 110.39 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.6 t -92.42 117.14 29.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.443 0.697 . . . . 0.0 110.389 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.5 166.0 39.33 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.657 1.122 . . . . 0.0 114.566 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -57.96 -33.87 69.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.571 1.148 . . . . 0.0 112.878 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.09 -19.12 57.45 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.095 1.358 . . . . 0.0 113.441 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.2 55.27 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 126.545 2.022 . . . . 0.0 114.171 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -68.23 160.09 29.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.011 1.724 . . . . 0.0 111.525 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.1 m -116.97 138.88 51.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.201 1.801 . . . . 0.0 111.415 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.25 176.3 8.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.4 1.88 . . . . 0.0 111.651 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.11 61.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.904 1.281 . . . . 0.0 114.359 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -162.72 178.14 8.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.206 1.802 . . . . 0.0 112.689 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.9 p -68.5 27.4 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.491 2.316 . . . . 0.0 117.032 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.8 t -119.85 -45.04 2.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.649 2.379 . . . . 0.0 110.394 174.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.06 -40.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 O-C-N 121.783 -0.573 . . . . 0.0 110.212 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.05 -53.21 59.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.93 1.292 . . . . 0.0 111.202 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -58.63 -36.62 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.958 1.303 . . . . 0.0 112.872 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 t -77.55 -29.54 52.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.754 0.822 . . . . 0.0 112.17 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -21.52 62.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.96 1.704 . . . . 0.0 113.56 167.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.45 10.61 33.15 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.563 1.554 . . . . 0.0 115.351 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.286 1.835 . . . . 0.0 110.798 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p -81.09 170.63 15.95 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.776 0.83 . . . . 0.0 111.027 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.99 149.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.798 1.239 . . . . 0.0 110.715 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -110.19 -26.89 9.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.401 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -161.89 170.28 19.72 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.597 1.159 . . . . 0.0 112.938 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.41 155.62 36.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.412 1.885 . . . . 0.0 111.97 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.16 164.92 28.7 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.575 1.56 . . . . 0.0 113.529 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 m -63.2 136.23 57.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.717 -0.872 . . . . 0.0 110.971 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.88 148.52 82.04 Favored Pre-proline 0 CA--C 1.548 0.903 0 O-C-N 121.82 -0.55 . . . . 0.0 111.9 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.71 162.24 41.74 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.094 2.529 . . . . 0.0 112.248 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.9 m -68.86 -18.52 64.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.011 1.324 . . . . 0.0 113.652 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.38 103.36 0.19 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.373 1.94 . . . . 0.0 111.73 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.254 1.33 0 C-N-CA 125.847 1.659 . . . . 0.0 113.166 176.856 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.747 0.308 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.4 172.81 14.82 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.022 1.729 . . . . 0.0 111.99 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.93 0.92 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 125.8 1.64 . . . . 0.0 111.671 172.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.3 m -76.23 93.89 3.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.949 2.1 . . . . 0.0 112.199 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.17 91.61 3.74 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.711 1.204 . . . . 0.0 111.269 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -124.23 156.65 66.34 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 126.012 1.725 . . . . 0.0 111.668 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.6 163.39 36.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.544 2.829 . . . . 0.0 113.196 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -84.52 -4.24 58.84 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 tt -48.68 131.56 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.085 2.154 . . . . 0.0 113.332 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.76 79.03 7.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.579 . . . . 0.0 110.576 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -143.32 71.48 17.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.835 0.854 . . . . 0.0 110.429 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.55 160.62 45.07 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.013 1.809 . . . . 0.0 112.089 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.52 155.19 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 110.198 -172.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -98.25 112.91 24.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.167 0.587 . . . . 0.0 111.112 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.07 164.42 51.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.433 0.539 . . . . 0.0 113.005 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -64.26 -18.89 65.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.35 -22.85 60.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.593 1.157 . . . . 0.0 113.242 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.33 42.2 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 127.043 2.259 . . . . 0.0 114.124 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -83.55 159.8 21.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.196 1.798 . . . . 0.0 111.244 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.8 t -113.89 147.95 37.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.451 1.501 . . . . 0.0 112.767 173.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.79 178.02 7.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.248 2.219 . . . . 0.0 110.688 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.55 74.09 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -157.2 -176.87 6.21 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.908 1.683 . . . . 0.0 113.366 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.9 p -73.73 14.0 0.43 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 116.009 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -107.12 -48.08 3.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.53 1.932 . . . . 0.0 111.179 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 tp -65.57 -41.4 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -176.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -61.59 -42.5 98.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.204 1.002 . . . . 0.0 112.196 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -64.25 -37.89 89.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.308 1.443 . . . . 0.0 112.597 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -71.8 -29.15 64.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.481 0.712 . . . . 0.0 112.01 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -10.44 57.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.428 1.891 . . . . 0.0 114.816 174.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.69 14.89 38.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.648 1.118 . . . . 0.0 115.326 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 159.22 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.9 1.68 . . . . 0.0 111.178 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 p -100.61 158.15 16.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.411 1.085 . . . . 0.0 111.814 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 27' ' ' ALA . 37.5 mm -93.34 109.72 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.958 1.303 . . . . 0.0 109.944 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -76.01 -46.0 31.7 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.041 1.336 . . . . 0.0 112.264 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 t -153.73 164.28 38.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.817 0.847 . . . . 0.0 112.907 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -84.63 155.19 22.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.421 1.488 . . . . 0.0 112.799 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.09 151.01 13.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.715 1.15 . . . . 0.0 111.596 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -61.63 135.44 57.63 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.697 -0.884 . . . . 0.0 111.609 173.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.41 150.56 97.8 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.927 0.491 . . . . 0.0 111.557 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.53 161.32 46.45 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.339 2.692 . . . . 0.0 112.633 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.6 m -131.81 32.19 4.13 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.388 1.475 . . . . 0.0 111.592 -172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.32 43.96 5.12 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.805 1.193 . . . . 0.0 113.804 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--O 1.254 1.295 0 C-N-CA 126.478 1.911 . . . . 0.0 113.295 176.041 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 52.8 pttt . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -126.12 97.89 5.27 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.431 1.493 . . . . 0.0 110.695 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 m -60.4 152.04 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.36 1.464 . . . . 0.0 111.813 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.5 m -104.08 145.12 30.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.066 0.946 . . . . 0.0 111.326 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.64 73.91 3.33 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.471 1.109 . . . . 0.0 112.042 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m -109.98 155.35 41.8 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.534 1.933 . . . . 0.0 111.904 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.26 162.92 19.95 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.539 2.826 . . . . 0.0 113.227 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -84.38 -7.94 59.15 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 pt -54.7 133.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.093 1.757 . . . . 0.0 112.946 -171.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -76.08 76.79 2.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.511 1.524 . . . . 0.0 111.21 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -132.85 66.97 77.5 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 126.194 1.797 . . . . 0.0 111.337 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -61.69 157.74 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.926 1.751 . . . . 0.0 111.945 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -143.77 154.96 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.012 2.125 . . . . 0.0 110.262 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -90.69 112.62 24.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.155 0.582 . . . . 0.0 109.8 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.87 159.17 46.55 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.681 0.657 . . . . 0.0 113.496 170.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 p -63.16 -22.41 66.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.34 1.456 . . . . 0.0 114.506 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -84.57 -10.27 57.55 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.527 1.131 . . . . 0.0 113.842 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.66 60.77 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 126.579 2.038 . . . . 0.0 113.908 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -66.31 157.62 31.21 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.841 1.656 . . . . 0.0 111.444 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.1 m -121.97 135.77 54.88 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.396 1.878 . . . . 0.0 110.519 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.32 177.61 6.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.33 1.852 . . . . 0.0 111.662 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.37 77.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -148.83 -179.69 7.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.221 1.408 . . . . 0.0 111.846 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.6 p -66.41 -43.97 84.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.475 1.11 . . . . 0.0 113.002 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 t -61.55 -41.67 97.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.95 1.3 . . . . 0.0 112.217 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 tp -67.39 -42.95 87.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.93 63.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.106 1.362 . . . . 0.0 111.431 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -56.73 -41.14 76.97 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.461 1.104 . . . . 0.0 112.54 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.84 -26.49 59.74 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -8.79 41.65 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.855 1.662 . . . . 0.0 114.175 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.27 15.69 46.72 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.914 1.245 . . . . 0.0 114.736 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.86 142.74 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.122 1.769 . . . . 0.0 110.779 -174.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -84.12 152.68 24.17 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.984 -0.447 . . . . 0.0 109.94 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.47 149.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 167.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -119.18 -22.34 7.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.259 1.424 . . . . 0.0 112.853 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.7 p -160.95 167.75 25.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.243 1.417 . . . . 0.0 112.616 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.33 154.23 25.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.72 1.208 . . . . 0.0 112.264 173.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.11 165.97 36.99 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.362 1.458 . . . . 0.0 113.185 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.7 t -60.15 149.66 32.12 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.731 -0.864 . . . . 0.0 111.576 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.49 141.24 22.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.564 0.746 . . . . 0.0 112.186 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.09 133.03 25.74 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.074 2.516 . . . . 0.0 112.32 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.9 p -76.97 72.61 3.54 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.81 1.644 . . . . 0.0 111.955 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.92 82.58 0.08 OUTLIER Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.095 1.331 . . . . 0.0 112.324 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.916 2.086 . . . . 0.0 112.316 -179.853 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -106.12 73.14 0.97 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 120.817 1.644 . . . . 0.0 111.52 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.26 157.88 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.58 1.152 . . . . 0.0 111.271 171.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.7 m -91.31 146.64 23.65 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.624 0.77 . . . . 0.0 111.506 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.95 99.09 1.72 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.467 1.107 . . . . 0.0 111.615 177.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.8 m -131.25 158.52 75.0 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 126.069 1.748 . . . . 0.0 112.244 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.45 162.56 35.79 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.755 2.97 . . . . 0.0 113.229 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -78.57 -9.17 59.26 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -50.52 113.9 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.942 2.097 . . . . 0.0 113.021 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -70.8 91.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.796 1.238 . . . . 0.0 110.508 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 69.77 14.46 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.179 0.991 . . . . 0.0 110.5 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.58 161.34 28.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.361 2.041 . . . . 0.0 112.214 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.89 155.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.401 2.28 . . . . 0.0 109.719 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -99.57 114.74 27.95 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.907 0.883 . . . . 0.0 109.584 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.96 166.54 40.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.547 1.07 . . . . 0.0 114.127 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.27 -30.2 59.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.997 1.319 . . . . 0.0 113.708 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.35 -18.39 49.2 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.927 1.291 . . . . 0.0 113.777 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.74 -3.87 49.65 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.358 1.932 . . . . 0.0 114.328 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -70.61 157.92 37.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 111.953 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -111.63 141.54 45.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 111.536 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.13 173.59 10.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.527 1.931 . . . . 0.0 111.053 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.92 82.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.041 . . . . 0.0 113.741 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -162.07 -176.38 5.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.343 1.457 . . . . 0.0 113.125 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -60.84 -35.61 77.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -62.52 -39.17 92.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.049 1.34 . . . . 0.0 112.444 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 tp -79.7 -42.32 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 O-C-N 121.773 -0.579 . . . . 0.0 110.49 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.1 70.0 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.287 1.035 . . . . 0.0 112.37 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -57.58 -41.66 81.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.546 1.138 . . . . 0.0 112.846 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.46 -24.08 50.33 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.816 1.246 . . . . 0.0 112.629 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -11.47 60.66 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.29 1.836 . . . . 0.0 113.797 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 17.92 39.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.014 1.292 . . . . 0.0 115.22 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.11 146.09 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.221 1.808 . . . . 0.0 111.134 -172.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -82.13 147.59 28.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.27 1.028 . . . . 0.0 110.918 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.83 131.8 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -89.79 -40.4 12.49 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.273 1.429 . . . . 0.0 111.98 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -145.37 160.33 41.7 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.167 1.387 . . . . 0.0 112.349 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.37 154.14 35.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.932 1.293 . . . . 0.0 112.167 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.19 162.39 28.63 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.152 1.358 . . . . 0.0 112.942 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.5 t -64.14 147.19 52.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.654 -0.909 . . . . 0.0 111.329 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.66 143.1 33.29 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.798 0.839 . . . . 0.0 112.08 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.6 157.76 48.24 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.813 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.3 t -78.23 -13.95 59.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.505 1.122 . . . . 0.0 113.923 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.97 -13.34 3.86 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.534 2.016 . . . . 0.0 114.943 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 C--O 1.254 1.323 0 C-N-CA 127.149 2.18 . . . . 0.0 110.229 177.335 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -122.25 103.23 8.62 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.651 1.581 . . . . 0.0 110.389 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.12 136.89 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.335 1.454 . . . . 0.0 109.622 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.3 m -78.11 133.51 37.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.232 1.013 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.58 95.68 0.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.425 1.09 . . . . 0.0 111.758 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.8 m -125.8 158.61 64.79 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.866 2.066 . . . . 0.0 111.061 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.9 163.3 35.75 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.479 2.786 . . . . 0.0 113.571 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -79.93 -8.34 59.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.116 1.766 . . . . 0.0 114.93 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 135.43 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.636 1.975 . . . . 0.0 113.077 -171.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.69 81.11 8.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.367 1.867 . . . . 0.0 111.79 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.29 70.0 77.54 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.094 1.358 . . . . 0.0 110.638 172.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.19 161.69 29.42 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.547 2.164 . . . . 0.0 112.817 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.6 m -147.16 153.62 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.915 2.086 . . . . 0.0 110.64 -172.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -99.29 111.61 23.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.831 0.852 . . . . 0.0 111.871 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.88 162.56 48.32 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.615 1.102 . . . . 0.0 113.967 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 m -59.54 -25.45 64.53 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -78.74 -15.86 57.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.373 1.069 . . . . 0.0 113.267 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 -1.45 59.68 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 126.61 2.052 . . . . 0.0 113.974 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -72.58 158.2 36.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.897 1.679 . . . . 0.0 111.116 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.0 m -116.85 140.6 49.25 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.695 1.998 . . . . 0.0 110.595 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.16 175.83 8.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.981 1.712 . . . . 0.0 111.418 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.67 72.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.508 1.123 . . . . 0.0 113.818 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.92 -174.52 4.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.377 1.871 . . . . 0.0 112.491 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 p -58.62 -39.87 81.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.67 -47.31 82.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.451 1.5 . . . . 0.0 111.654 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.46 -42.56 64.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.06 74.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.543 1.137 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -56.12 -43.37 78.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.64 1.976 . . . . 0.0 112.162 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -76.18 -24.98 54.78 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -9.73 49.02 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.94 1.696 . . . . 0.0 114.073 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.6 15.55 54.65 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.893 1.235 . . . . 0.0 114.906 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.6 162.19 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.497 1.919 . . . . 0.0 111.468 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 132.3 56.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.249 1.42 . . . . 0.0 109.376 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 pt -78.99 140.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.998 -0.439 . . . . 0.0 111.245 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -93.12 -35.25 13.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.444 1.098 . . . . 0.0 112.285 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -149.38 161.16 42.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.629 1.172 . . . . 0.0 112.303 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.57 160.31 25.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 169.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.3 166.0 40.21 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.48 1.514 . . . . 0.0 113.132 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.9 t -63.11 150.42 42.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.926 -0.749 . . . . 0.0 111.282 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.49 137.02 19.27 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.328 1.051 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.54 155.37 54.95 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 112.765 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.9 p -80.67 -5.44 56.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.275 1.43 . . . . 0.0 114.351 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.3 -36.16 0.18 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.832 1.206 . . . . 0.0 114.77 173.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mt . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.553 1.941 . . . . 0.0 110.217 178.787 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 110.778 -0.082 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.74 169.53 12.75 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.671 1.189 . . . . 0.0 111.842 173.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.29 153.31 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 126.429 1.891 . . . . 0.0 110.085 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.07 151.06 38.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.258 1.423 . . . . 0.0 112.51 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.71 91.88 3.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.746 1.218 . . . . 0.0 111.046 173.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.4 m -125.77 158.39 65.45 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.512 1.925 . . . . 0.0 110.974 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.72 158.16 57.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.16 2.573 . . . . 0.0 113.016 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.83 -5.44 43.54 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.419 1.888 . . . . 0.0 114.73 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 tt -51.24 131.89 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.886 2.074 . . . . 0.0 113.539 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 tt -82.12 78.63 8.78 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.116 1.766 . . . . 0.0 109.531 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -143.25 68.39 17.43 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 111.567 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.22 168.69 12.07 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.741 2.961 . . . . 0.0 113.615 -172.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.06 158.58 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.485 1.914 . . . . 0.0 111.023 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -98.71 113.17 25.13 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.889 0.875 . . . . 0.0 109.758 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 153.7 51.45 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 113.414 173.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -59.72 -26.41 65.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.112 0.965 . . . . 0.0 113.204 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.06 -19.3 61.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.225 1.41 . . . . 0.0 113.337 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.41 -8.15 40.62 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.859 2.171 . . . . 0.0 114.507 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -75.77 160.15 30.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.486 1.915 . . . . 0.0 111.701 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -111.58 143.31 42.65 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.668 1.987 . . . . 0.0 110.77 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.34 175.21 9.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.559 1.943 . . . . 0.0 110.979 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -47.76 79.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.201 1.001 . . . . 0.0 113.591 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -156.55 -173.31 4.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 112.433 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 p -60.81 -37.14 80.96 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -60.53 -46.91 88.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.429 1.492 . . . . 0.0 112.474 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 tp -69.76 -39.71 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 122.359 1.076 . . . . 0.0 110.339 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.77 77.84 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.932 1.693 . . . . 0.0 112.472 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -58.09 -34.56 70.32 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.574 1.55 . . . . 0.0 112.682 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.3 t -79.54 -30.73 41.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.432 0.693 . . . . 0.0 111.653 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -66.49 -5.32 10.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.128 1.771 . . . . 0.0 113.942 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 9.66 68.2 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.586 1.565 . . . . 0.0 115.19 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.0 152.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.909 1.283 . . . . 0.0 111.896 -171.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.4 m -85.23 -19.27 31.9 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -168.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.2 mm 53.49 88.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 130.74 3.616 . . . . 0.0 112.73 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -75.07 -32.96 61.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.778 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -160.54 168.79 24.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 0.0 112.714 172.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -93.18 163.43 13.63 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.813 1.645 . . . . 0.0 112.319 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.05 165.42 26.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.607 1.575 . . . . 0.0 112.63 -171.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -64.82 147.22 53.64 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.436 -1.038 . . . . 0.0 111.273 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.73 143.67 36.03 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.579 0.752 . . . . 0.0 111.902 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.57 86.16 1.61 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.547 2.831 . . . . 0.0 112.971 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.7 p -83.74 -10.19 58.3 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.819 1.648 . . . . 0.0 113.979 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.56 81.36 1.75 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.1 1.81 . . . . 0.0 112.559 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.957 2.103 . . . . 0.0 112.59 -179.179 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.2 tptm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.12 163.97 31.29 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.386 1.875 . . . . 0.0 109.934 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.07 149.82 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.472 1.509 . . . . 0.0 111.293 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.9 m -66.41 124.7 23.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.142 0.977 . . . . 0.0 110.919 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.18 101.08 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.469 1.107 . . . . 0.0 111.508 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.3 m -126.69 157.44 71.2 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.31 1.844 . . . . 0.0 111.625 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.83 161.45 46.04 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.554 2.836 . . . . 0.0 113.366 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.8 -7.0 52.08 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 tt -51.61 127.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.321 1.848 . . . . 0.0 113.458 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -80.75 97.34 7.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -156.69 72.85 4.8 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 123.486 0.714 . . . . 0.0 111.945 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.99 166.98 16.94 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.238 1.959 . . . . 0.0 113.012 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.38 147.77 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 127.091 2.156 . . . . 0.0 110.113 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.05 115.93 26.96 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.54 165.66 46.99 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.069 0.842 . . . . 0.0 114.083 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 t -62.06 -27.45 68.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 113.154 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.95 -24.2 58.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.918 1.287 . . . . 0.0 113.226 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.92 -8.41 39.18 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 126.785 2.136 . . . . 0.0 114.333 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -66.95 160.76 25.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.764 1.626 . . . . 0.0 111.088 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.5 t -109.5 156.5 20.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.706 1.202 . . . . 0.0 112.022 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.28 169.54 17.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.702 2.001 . . . . 0.0 110.272 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.28 81.41 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -159.13 -176.85 6.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.428 1.491 . . . . 0.0 112.461 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 p -58.87 -34.86 72.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.92 -43.22 96.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 112.65 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -38.96 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.704 -0.622 . . . . 0.0 110.255 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -51.36 69.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.951 1.301 . . . . 0.0 112.519 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -61.11 -32.5 72.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -88.19 -19.56 26.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.244 1.417 . . . . 0.0 112.384 -173.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.07 -6.27 32.63 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.926 2.09 . . . . 0.0 114.448 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.16 60.12 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.641 1.115 . . . . 0.0 114.736 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.27 168.14 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.054 2.542 . . . . 0.0 110.622 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -119.38 167.43 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.871 1.268 . . . . 0.0 110.642 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.91 138.15 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.027 1.331 . . . . 0.0 110.462 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -100.94 -31.57 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.846 1.659 . . . . 0.0 113.097 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 164.01 39.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.622 1.169 . . . . 0.0 112.022 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.29 152.11 23.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.66 1.584 . . . . 0.0 112.693 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.46 167.39 28.66 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.938 1.256 . . . . 0.0 112.48 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.8 t -63.67 148.72 48.29 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.718 -0.872 . . . . 0.0 111.387 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.28 145.42 60.0 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 111.402 174.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.45 149.85 84.45 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.68 2.254 . . . . 0.0 111.573 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.9 m 55.38 30.13 14.35 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.215 1.406 . . . . 0.0 113.14 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.43 -65.73 2.77 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.523 1.535 . . . . 0.0 114.72 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.486 1.332 0 C-N-CA 129.765 3.226 . . . . 0.0 113.229 -174.511 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.5 m . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 120.256 0.074 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.8 165.24 28.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.418 2.745 . . . . 0.0 112.919 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -75.79 -8.09 56.01 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -56.02 131.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.55 1.94 . . . . 0.0 111.183 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -84.26 79.01 9.68 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 109.69 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -127.41 63.09 57.39 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 125.376 1.471 . . . . 0.0 110.963 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.86 161.99 33.99 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.859 2.373 . . . . 0.0 112.663 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.84 154.58 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.889 2.075 . . . . 0.0 110.454 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.26 113.78 25.06 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.415 0.686 . . . . 0.0 109.728 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.66 160.38 53.0 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.128 0.394 . . . . 0.0 113.313 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -64.76 -23.3 67.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.59 -19.14 58.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.097 1.359 . . . . 0.0 113.17 171.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.52 -7.92 47.03 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.16 2.315 . . . . 0.0 113.789 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -67.23 156.85 35.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.915 1.686 . . . . 0.0 111.964 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.4 m -113.64 136.28 53.0 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.021 2.128 . . . . 0.0 110.184 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.22 174.21 9.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.181 1.792 . . . . 0.0 111.133 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.67 72.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.391 1.076 . . . . 0.0 113.853 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -162.33 -176.7 5.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.314 1.446 . . . . 0.0 112.764 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -57.02 -39.95 75.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -55.46 -45.92 76.87 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.942 1.297 . . . . 0.0 111.843 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 tp -75.99 -43.0 39.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.212 -0.305 . . . . 0.0 110.479 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.35 -48.85 75.94 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.571 1.148 . . . . 0.0 112.526 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.953 1.701 . . . . 0.0 111.987 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.23 -30.79 67.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.995 0.918 . . . . 0.0 112.331 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -7.29 17.98 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.662 1.585 . . . . 0.0 114.191 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.08 18.92 52.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.813 1.197 . . . . 0.0 114.847 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.67 158.49 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.629 1.572 . . . . 0.0 110.908 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 t -96.52 166.05 11.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 0.0 110.574 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -102.66 142.37 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.215 1.406 . . . . 0.0 110.149 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -97.47 -31.34 12.4 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.347 1.459 . . . . 0.0 111.633 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.2 p -162.37 169.61 20.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.706 1.602 . . . . 0.0 112.474 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.61 160.44 29.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.903 1.281 . . . . 0.0 112.597 168.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.05 166.25 25.16 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.347 1.451 . . . . 0.0 112.811 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 p -64.06 146.7 53.71 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.443 -1.034 . . . . 0.0 111.94 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.14 146.66 40.78 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 122.931 0.492 . . . . 0.0 111.508 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.539 0.738 0 C-N-CA 122.645 2.23 . . . . 0.0 112.032 178.197 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.0 m . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.53 166.89 26.56 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.513 2.808 . . . . 0.0 113.386 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -80.28 -6.65 58.26 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.6 133.35 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.455 1.902 . . . . 0.0 111.361 -172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 79.98 8.64 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.33 1.852 . . . . 0.0 110.469 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -129.83 66.88 78.51 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 125.269 1.428 . . . . 0.0 110.907 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.35 162.2 31.4 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.985 2.457 . . . . 0.0 113.065 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -144.83 155.83 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.505 1.922 . . . . 0.0 110.881 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t -94.98 111.09 22.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.916 0.887 . . . . 0.0 111.18 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.51 163.71 51.33 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.053 0.835 . . . . 0.0 114.307 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.4 t -63.62 -25.63 68.31 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.4 -17.12 60.85 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.072 1.349 . . . . 0.0 113.121 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.99 -5.68 63.69 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.872 2.177 . . . . 0.0 113.711 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -68.21 157.53 35.26 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.369 1.868 . . . . 0.0 111.775 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.6 m -113.76 137.94 50.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.48 1.912 . . . . 0.0 110.702 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.34 176.03 8.27 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.124 1.77 . . . . 0.0 111.395 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.3 -51.02 71.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.73 1.212 . . . . 0.0 113.814 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -159.78 -174.95 4.86 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.581 1.553 . . . . 0.0 112.569 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -58.4 -39.69 80.39 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.4 t -57.02 -48.45 78.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.284 1.434 . . . . 0.0 111.237 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 tp -71.12 -43.32 75.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -51.5 68.45 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.532 1.133 . . . . 0.0 112.347 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -61.14 -41.4 96.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.987 1.715 . . . . 0.0 111.835 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.1 t -74.15 -24.06 59.36 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.487 0.715 . . . . 0.0 112.413 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -10.89 59.07 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.903 1.681 . . . . 0.0 113.94 169.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.59 15.4 56.88 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.79 1.186 . . . . 0.0 115.184 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.06 148.65 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.666 1.586 . . . . 0.0 111.675 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -78.71 168.58 19.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.914 0.886 . . . . 0.0 111.231 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.68 134.85 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 110.532 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -69.61 -47.97 61.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.854 1.261 . . . . 0.0 110.768 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 t -165.81 177.67 7.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.225 1.41 . . . . 0.0 112.104 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.45 164.99 24.95 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.841 1.656 . . . . 0.0 113.321 172.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.5 162.4 21.04 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.015 1.769 . . . . 0.0 113.426 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -65.63 135.38 54.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.888 0.875 . . . . 0.0 110.975 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 142.65 64.88 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.817 -0.552 . . . . 0.0 112.097 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 C--N 1.35 0.624 0 C-N-CA 122.77 2.313 . . . . 0.0 111.162 179.015 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.5 m . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.66 163.9 36.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.694 2.929 . . . . 0.0 114.222 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -75.52 -6.35 49.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.115 2.166 . . . . 0.0 115.317 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -54.35 136.25 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 112.799 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.95 85.29 5.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.926 1.691 . . . . 0.0 110.583 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -140.97 68.09 28.03 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.387 1.075 . . . . 0.0 111.057 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.49 159.93 34.08 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.819 1.679 . . . . 0.0 111.817 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.81 158.12 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.771 2.029 . . . . 0.0 109.961 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -97.1 114.13 25.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.325 0.65 . . . . 0.0 109.618 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.67 163.0 47.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.77 0.7 . . . . 0.0 113.03 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 t -63.36 -19.75 64.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.83 -12.69 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 172.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.18 -4.48 58.73 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.745 2.117 . . . . 0.0 114.32 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -67.11 156.49 36.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.286 1.834 . . . . 0.0 111.615 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.7 m -115.07 132.63 56.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.769 2.028 . . . . 0.0 110.59 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.6 174.81 6.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.246 1.819 . . . . 0.0 111.418 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -49.63 76.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.384 1.074 . . . . 0.0 113.564 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -162.06 -175.97 4.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 113.896 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -62.64 -37.85 87.97 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.01 -46.05 85.89 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.793 1.237 . . . . 0.0 111.823 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.26 -46.53 65.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.34 -46.0 80.13 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.143 0.977 . . . . 0.0 113.023 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.45 -28.64 65.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.656 1.982 . . . . 0.0 114.019 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.8 t -97.72 -24.71 15.36 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.355 1.462 . . . . 0.0 111.926 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -69.54 -11.8 61.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.476 1.91 . . . . 0.0 113.503 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.99 56.03 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.433 1.016 . . . . 0.0 114.782 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.41 151.49 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.992 1.317 . . . . 0.0 110.879 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.14 138.3 31.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 108.955 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.88 137.67 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.976 0.807 . . . . 0.0 109.53 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -96.98 -34.1 11.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 112.433 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -157.27 168.33 27.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.07 0.948 . . . . 0.0 112.682 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.25 149.27 25.6 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.403 1.881 . . . . 0.0 111.675 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.56 161.85 28.36 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.908 1.242 . . . . 0.0 112.28 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -63.59 149.89 45.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.574 -0.957 . . . . 0.0 112.236 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.98 149.44 50.46 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.132 0.573 . . . . 0.0 112.17 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo . . . . . 0 CA--C 1.539 0.764 0 C-N-CA 123.395 2.73 . . . . 0.0 112.566 177.886 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.27 167.86 24.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.023 3.149 . . . . 0.0 114.335 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.08 -9.85 58.95 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 pt -58.1 114.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.418 1.887 . . . . 0.0 113.813 -171.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.98 85.66 0.52 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 110.848 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.74 72.6 55.7 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 125.91 1.684 . . . . 0.0 109.888 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.79 160.64 35.94 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.189 1.926 . . . . 0.0 112.085 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.19 157.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.857 2.063 . . . . 0.0 110.48 -170.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.71 114.04 27.94 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.605 0.762 . . . . 0.0 111.693 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.29 163.08 51.44 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.88 1.229 . . . . 0.0 114.406 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 t -61.89 -28.55 69.59 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.216 . . . . 0.0 113.551 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.39 -10.79 59.83 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.285 1.034 . . . . 0.0 113.313 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.05 -5.51 61.43 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.84 2.162 . . . . 0.0 113.884 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -70.3 157.03 38.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.429 1.892 . . . . 0.0 111.798 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 m -115.17 137.59 51.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.039 2.136 . . . . 0.0 110.525 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 173.04 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.984 1.714 . . . . 0.0 111.439 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.15 86.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.546 1.138 . . . . 0.0 114.018 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -160.12 -174.7 4.67 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.801 1.64 . . . . 0.0 112.494 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.2 p -59.98 -41.39 91.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.79 -47.42 80.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.3 1.44 . . . . 0.0 111.405 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 tp -71.93 -43.71 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.56 76.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 112.27 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -59.82 -41.79 92.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.895 1.678 . . . . 0.0 111.952 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.4 t -74.25 -25.09 59.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.947 0.899 . . . . 0.0 112.504 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -11.07 59.8 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.044 1.738 . . . . 0.0 114.179 172.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.14 44.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.694 1.14 . . . . 0.0 115.105 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.5 154.6 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.04 1.736 . . . . 0.0 111.133 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -98.77 144.59 27.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.386 1.074 . . . . 0.0 109.444 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 pt -91.82 134.91 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.651 0.659 . . . . 0.0 111.025 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.08 -34.98 22.12 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 112.227 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -160.62 173.65 15.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.496 1.118 . . . . 0.0 112.458 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.68 161.44 23.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.058 1.743 . . . . 0.0 112.839 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.81 156.97 15.08 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.325 1.441 . . . . 0.0 112.262 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -64.01 142.32 58.45 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.607 -0.937 . . . . 0.0 111.5 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.12 150.66 71.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.539 0.73 0 C-N-CA 123.096 2.531 . . . . 0.0 112.079 177.019 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.88 163.88 34.62 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.745 2.963 . . . . 0.0 113.596 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.05 -8.52 57.58 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -53.36 111.84 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.59 1.956 . . . . 0.0 113.285 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.97 84.3 0.97 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.712 1.605 . . . . 0.0 111.332 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -141.45 74.05 24.26 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.205 1.402 . . . . 0.0 109.748 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.98 165.38 21.66 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.82 2.347 . . . . 0.0 112.84 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -145.6 153.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -98.19 113.0 24.77 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.009 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.59 164.82 37.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.403 1.002 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -60.61 -29.71 69.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.41 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -79.01 -13.5 59.75 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.847 1.259 . . . . 0.0 113.488 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.51 -3.17 59.3 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 126.281 1.896 . . . . 0.0 114.049 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -66.16 156.28 34.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.722 1.609 . . . . 0.0 111.464 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 m -114.0 138.4 50.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.54 1.936 . . . . 0.0 110.111 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.89 174.1 9.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.691 1.596 . . . . 0.0 111.25 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.43 -49.03 77.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 113.443 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -159.7 -174.29 4.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.462 1.505 . . . . 0.0 113.206 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.7 p -61.17 -38.0 84.94 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.04 -46.09 85.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.19 1.396 . . . . 0.0 111.79 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.64 -41.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 O-C-N 122.066 -0.397 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.36 -47.77 82.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.731 1.212 . . . . 0.0 112.405 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -59.06 -42.51 90.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 111.82 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.6 -27.87 61.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.917 0.887 . . . . 0.0 112.598 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -7.33 22.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.724 1.61 . . . . 0.0 114.113 175.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 18.84 48.99 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.875 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.3 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.779 1.631 . . . . 0.0 111.093 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.3 p -82.74 168.32 17.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.586 0.754 . . . . 0.0 111.488 168.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.58 137.49 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.102 1.361 . . . . 0.0 110.064 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -92.54 -33.55 14.41 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.698 1.199 . . . . 0.0 112.039 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 m -150.93 162.41 40.86 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.708 1.603 . . . . 0.0 112.26 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.87 162.91 27.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.43 1.092 . . . . 0.0 112.329 165.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 167.63 31.21 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.313 1.435 . . . . 0.0 113.002 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 p -66.13 149.09 50.83 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.51 -0.994 . . . . 0.0 111.562 169.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 145.17 32.04 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.002 0.521 . . . . 0.0 112.194 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 C-N-CA 122.916 2.411 . . . . 0.0 112.359 177.914 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.9 m . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 110.979 -0.008 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.12 164.09 29.85 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.341 2.694 . . . . 0.0 112.962 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -81.22 -5.78 58.13 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.01 131.2 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.222 1.809 . . . . 0.0 110.749 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.15 78.4 8.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.158 1.783 . . . . 0.0 110.318 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -130.06 69.64 81.88 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.899 1.28 . . . . 0.0 109.667 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.19 161.74 38.98 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.15 1.9 . . . . 0.0 112.44 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.7 157.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 127.007 2.123 . . . . 0.0 110.627 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -102.53 114.81 29.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.783 0.833 . . . . 0.0 111.674 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 162.33 54.6 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.15 0.881 . . . . 0.0 113.943 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -61.74 -26.05 67.82 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.4 1.48 . . . . 0.0 114.228 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.1 -19.44 54.15 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.67 1.188 . . . . 0.0 112.989 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.16 -7.15 32.61 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 127.381 2.419 . . . . 0.0 114.166 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -74.38 158.01 34.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.61 1.564 . . . . 0.0 112.199 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.3 m -114.74 125.85 54.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.658 2.383 . . . . 0.0 110.653 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.17 174.6 6.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.884 1.674 . . . . 0.0 111.65 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.46 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.455 1.102 . . . . 0.0 113.751 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -163.18 -175.92 4.55 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.658 1.983 . . . . 0.0 112.665 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -57.87 -39.28 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.77 -46.7 81.31 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.062 1.345 . . . . 0.0 111.829 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -75.06 -41.6 45.29 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 O-C-N 122.225 -0.297 . . . . 0.0 110.284 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.87 78.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.445 1.098 . . . . 0.0 112.234 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -59.42 -39.92 85.03 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.032 1.733 . . . . 0.0 112.436 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.9 -34.63 73.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -8.92 17.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.889 1.676 . . . . 0.0 114.545 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.84 50.58 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.975 1.274 . . . . 0.0 114.814 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.04 156.65 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.912 2.085 . . . . 0.0 110.823 -172.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -106.96 139.02 42.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 109.606 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.0 pt -85.56 136.02 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.753 -0.592 . . . . 0.0 111.175 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -90.74 -31.66 16.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.818 1.247 . . . . 0.0 112.537 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 m -158.85 164.55 35.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.886 1.675 . . . . 0.0 111.928 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -80.45 160.64 25.24 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 111.811 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.2 159.88 23.71 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.205 1.383 . . . . 0.0 112.425 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -63.58 143.0 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.59 -0.947 . . . . 0.0 111.598 171.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 149.09 61.51 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 122.05 -0.406 . . . . 0.0 111.89 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 CA--C 1.54 0.783 0 C-N-CA 123.049 2.499 . . . . 0.0 112.104 176.399 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.4 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.4 161.44 45.56 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.575 2.85 . . . . 0.0 113.446 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -74.82 -8.3 56.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.837 1.655 . . . . 0.0 114.73 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -49.47 128.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.683 1.993 . . . . 0.0 113.378 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.8 mt -84.85 77.19 10.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 110.178 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -142.4 73.42 20.87 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 124.151 0.98 . . . . 0.0 110.69 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.23 164.19 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.12 1.88 . . . . 0.0 112.551 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.15 169.17 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.932 2.093 . . . . 0.0 110.383 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -113.7 110.07 19.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.415 0.686 . . . . 0.0 110.577 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.45 155.14 52.9 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.927 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -57.4 -23.37 48.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.802 1.641 . . . . 0.0 114.44 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.32 -24.3 64.82 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.314 1.446 . . . . 0.0 113.086 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.15 -8.03 35.55 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 127.502 2.477 . . . . 0.0 114.01 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -78.68 158.75 28.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.535 1.934 . . . . 0.0 111.458 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.4 t -116.84 149.57 39.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.662 1.585 . . . . 0.0 112.699 172.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.86 177.19 8.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.974 2.11 . . . . 0.0 110.814 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -158.77 -177.35 6.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.939 1.696 . . . . 0.0 112.712 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 p -58.13 -36.51 73.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.7 t -63.29 -42.56 99.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.721 1.608 . . . . 0.0 112.248 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.88 -44.87 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.675 -0.641 . . . . 0.0 110.106 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.44 98.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.784 1.234 . . . . 0.0 113.215 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.37 -42.28 98.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.419 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.8 t -76.11 -21.29 56.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.845 1.258 . . . . 0.0 112.412 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -10.04 39.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.84 2.056 . . . . 0.0 113.901 165.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.12 15.03 37.2 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.178 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.43 148.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.847 1.324 . . . . 0.0 111.865 -173.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 132.42 40.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.181 1.793 . . . . 0.0 111.1 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.43 109.62 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.036 0.935 . . . . 0.0 109.999 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -91.72 -35.99 13.84 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.943 0.897 . . . . 0.0 113.062 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -159.94 168.25 26.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.571 1.149 . . . . 0.0 112.276 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.82 163.88 12.02 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.18 1.392 . . . . 0.0 113.645 177.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 160.48 23.08 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.481 1.515 . . . . 0.0 112.11 -168.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.0 m -62.61 135.38 57.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.997 -0.708 . . . . 0.0 110.685 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 146.92 98.7 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 121.961 -0.462 . . . . 0.0 111.212 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 CA--C 1.54 0.797 0 C-N-CA 123.75 2.966 . . . . 0.0 112.217 -176.282 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.2 m . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 111.106 0.039 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.24 155.12 56.58 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.264 2.643 . . . . 0.0 112.272 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -77.72 -6.48 54.09 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.3 tp -45.74 125.46 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.968 2.107 . . . . 0.0 113.459 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -76.9 83.87 3.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.288 1.835 . . . . 0.0 109.814 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -145.5 65.36 11.38 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 111.834 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.43 161.45 34.76 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.232 2.621 . . . . 0.0 112.437 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 157.42 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.716 2.006 . . . . 0.0 111.024 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -91.18 117.19 29.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.146 0.979 . . . . 0.0 110.32 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.5 166.03 42.95 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.437 1.018 . . . . 0.0 114.348 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -56.41 -26.82 54.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 114.412 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.4 -4.68 37.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.733 1.613 . . . . 0.0 113.771 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.19 62.4 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.741 1.638 . . . . 0.0 114.489 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.24 159.04 18.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.926 1.69 . . . . 0.0 111.179 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -124.43 122.35 37.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.687 1.995 . . . . 0.0 110.252 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.97 175.02 5.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.134 1.774 . . . . 0.0 111.196 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.52 87.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -157.23 -175.53 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.9 m -77.84 8.75 4.18 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -104.8 -46.42 4.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.652 1.581 . . . . 0.0 110.714 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.4 -41.06 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.826 0.851 . . . . 0.0 110.233 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.76 72.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.876 1.27 . . . . 0.0 111.495 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.263 1.825 . . . . 0.0 112.561 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.85 -32.77 65.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.507 0.723 . . . . 0.0 112.319 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -10.57 35.04 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.472 1.509 . . . . 0.0 114.206 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 13.71 57.53 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.039 1.304 . . . . 0.0 114.951 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.27 132.52 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.808 2.043 . . . . 0.0 110.626 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 p -75.48 164.57 26.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.727 0.811 . . . . 0.0 111.623 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 pp -102.79 135.48 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.402 1.081 . . . . 0.0 109.381 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -89.17 -35.63 16.13 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.312 1.445 . . . . 0.0 112.488 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -160.12 170.12 21.89 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 112.715 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.06 153.35 32.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.67 1.588 . . . . 0.0 112.904 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.18 156.89 13.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.996 1.284 . . . . 0.0 112.837 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -58.23 136.55 57.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.941 0.897 . . . . 0.0 111.108 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 147.67 82.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 121.837 -0.539 . . . . 0.0 111.29 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo . . . . . 0 CA--C 1.539 0.725 0 C-N-CA 122.766 2.311 . . . . 0.0 111.994 -178.791 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.8 m . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 111.471 0.175 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -80.02 167.5 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.481 2.787 . . . . 0.0 113.488 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -79.63 -7.3 58.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.575 1.55 . . . . 0.0 114.958 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.4 128.42 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 111.261 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.2 mt -80.33 77.97 7.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.484 1.913 . . . . 0.0 110.268 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -133.7 69.19 76.17 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.704 1.202 . . . . 0.0 109.624 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.99 162.89 30.58 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.893 1.729 . . . . 0.0 112.644 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.44 145.13 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.59 1.956 . . . . 0.0 110.037 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -89.67 118.58 29.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.432 0.693 . . . . 0.0 110.803 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.89 161.91 52.56 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.139 0.876 . . . . 0.0 114.326 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.3 t -59.59 -29.67 68.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.811 1.244 . . . . 0.0 113.664 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -74.9 -20.08 59.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.489 1.116 . . . . 0.0 113.013 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.94 -8.75 31.66 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 126.741 2.115 . . . . 0.0 114.238 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -73.39 161.31 30.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.865 1.666 . . . . 0.0 111.505 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 t -110.52 151.75 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.168 1.387 . . . . 0.0 111.838 165.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.34 175.33 9.37 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.203 1.801 . . . . 0.0 111.167 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.38 69.51 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.535 1.134 . . . . 0.0 114.041 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -160.93 -175.39 4.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.276 1.83 . . . . 0.0 112.753 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -57.86 -40.97 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.89 -47.34 77.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.061 1.344 . . . . 0.0 111.869 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.35 -43.95 63.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.21 -49.24 76.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.474 1.11 . . . . 0.0 112.253 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.3 -42.96 87.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.884 1.674 . . . . 0.0 112.2 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.2 t -73.53 -27.54 61.41 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.071 0.549 . . . . 0.0 112.425 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -11.52 60.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.971 1.708 . . . . 0.0 114.114 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 17.33 57.66 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.545 1.069 . . . . 0.0 115.238 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.44 149.01 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.962 1.705 . . . . 0.0 111.38 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -77.12 156.02 31.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.411 0.684 . . . . 0.0 110.598 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.33 126.76 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.257 1.023 . . . . 0.0 109.681 170.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -91.16 -30.06 16.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.278 1.831 . . . . 0.0 112.201 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -162.01 173.37 14.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.515 1.926 . . . . 0.0 111.124 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -84.35 164.02 19.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 0.0 113.233 172.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.95 166.69 25.77 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.509 1.528 . . . . 0.0 112.69 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -67.39 137.61 56.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.645 -0.915 . . . . 0.0 110.83 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 147.84 91.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 122.052 -0.405 . . . . 0.0 111.777 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo . . . . . 0 CA--C 1.54 0.78 0 C-N-CA 123.175 2.583 . . . . 0.0 112.438 178.599 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m . . . . . 0 CA--C 1.545 0.759 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.32 162.52 41.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.731 2.954 . . . . 0.0 113.732 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -77.46 -5.42 49.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.474 1.91 . . . . 0.0 114.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -50.7 131.45 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.227 1.811 . . . . 0.0 112.893 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.59 71.36 7.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.126 1.77 . . . . 0.0 110.47 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.04 68.69 80.43 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.005 1.322 . . . . 0.0 111.084 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.02 161.18 34.36 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.383 2.056 . . . . 0.0 112.756 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.12 152.91 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.11 2.164 . . . . 0.0 110.323 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.08 116.39 30.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.568 0.747 . . . . 0.0 111.152 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.56 164.6 50.82 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.711 1.148 . . . . 0.0 114.284 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t -57.42 -30.8 65.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.831 1.252 . . . . 0.0 113.373 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.76 -12.29 59.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.116 1.366 . . . . 0.0 113.936 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.79 -2.23 61.98 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 126.028 1.775 . . . . 0.0 114.215 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -68.46 157.83 35.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.928 1.691 . . . . 0.0 110.957 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.8 m -112.32 141.42 46.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.104 1.761 . . . . 0.0 110.695 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.98 172.16 12.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.131 1.772 . . . . 0.0 110.961 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -160.14 -175.2 4.94 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.444 1.897 . . . . 0.0 112.42 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.5 p -59.65 -38.65 82.01 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.8 t -57.68 -47.51 82.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 111.587 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.37 -42.06 65.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 O-C-N 122.131 -0.356 . . . . 0.0 110.153 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.57 72.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.106 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -59.26 -41.36 88.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.479 1.512 . . . . 0.0 111.956 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.78 -24.76 58.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.746 0.818 . . . . 0.0 112.497 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -10.58 58.33 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.054 1.742 . . . . 0.0 114.089 170.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.78 15.33 59.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.646 1.117 . . . . 0.0 115.088 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.56 151.23 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.157 1.783 . . . . 0.0 111.182 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 m -84.69 157.09 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.624 0.77 . . . . 0.0 110.038 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.51 140.09 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.556 0.742 . . . . 0.0 110.31 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -92.39 -31.07 15.46 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.659 1.184 . . . . 0.0 111.48 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 99.2 p -160.32 169.02 24.01 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.537 1.535 . . . . 0.0 112.421 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.37 164.38 21.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.338 1.055 . . . . 0.0 112.762 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.23 164.2 29.79 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.504 1.526 . . . . 0.0 112.705 -173.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 t -65.5 146.73 54.49 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.57 -0.959 . . . . 0.0 111.024 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.42 146.54 37.91 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.537 . . . . 0.0 111.856 176.159 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 165.55 31.26 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.65 2.9 . . . . 0.0 113.695 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -77.51 -8.26 57.51 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 pt -57.33 113.23 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.358 1.863 . . . . 0.0 113.006 -173.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.67 84.61 0.89 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.586 1.554 . . . . 0.0 111.018 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -142.93 75.67 17.51 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.364 1.465 . . . . 0.0 109.422 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.34 165.19 20.59 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.858 2.372 . . . . 0.0 112.8 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.56 159.79 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.482 1.913 . . . . 0.0 110.058 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.0 t -105.99 119.51 39.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.671 . . . . 0.0 111.944 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.01 164.95 53.96 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.732 1.158 . . . . 0.0 114.143 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -59.29 -26.8 65.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.39 1.476 . . . . 0.0 113.534 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -73.38 -17.05 61.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.158 1.383 . . . . 0.0 113.294 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.5 -2.0 67.13 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.238 1.875 . . . . 0.0 113.785 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -70.04 156.38 39.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 111.22 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.1 m -114.84 138.04 51.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.581 1.952 . . . . 0.0 110.621 172.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.04 173.1 10.75 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.726 1.61 . . . . 0.0 111.236 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.85 85.44 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.395 1.078 . . . . 0.0 113.343 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 26' ' ' ILE . 43.8 p-10 -159.32 -176.36 5.76 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.019 1.328 . . . . 0.0 113.548 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -58.66 -38.6 78.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -60.31 -44.8 95.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.368 1.067 . . . . 0.0 112.63 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 23' ' ' ASN . 4.8 tt -73.53 -39.17 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.13 75.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.631 1.172 . . . . 0.0 112.458 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -63.9 -34.76 78.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.495 1.118 . . . . 0.0 113.414 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.3 t -85.05 -21.35 29.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.727 1.211 . . . . 0.0 111.982 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -67.12 -7.26 21.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.799 1.639 . . . . 0.0 113.775 162.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 21.16 53.53 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.392 0.996 . . . . 0.0 114.874 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 143.01 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.049 1.34 . . . . 0.0 111.28 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.34 135.49 34.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.762 0.825 . . . . 0.0 110.248 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.7 pt -81.26 138.01 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.74 0.7 . . . . 0.0 111.053 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -94.17 -31.47 14.13 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.293 1.437 . . . . 0.0 112.69 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -160.52 174.17 14.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.956 1.302 . . . . 0.0 112.078 174.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.09 161.64 16.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.921 1.688 . . . . 0.0 111.865 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.41 166.97 24.34 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.613 1.577 . . . . 0.0 113.241 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 m -65.63 137.38 57.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.187 0.595 . . . . 0.0 110.545 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 145.23 83.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.364 0.666 . . . . 0.0 111.817 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 CA--C 1.538 0.716 0 C-N-CA 124.239 3.292 . . . . 0.0 111.738 179.062 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.9 m . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 164.12 32.52 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.748 2.966 . . . . 0.0 113.875 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -76.97 -10.27 59.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.386 1.874 . . . . 0.0 115.37 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 pt -51.55 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.297 2.239 . . . . 0.0 113.107 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.27 90.61 0.5 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.279 1.832 . . . . 0.0 111.124 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.49 68.2 16.85 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.837 1.255 . . . . 0.0 111.049 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -63.62 159.07 42.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.285 1.99 . . . . 0.0 112.284 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.59 158.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.159 2.183 . . . . 0.0 110.463 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.17 115.25 29.4 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.602 0.761 . . . . 0.0 110.957 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.38 160.09 53.98 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.494 0.569 . . . . 0.0 113.737 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.3 m -59.9 -24.15 64.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.23 -14.38 59.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.938 1.295 . . . . 0.0 113.197 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.24 -4.66 55.25 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.005 2.241 . . . . 0.0 114.154 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -75.26 157.45 34.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.462 1.905 . . . . 0.0 111.87 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.1 m -111.66 138.04 48.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.006 2.123 . . . . 0.0 110.566 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.33 174.57 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.886 1.674 . . . . 0.0 111.7 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.78 80.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.73 1.212 . . . . 0.0 113.662 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -160.82 -174.98 4.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.194 1.398 . . . . 0.0 112.935 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.1 p -59.57 -40.04 86.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.0 t -57.28 -46.24 83.3 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.029 1.331 . . . . 0.0 111.654 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -73.64 -42.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 O-C-N 122.155 -0.34 . . . . 0.0 110.18 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.5 74.96 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.545 1.138 . . . . 0.0 112.384 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -58.55 -39.72 81.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.019 1.728 . . . . 0.0 112.433 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.4 t -74.8 -29.27 61.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.797 0.839 . . . . 0.0 112.688 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -9.38 36.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.698 1.599 . . . . 0.0 114.38 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.56 19.53 51.67 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.643 1.116 . . . . 0.0 114.805 175.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.41 147.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.188 1.795 . . . . 0.0 110.358 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 m -80.67 163.04 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.982 -0.449 . . . . 0.0 110.164 172.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.87 131.59 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 109.371 171.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -89.56 -32.61 17.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.042 0.937 . . . . 0.0 112.093 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -159.62 171.24 19.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.159 1.384 . . . . 0.0 112.229 172.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.73 160.28 24.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.269 1.828 . . . . 0.0 112.936 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 159.16 15.97 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.143 1.354 . . . . 0.0 112.251 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.9 p -62.65 143.74 57.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.521 -0.988 . . . . 0.0 111.808 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.33 146.17 57.31 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.001 -0.437 . . . . 0.0 111.606 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.538 0.693 0 C-N-CA 122.787 2.325 . . . . 0.0 111.962 179.479 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m . . . . . 0 CA--C 1.545 0.769 0 N-CA-C 111.155 0.057 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.1 165.78 30.45 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 114.197 -174.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -75.25 -8.77 57.52 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.561 1.944 . . . . 0.0 115.742 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.4 153.97 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.923 2.089 . . . . 0.0 112.675 -172.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.37 81.89 1.62 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.143 1.377 . . . . 0.0 110.579 -170.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -139.63 73.42 35.06 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.36 1.464 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.1 162.99 24.16 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.988 1.792 . . . . 0.0 112.591 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.07 152.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.588 1.955 . . . . 0.0 109.962 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.6 t -103.03 122.18 44.1 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.804 0.842 . . . . 0.0 110.761 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.93 166.54 54.43 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.502 1.049 . . . . 0.0 113.536 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 p -59.47 -22.67 61.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.42 -23.93 42.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.032 1.333 . . . . 0.0 113.395 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.49 -5.17 33.13 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.481 1.991 . . . . 0.0 114.325 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -74.66 157.24 35.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.507 1.523 . . . . 0.0 111.643 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.6 m -113.26 136.73 52.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.904 1.682 . . . . 0.0 112.115 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.68 171.78 10.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.78 1.632 . . . . 0.0 111.707 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.35 93.12 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -157.81 -175.45 5.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.636 1.574 . . . . 0.0 112.559 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.0 p -59.37 -43.22 92.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.005 0.922 . . . . 0.0 113.423 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.2 t -55.12 -46.73 75.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.619 1.567 . . . . 0.0 111.569 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -72.97 -44.13 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.5 80.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.217 1.007 . . . . 0.0 112.033 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -60.03 -40.67 90.14 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.824 1.65 . . . . 0.0 112.199 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.0 t -72.4 -28.38 62.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.088 0.555 . . . . 0.0 112.386 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -9.51 41.02 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.128 1.771 . . . . 0.0 114.103 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 16.83 52.4 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.625 1.107 . . . . 0.0 114.752 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.52 156.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.464 1.906 . . . . 0.0 111.257 -174.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -92.62 155.99 17.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.941 0.896 . . . . 0.0 109.935 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.98 130.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -85.52 -35.38 21.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.749 1.22 . . . . 0.0 112.343 173.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -156.12 169.47 24.42 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 0.0 112.374 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.47 160.03 22.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.15 1.78 . . . . 0.0 112.64 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.75 170.31 28.7 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.039 1.304 . . . . 0.0 112.933 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.8 m -67.42 138.05 56.38 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.772 -0.84 . . . . 0.0 111.024 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 152.14 92.5 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.889 -0.507 . . . . 0.0 112.038 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.54 0.796 0 C-N-CA 123.619 2.879 . . . . 0.0 112.619 176.337 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 111.233 0.086 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.74 160.85 30.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.9 2.4 . . . . 0.0 113.614 -173.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -75.07 -9.54 58.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.525 1.93 . . . . 0.0 114.409 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mt -60.11 131.84 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.347 1.859 . . . . 0.0 111.09 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 63.89 5.34 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.498 2.319 . . . . 0.0 112.022 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -122.91 71.24 41.39 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.347 1.459 . . . . 0.0 110.222 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.03 164.66 24.15 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.723 2.282 . . . . 0.0 112.6 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -145.4 151.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.714 2.006 . . . . 0.0 110.39 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.6 t -92.42 117.14 29.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.443 0.697 . . . . 0.0 110.389 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.5 166.0 39.33 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.657 1.122 . . . . 0.0 114.566 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -57.96 -33.87 69.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.571 1.148 . . . . 0.0 112.878 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.09 -19.12 57.45 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.095 1.358 . . . . 0.0 113.441 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.2 55.27 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 126.545 2.022 . . . . 0.0 114.171 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -68.23 160.09 29.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.011 1.724 . . . . 0.0 111.525 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.1 m -116.97 138.88 51.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.201 1.801 . . . . 0.0 111.415 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.25 176.3 8.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.4 1.88 . . . . 0.0 111.651 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.11 61.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.904 1.281 . . . . 0.0 114.359 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -162.72 178.14 8.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.206 1.802 . . . . 0.0 112.689 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.9 p -68.5 27.4 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.491 2.316 . . . . 0.0 117.032 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.8 t -119.85 -45.04 2.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.649 2.379 . . . . 0.0 110.394 174.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.06 -40.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 O-C-N 121.783 -0.573 . . . . 0.0 110.212 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.05 -53.21 59.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.93 1.292 . . . . 0.0 111.202 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -58.63 -36.62 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.958 1.303 . . . . 0.0 112.872 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 t -77.55 -29.54 52.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.754 0.822 . . . . 0.0 112.17 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -21.52 62.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.96 1.704 . . . . 0.0 113.56 167.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.45 10.61 33.15 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.563 1.554 . . . . 0.0 115.351 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.286 1.835 . . . . 0.0 110.798 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p -81.09 170.63 15.95 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.776 0.83 . . . . 0.0 111.027 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.99 149.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.798 1.239 . . . . 0.0 110.715 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -110.19 -26.89 9.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.401 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -161.89 170.28 19.72 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.597 1.159 . . . . 0.0 112.938 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.41 155.62 36.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.412 1.885 . . . . 0.0 111.97 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.16 164.92 28.7 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.575 1.56 . . . . 0.0 113.529 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 m -63.2 136.23 57.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.717 -0.872 . . . . 0.0 110.971 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.88 148.52 82.04 Favored Pre-proline 0 CA--C 1.548 0.903 0 O-C-N 121.82 -0.55 . . . . 0.0 111.9 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo . . . . . 0 CA--C 1.539 0.732 0 C-N-CA 123.094 2.529 . . . . 0.0 112.248 176.961 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 111.668 0.247 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.6 163.39 36.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.544 2.829 . . . . 0.0 113.196 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -84.52 -4.24 58.84 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 tt -48.68 131.56 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.085 2.154 . . . . 0.0 113.332 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.76 79.03 7.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.579 . . . . 0.0 110.576 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -143.32 71.48 17.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.835 0.854 . . . . 0.0 110.429 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.55 160.62 45.07 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.013 1.809 . . . . 0.0 112.089 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.52 155.19 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 110.198 -172.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -98.25 112.91 24.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.167 0.587 . . . . 0.0 111.112 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.07 164.42 51.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.433 0.539 . . . . 0.0 113.005 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -64.26 -18.89 65.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.35 -22.85 60.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.593 1.157 . . . . 0.0 113.242 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.33 42.2 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 127.043 2.259 . . . . 0.0 114.124 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -83.55 159.8 21.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.196 1.798 . . . . 0.0 111.244 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.8 t -113.89 147.95 37.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.451 1.501 . . . . 0.0 112.767 173.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.79 178.02 7.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.248 2.219 . . . . 0.0 110.688 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.55 74.09 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -157.2 -176.87 6.21 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.908 1.683 . . . . 0.0 113.366 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.9 p -73.73 14.0 0.43 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 116.009 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -107.12 -48.08 3.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.53 1.932 . . . . 0.0 111.179 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 tp -65.57 -41.4 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -61.59 -42.5 98.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.204 1.002 . . . . 0.0 112.196 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -64.25 -37.89 89.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.308 1.443 . . . . 0.0 112.597 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -71.8 -29.15 64.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.481 0.712 . . . . 0.0 112.01 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -10.44 57.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.428 1.891 . . . . 0.0 114.816 174.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.69 14.89 38.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.648 1.118 . . . . 0.0 115.326 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 159.22 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.9 1.68 . . . . 0.0 111.178 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 p -100.61 158.15 16.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.411 1.085 . . . . 0.0 111.814 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 27' ' ' ALA . 37.5 mm -93.34 109.72 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.958 1.303 . . . . 0.0 109.944 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -76.01 -46.0 31.7 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.041 1.336 . . . . 0.0 112.264 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 t -153.73 164.28 38.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.817 0.847 . . . . 0.0 112.907 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -84.63 155.19 22.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.421 1.488 . . . . 0.0 112.799 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.09 151.01 13.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.715 1.15 . . . . 0.0 111.596 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -61.63 135.44 57.63 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.697 -0.884 . . . . 0.0 111.609 173.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.41 150.56 97.8 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.927 0.491 . . . . 0.0 111.557 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 CA--C 1.54 0.805 0 C-N-CA 123.339 2.692 . . . . 0.0 112.633 179.497 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.26 162.92 19.95 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.539 2.826 . . . . 0.0 113.227 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -84.38 -7.94 59.15 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 pt -54.7 133.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.093 1.757 . . . . 0.0 112.946 -171.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -76.08 76.79 2.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.511 1.524 . . . . 0.0 111.21 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -132.85 66.97 77.5 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 126.194 1.797 . . . . 0.0 111.337 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -61.69 157.74 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.926 1.751 . . . . 0.0 111.945 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -143.77 154.96 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.012 2.125 . . . . 0.0 110.262 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -90.69 112.62 24.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.155 0.582 . . . . 0.0 109.8 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.87 159.17 46.55 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.681 0.657 . . . . 0.0 113.496 170.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 p -63.16 -22.41 66.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.34 1.456 . . . . 0.0 114.506 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -84.57 -10.27 57.55 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.527 1.131 . . . . 0.0 113.842 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.66 60.77 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 126.579 2.038 . . . . 0.0 113.908 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -66.31 157.62 31.21 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.841 1.656 . . . . 0.0 111.444 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.1 m -121.97 135.77 54.88 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.396 1.878 . . . . 0.0 110.519 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.32 177.61 6.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.33 1.852 . . . . 0.0 111.662 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.37 77.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -148.83 -179.69 7.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.221 1.408 . . . . 0.0 111.846 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.6 p -66.41 -43.97 84.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.475 1.11 . . . . 0.0 113.002 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 t -61.55 -41.67 97.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.95 1.3 . . . . 0.0 112.217 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 tp -67.39 -42.95 87.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.93 63.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.106 1.362 . . . . 0.0 111.431 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -56.73 -41.14 76.97 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.461 1.104 . . . . 0.0 112.54 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.84 -26.49 59.74 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -8.79 41.65 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.855 1.662 . . . . 0.0 114.175 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.27 15.69 46.72 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.914 1.245 . . . . 0.0 114.736 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.86 142.74 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.122 1.769 . . . . 0.0 110.779 -174.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -84.12 152.68 24.17 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.984 -0.447 . . . . 0.0 109.94 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.47 149.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 167.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -119.18 -22.34 7.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.259 1.424 . . . . 0.0 112.853 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.7 p -160.95 167.75 25.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.243 1.417 . . . . 0.0 112.616 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.33 154.23 25.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.72 1.208 . . . . 0.0 112.264 173.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.11 165.97 36.99 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.362 1.458 . . . . 0.0 113.185 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.7 t -60.15 149.66 32.12 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.731 -0.864 . . . . 0.0 111.576 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.49 141.24 22.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.564 0.746 . . . . 0.0 112.186 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo . . . . . 0 CA--C 1.537 0.672 0 C-N-CA 123.074 2.516 . . . . 0.0 112.32 -176.484 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.8 m . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.45 162.56 35.79 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.755 2.97 . . . . 0.0 113.229 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -78.57 -9.17 59.26 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -50.52 113.9 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.942 2.097 . . . . 0.0 113.021 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -70.8 91.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.796 1.238 . . . . 0.0 110.508 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 69.77 14.46 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.179 0.991 . . . . 0.0 110.5 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.58 161.34 28.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.361 2.041 . . . . 0.0 112.214 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.89 155.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.401 2.28 . . . . 0.0 109.719 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -99.57 114.74 27.95 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.907 0.883 . . . . 0.0 109.584 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.96 166.54 40.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.547 1.07 . . . . 0.0 114.127 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.27 -30.2 59.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.997 1.319 . . . . 0.0 113.708 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.35 -18.39 49.2 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.927 1.291 . . . . 0.0 113.777 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.74 -3.87 49.65 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.358 1.932 . . . . 0.0 114.328 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -70.61 157.92 37.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 111.953 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -111.63 141.54 45.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 111.536 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.13 173.59 10.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.527 1.931 . . . . 0.0 111.053 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.92 82.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.041 . . . . 0.0 113.741 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -162.07 -176.38 5.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.343 1.457 . . . . 0.0 113.125 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -60.84 -35.61 77.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -62.52 -39.17 92.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.049 1.34 . . . . 0.0 112.444 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 tp -79.7 -42.32 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 O-C-N 121.773 -0.579 . . . . 0.0 110.49 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.1 70.0 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.287 1.035 . . . . 0.0 112.37 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -57.58 -41.66 81.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.546 1.138 . . . . 0.0 112.846 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.46 -24.08 50.33 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.816 1.246 . . . . 0.0 112.629 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -11.47 60.66 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.29 1.836 . . . . 0.0 113.797 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 17.92 39.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.014 1.292 . . . . 0.0 115.22 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.11 146.09 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.221 1.808 . . . . 0.0 111.134 -172.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -82.13 147.59 28.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.27 1.028 . . . . 0.0 110.918 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.83 131.8 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -89.79 -40.4 12.49 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.273 1.429 . . . . 0.0 111.98 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -145.37 160.33 41.7 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.167 1.387 . . . . 0.0 112.349 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.37 154.14 35.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.932 1.293 . . . . 0.0 112.167 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.19 162.39 28.63 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.152 1.358 . . . . 0.0 112.942 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.5 t -64.14 147.19 52.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.654 -0.909 . . . . 0.0 111.329 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.66 143.1 33.29 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.798 0.839 . . . . 0.0 112.08 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.813 -179.727 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.8 m . . . . . 0 CA--C 1.545 0.752 0 CA-C-O 120.312 0.101 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.9 163.3 35.75 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.479 2.786 . . . . 0.0 113.571 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -79.93 -8.34 59.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.116 1.766 . . . . 0.0 114.93 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 135.43 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.636 1.975 . . . . 0.0 113.077 -171.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.69 81.11 8.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.367 1.867 . . . . 0.0 111.79 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.29 70.0 77.54 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.094 1.358 . . . . 0.0 110.638 172.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.19 161.69 29.42 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.547 2.164 . . . . 0.0 112.817 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.6 m -147.16 153.62 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.915 2.086 . . . . 0.0 110.64 -172.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -99.29 111.61 23.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.831 0.852 . . . . 0.0 111.871 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.88 162.56 48.32 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.615 1.102 . . . . 0.0 113.967 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 m -59.54 -25.45 64.53 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -78.74 -15.86 57.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.373 1.069 . . . . 0.0 113.267 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 -1.45 59.68 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 126.61 2.052 . . . . 0.0 113.974 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -72.58 158.2 36.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.897 1.679 . . . . 0.0 111.116 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.0 m -116.85 140.6 49.25 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.695 1.998 . . . . 0.0 110.595 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.16 175.83 8.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.981 1.712 . . . . 0.0 111.418 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.67 72.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.508 1.123 . . . . 0.0 113.818 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.92 -174.52 4.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.377 1.871 . . . . 0.0 112.491 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 p -58.62 -39.87 81.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.67 -47.31 82.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.451 1.5 . . . . 0.0 111.654 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.46 -42.56 64.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.06 74.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.543 1.137 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -56.12 -43.37 78.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.64 1.976 . . . . 0.0 112.162 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -76.18 -24.98 54.78 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -9.73 49.02 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.94 1.696 . . . . 0.0 114.073 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.6 15.55 54.65 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.893 1.235 . . . . 0.0 114.906 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.6 162.19 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.497 1.919 . . . . 0.0 111.468 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 132.3 56.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.249 1.42 . . . . 0.0 109.376 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 pt -78.99 140.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.998 -0.439 . . . . 0.0 111.245 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -93.12 -35.25 13.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.444 1.098 . . . . 0.0 112.285 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -149.38 161.16 42.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.629 1.172 . . . . 0.0 112.303 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.57 160.31 25.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 169.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.3 166.0 40.21 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.48 1.514 . . . . 0.0 113.132 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.9 t -63.11 150.42 42.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.926 -0.749 . . . . 0.0 111.282 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.49 137.02 19.27 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.328 1.051 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.539 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 112.765 -178.274 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.543 0.676 0 CA-C-O 120.304 0.097 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.72 158.16 57.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.16 2.573 . . . . 0.0 113.016 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.83 -5.44 43.54 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.419 1.888 . . . . 0.0 114.73 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 tt -51.24 131.89 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.886 2.074 . . . . 0.0 113.539 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 tt -82.12 78.63 8.78 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.116 1.766 . . . . 0.0 109.531 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -143.25 68.39 17.43 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 111.567 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.22 168.69 12.07 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.741 2.961 . . . . 0.0 113.615 -172.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.06 158.58 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.485 1.914 . . . . 0.0 111.023 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -98.71 113.17 25.13 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.889 0.875 . . . . 0.0 109.758 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 153.7 51.45 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 113.414 173.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -59.72 -26.41 65.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.112 0.965 . . . . 0.0 113.204 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.06 -19.3 61.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.225 1.41 . . . . 0.0 113.337 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.41 -8.15 40.62 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.859 2.171 . . . . 0.0 114.507 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -75.77 160.15 30.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.486 1.915 . . . . 0.0 111.701 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -111.58 143.31 42.65 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.668 1.987 . . . . 0.0 110.77 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.34 175.21 9.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.559 1.943 . . . . 0.0 110.979 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -47.76 79.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.201 1.001 . . . . 0.0 113.591 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -156.55 -173.31 4.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 112.433 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 p -60.81 -37.14 80.96 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -60.53 -46.91 88.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.429 1.492 . . . . 0.0 112.474 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 tp -69.76 -39.71 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 122.359 1.076 . . . . 0.0 110.339 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.77 77.84 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.932 1.693 . . . . 0.0 112.472 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -58.09 -34.56 70.32 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.574 1.55 . . . . 0.0 112.682 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.3 t -79.54 -30.73 41.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.432 0.693 . . . . 0.0 111.653 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -66.49 -5.32 10.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.128 1.771 . . . . 0.0 113.942 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 9.66 68.2 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.586 1.565 . . . . 0.0 115.19 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.0 152.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.909 1.283 . . . . 0.0 111.896 -171.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.4 m -85.23 -19.27 31.9 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -168.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.2 mm 53.49 88.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 130.74 3.616 . . . . 0.0 112.73 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -75.07 -32.96 61.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.778 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -160.54 168.79 24.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 0.0 112.714 172.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -93.18 163.43 13.63 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.813 1.645 . . . . 0.0 112.319 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.05 165.42 26.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.607 1.575 . . . . 0.0 112.63 -171.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -64.82 147.22 53.64 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.436 -1.038 . . . . 0.0 111.273 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.73 143.67 36.03 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.579 0.752 . . . . 0.0 111.902 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 CA--C 1.539 0.763 0 C-N-CA 123.547 2.831 . . . . 0.0 112.971 -176.592 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.3 m . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.83 161.45 46.04 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.554 2.836 . . . . 0.0 113.366 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.8 -7.0 52.08 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 tt -51.61 127.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.321 1.848 . . . . 0.0 113.458 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -80.75 97.34 7.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -156.69 72.85 4.8 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 123.486 0.714 . . . . 0.0 111.945 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.99 166.98 16.94 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.238 1.959 . . . . 0.0 113.012 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.38 147.77 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 127.091 2.156 . . . . 0.0 110.113 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.05 115.93 26.96 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.54 165.66 46.99 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.069 0.842 . . . . 0.0 114.083 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 t -62.06 -27.45 68.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 113.154 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.95 -24.2 58.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.918 1.287 . . . . 0.0 113.226 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.92 -8.41 39.18 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 126.785 2.136 . . . . 0.0 114.333 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -66.95 160.76 25.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.764 1.626 . . . . 0.0 111.088 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.5 t -109.5 156.5 20.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.706 1.202 . . . . 0.0 112.022 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.28 169.54 17.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.702 2.001 . . . . 0.0 110.272 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.28 81.41 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -159.13 -176.85 6.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.428 1.491 . . . . 0.0 112.461 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 p -58.87 -34.86 72.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.92 -43.22 96.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 112.65 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -38.96 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.704 -0.622 . . . . 0.0 110.255 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -51.36 69.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.951 1.301 . . . . 0.0 112.519 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -61.11 -32.5 72.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -88.19 -19.56 26.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.244 1.417 . . . . 0.0 112.384 -173.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.07 -6.27 32.63 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.926 2.09 . . . . 0.0 114.448 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.16 60.12 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.641 1.115 . . . . 0.0 114.736 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.27 168.14 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.054 2.542 . . . . 0.0 110.622 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -119.38 167.43 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.871 1.268 . . . . 0.0 110.642 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.91 138.15 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.027 1.331 . . . . 0.0 110.462 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -100.94 -31.57 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.846 1.659 . . . . 0.0 113.097 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 164.01 39.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.622 1.169 . . . . 0.0 112.022 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.29 152.11 23.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.66 1.584 . . . . 0.0 112.693 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.46 167.39 28.66 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.938 1.256 . . . . 0.0 112.48 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.8 t -63.67 148.72 48.29 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.718 -0.872 . . . . 0.0 111.387 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.28 145.42 60.0 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 111.402 174.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.539 0.739 0 C-N-CA 122.68 2.254 . . . . 0.0 111.573 176.531 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.862 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -81.48 57.9 3.46 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 119.849 -1.782 . . . . 0.0 112.013 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 t -67.03 142.33 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.219 1.407 . . . . 0.0 110.56 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.38 139.22 58.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.533 0.733 . . . . 0.0 112.2 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.99 92.72 1.31 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.572 1.149 . . . . 0.0 111.228 173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.5 m -121.61 159.3 51.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 126.661 1.984 . . . . 0.0 111.151 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.8 165.24 28.95 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.418 2.745 . . . . 0.0 112.919 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -75.79 -8.09 56.01 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -56.02 131.89 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.55 1.94 . . . . 0.0 111.183 -173.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.3 mp -84.26 79.01 9.68 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.139 1.776 . . . . 0.0 109.69 175.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -127.41 63.09 57.39 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 125.376 1.471 . . . . 0.0 110.963 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.86 161.99 33.99 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.859 2.373 . . . . 0.0 112.663 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.84 154.58 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.889 2.075 . . . . 0.0 110.454 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.26 113.78 25.06 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.415 0.686 . . . . 0.0 109.728 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.66 160.38 53.0 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 123.128 0.394 . . . . 0.0 113.313 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -64.76 -23.3 67.2 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -76.59 -19.14 58.18 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.097 1.359 . . . . 0.0 113.17 171.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.52 -7.92 47.03 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 127.16 2.315 . . . . 0.0 113.789 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -67.23 156.85 35.28 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.915 1.686 . . . . 0.0 111.964 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 53.4 m -113.64 136.28 53.0 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.021 2.128 . . . . 0.0 110.184 172.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.22 174.21 9.79 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.181 1.792 . . . . 0.0 111.133 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.67 72.39 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.391 1.076 . . . . 0.0 113.853 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -162.33 -176.7 5.24 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.314 1.446 . . . . 0.0 112.764 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -57.02 -39.95 75.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.4 t -55.46 -45.92 76.87 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.942 1.297 . . . . 0.0 111.843 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 tp -75.99 -43.0 39.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.212 -0.305 . . . . 0.0 110.479 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.35 -48.85 75.94 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.571 1.148 . . . . 0.0 112.526 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -61.2 -42.59 98.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.953 1.701 . . . . 0.0 111.987 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.6 t -70.23 -30.79 67.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.995 0.918 . . . . 0.0 112.331 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -7.29 17.98 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.662 1.585 . . . . 0.0 114.191 171.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.08 18.92 52.78 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.813 1.197 . . . . 0.0 114.847 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.67 158.49 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 125.629 1.572 . . . . 0.0 110.908 -175.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.7 t -96.52 166.05 11.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 0.0 110.574 166.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 pp -102.66 142.37 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.215 1.406 . . . . 0.0 110.149 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -97.47 -31.34 12.4 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.347 1.459 . . . . 0.0 111.633 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 91.2 p -162.37 169.61 20.23 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.706 1.602 . . . . 0.0 112.474 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.61 160.44 29.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.903 1.281 . . . . 0.0 112.597 168.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.05 166.25 25.16 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 125.347 1.451 . . . . 0.0 112.811 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.2 p -64.06 146.7 53.71 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.443 -1.034 . . . . 0.0 111.94 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -87.14 146.66 40.78 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 122.931 0.492 . . . . 0.0 111.508 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.33 152.23 66.26 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.645 2.23 . . . . 0.0 112.032 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.1 t -75.14 -13.62 60.48 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.42 72.78 0.89 Allowed Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.309 1.909 . . . . 0.0 112.644 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.687 1.595 . . . . 0.0 113.217 175.868 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 160.86 29.98 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.508 -0.745 . . . . 0.0 111.234 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.68 2.24 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 125.525 1.53 . . . . 0.0 112.396 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 3.0 t -147.11 143.92 28.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.486 1.514 . . . . 0.0 111.725 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.76 94.07 3.78 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.731 1.212 . . . . 0.0 111.67 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 97.0 m -128.25 159.19 68.52 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.395 1.878 . . . . 0.0 111.556 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.53 166.89 26.56 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.513 2.808 . . . . 0.0 113.386 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -80.28 -6.65 58.26 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.6 133.35 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.455 1.902 . . . . 0.0 111.361 -172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.33 79.98 8.64 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.33 1.852 . . . . 0.0 110.469 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -129.83 66.88 78.51 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 125.269 1.428 . . . . 0.0 110.907 173.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.35 162.2 31.4 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.985 2.457 . . . . 0.0 113.065 -174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -144.83 155.83 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 126.505 1.922 . . . . 0.0 110.881 -175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.5 t -94.98 111.09 22.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.916 0.887 . . . . 0.0 111.18 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.51 163.71 51.33 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.053 0.835 . . . . 0.0 114.307 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.4 t -63.62 -25.63 68.31 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -74.4 -17.12 60.85 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.072 1.349 . . . . 0.0 113.121 171.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.99 -5.68 63.69 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.872 2.177 . . . . 0.0 113.711 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -68.21 157.53 35.26 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.369 1.868 . . . . 0.0 111.775 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.6 m -113.76 137.94 50.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.48 1.912 . . . . 0.0 110.702 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.34 176.03 8.27 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.124 1.77 . . . . 0.0 111.395 178.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.3 -51.02 71.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.73 1.212 . . . . 0.0 113.814 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -159.78 -174.95 4.86 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.581 1.553 . . . . 0.0 112.569 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.8 p -58.4 -39.69 80.39 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.4 t -57.02 -48.45 78.44 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.284 1.434 . . . . 0.0 111.237 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.4 tp -71.12 -43.32 75.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.091 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -51.5 68.45 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.532 1.133 . . . . 0.0 112.347 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.1 mmm180 -61.14 -41.4 96.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.987 1.715 . . . . 0.0 111.835 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 9.1 t -74.15 -24.06 59.36 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.487 0.715 . . . . 0.0 112.413 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.72 -10.89 59.07 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.903 1.681 . . . . 0.0 113.94 169.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.59 15.4 56.88 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.79 1.186 . . . . 0.0 115.184 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.06 148.65 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.666 1.586 . . . . 0.0 111.675 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -78.71 168.58 19.53 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.914 0.886 . . . . 0.0 111.231 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -120.68 134.85 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.398 1.479 . . . . 0.0 110.532 174.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -69.61 -47.97 61.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.854 1.261 . . . . 0.0 110.768 172.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.6 t -165.81 177.67 7.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.225 1.41 . . . . 0.0 112.104 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.45 164.99 24.95 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.841 1.656 . . . . 0.0 113.321 172.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.5 162.4 21.04 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 126.015 1.769 . . . . 0.0 113.426 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 m -65.63 135.38 54.97 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.888 0.875 . . . . 0.0 110.975 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.98 142.65 64.88 Favored Pre-proline 0 CA--C 1.548 0.879 0 O-C-N 121.817 -0.552 . . . . 0.0 112.097 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.17 137.43 52.0 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.77 2.313 . . . . 0.0 111.162 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.3 m 59.55 13.99 3.65 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.66 1.584 . . . . 0.0 113.584 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.15 0.1 89.09 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 125.656 1.598 . . . . 0.0 116.119 -174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.5 mt . . . . . 0 C--O 1.253 1.264 0 C-N-CA 127.241 2.217 . . . . 0.0 109.937 178.536 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -129.22 106.15 8.63 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.327 1.851 . . . . 0.0 110.494 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.3 t -105.58 146.83 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.852 1.661 . . . . 0.0 109.83 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 136.89 57.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.663 0.785 . . . . 0.0 112.192 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.4 96.86 1.52 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.192 0.997 . . . . 0.0 110.874 171.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.5 m -124.68 157.49 65.61 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.88 1.672 . . . . 0.0 112.264 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.66 163.9 36.17 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.694 2.929 . . . . 0.0 114.222 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -75.52 -6.35 49.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 127.115 2.166 . . . . 0.0 115.317 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.3 tt -54.35 136.25 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 126.09 1.756 . . . . 0.0 112.799 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.95 85.29 5.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.926 1.691 . . . . 0.0 110.583 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -140.97 68.09 28.03 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.387 1.075 . . . . 0.0 111.057 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -62.49 159.93 34.08 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.819 1.679 . . . . 0.0 111.817 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.81 158.12 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.771 2.029 . . . . 0.0 109.961 -178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.5 t -97.1 114.13 25.77 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.325 0.65 . . . . 0.0 109.618 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.67 163.0 47.32 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.77 0.7 . . . . 0.0 113.03 173.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 t -63.36 -19.75 64.92 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.83 -12.69 55.23 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.798 1.639 . . . . 0.0 113.448 172.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.18 -4.48 58.73 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.745 2.117 . . . . 0.0 114.32 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -67.11 156.49 36.03 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.286 1.834 . . . . 0.0 111.615 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.7 m -115.07 132.63 56.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.769 2.028 . . . . 0.0 110.59 173.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -122.6 174.81 6.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.246 1.819 . . . . 0.0 111.418 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.52 -49.63 76.79 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.384 1.074 . . . . 0.0 113.564 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.6 p-10 -162.06 -175.97 4.91 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.876 1.27 . . . . 0.0 113.896 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -62.64 -37.85 87.97 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.3 t -58.01 -46.05 85.89 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.793 1.237 . . . . 0.0 111.823 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -71.26 -46.53 65.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.34 -46.0 80.13 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.143 0.977 . . . . 0.0 113.023 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.45 -28.64 65.47 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.656 1.982 . . . . 0.0 114.019 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 20.8 t -97.72 -24.71 15.36 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.355 1.462 . . . . 0.0 111.926 -175.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -69.54 -11.8 61.13 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.476 1.91 . . . . 0.0 113.503 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.99 56.03 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.433 1.016 . . . . 0.0 114.782 176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 t -118.41 151.49 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 124.992 1.317 . . . . 0.0 110.879 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.14 138.3 31.69 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.431 1.092 . . . . 0.0 108.955 176.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.2 pp -76.88 137.67 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 118.976 0.807 . . . . 0.0 109.53 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -96.98 -34.1 11.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.635 1.574 . . . . 0.0 112.433 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -157.27 168.33 27.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.07 0.948 . . . . 0.0 112.682 175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.25 149.27 25.6 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.403 1.881 . . . . 0.0 111.675 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.56 161.85 28.36 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.908 1.242 . . . . 0.0 112.28 -173.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.2 p -63.59 149.89 45.33 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.574 -0.957 . . . . 0.0 112.236 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.98 149.44 50.46 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.132 0.573 . . . . 0.0 112.17 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.5 162.6 39.65 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.395 2.73 . . . . 0.0 112.566 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.4 p -93.21 68.53 4.28 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.146 1.378 . . . . 0.0 111.959 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.65 124.79 1.69 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.335 1.445 . . . . 0.0 112.74 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.783 2.033 . . . . 0.0 112.032 174.512 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 119.788 -0.149 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.29 -178.66 6.26 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.797 1.639 . . . . 0.0 112.273 175.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -135.27 154.44 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.354 1.462 . . . . 0.0 112.011 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.1 m -72.03 93.28 1.37 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.928 1.691 . . . . 0.0 111.37 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.03 97.75 1.51 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.384 1.074 . . . . 0.0 111.307 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.8 m -122.39 157.81 57.74 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.958 1.703 . . . . 0.0 112.423 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.27 167.86 24.0 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.023 3.149 . . . . 0.0 114.335 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -76.08 -9.85 58.95 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.0 pt -58.1 114.18 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 126.418 1.887 . . . . 0.0 113.813 -171.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.98 85.66 0.52 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.282 1.433 . . . . 0.0 110.848 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.74 72.6 55.7 Favored Pre-proline 0 N--CA 1.47 0.549 0 C-N-CA 125.91 1.684 . . . . 0.0 109.888 171.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -63.79 160.64 35.94 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.189 1.926 . . . . 0.0 112.085 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.19 157.06 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 126.857 2.063 . . . . 0.0 110.48 -170.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.0 t -102.71 114.04 27.94 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.605 0.762 . . . . 0.0 111.693 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.29 163.08 51.44 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.88 1.229 . . . . 0.0 114.406 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.4 t -61.89 -28.55 69.59 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.739 1.216 . . . . 0.0 113.551 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.39 -10.79 59.83 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.285 1.034 . . . . 0.0 113.313 173.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.05 -5.51 61.43 Favored Glycine 0 N--CA 1.472 1.062 0 C-N-CA 126.84 2.162 . . . . 0.0 113.884 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -70.3 157.03 38.46 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.429 1.892 . . . . 0.0 111.798 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 48.4 m -115.17 137.59 51.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.039 2.136 . . . . 0.0 110.525 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.62 173.04 11.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.984 1.714 . . . . 0.0 111.439 176.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.25 -47.15 86.43 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.546 1.138 . . . . 0.0 114.018 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -160.12 -174.7 4.67 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.801 1.64 . . . . 0.0 112.494 178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.2 p -59.98 -41.39 91.91 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 174.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.7 t -56.79 -47.42 80.23 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.3 1.44 . . . . 0.0 111.405 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.7 tp -71.93 -43.71 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.56 76.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.325 1.05 . . . . 0.0 112.27 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -59.82 -41.79 92.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.895 1.678 . . . . 0.0 111.952 175.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 16.4 t -74.25 -25.09 59.43 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.947 0.899 . . . . 0.0 112.504 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -11.07 59.8 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.044 1.738 . . . . 0.0 114.179 172.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.14 44.92 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.694 1.14 . . . . 0.0 115.105 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.5 154.6 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.04 1.736 . . . . 0.0 111.133 -174.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -98.77 144.59 27.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.386 1.074 . . . . 0.0 109.444 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 pt -91.82 134.91 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 118.651 0.659 . . . . 0.0 111.025 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.08 -34.98 22.12 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.006 1.322 . . . . 0.0 112.227 175.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 t -160.62 173.65 15.17 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.496 1.118 . . . . 0.0 112.458 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.68 161.44 23.4 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.058 1.743 . . . . 0.0 112.839 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.81 156.97 15.08 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 125.325 1.441 . . . . 0.0 112.262 -172.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 p -64.01 142.32 58.45 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.607 -0.937 . . . . 0.0 111.5 170.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.12 150.66 71.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -177.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.63 151.15 57.99 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.096 2.531 . . . . 0.0 112.079 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 m -78.36 -10.81 59.83 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.093 1.357 . . . . 0.0 113.166 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 161.55 149.59 5.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 128.058 2.742 . . . . 0.0 110.997 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 C--O 1.254 1.3 0 C-N-CA 125.596 1.558 . . . . 0.0 112.569 -177.146 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 24.6 pttm . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -76.12 102.1 5.59 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 121.39 1.905 . . . . 0.0 112.662 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.1 t -89.37 147.08 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.88 1.672 . . . . 0.0 110.999 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 137.97 56.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.279 1.032 . . . . 0.0 112.713 173.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -73.39 97.92 2.62 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.458 1.103 . . . . 0.0 111.416 170.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 98.6 m -124.01 157.77 62.55 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.414 1.886 . . . . 0.0 111.732 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.88 163.88 34.62 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 123.745 2.963 . . . . 0.0 113.596 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.05 -8.52 57.58 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 3.7 pt -53.36 111.84 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.59 1.956 . . . . 0.0 113.285 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.97 84.3 0.97 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.712 1.605 . . . . 0.0 111.332 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -141.45 74.05 24.26 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.205 1.402 . . . . 0.0 109.748 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.98 165.38 21.66 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.82 2.347 . . . . 0.0 112.84 -175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -145.6 153.45 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.575 1.95 . . . . 0.0 110.452 -176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -98.19 113.0 24.77 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.064 0.946 . . . . 0.0 111.009 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.59 164.82 37.66 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.403 1.002 . . . . 0.0 114.282 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.8 t -60.61 -29.71 69.4 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.148 0.979 . . . . 0.0 113.41 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -79.01 -13.5 59.75 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.847 1.259 . . . . 0.0 113.488 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.51 -3.17 59.3 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 126.281 1.896 . . . . 0.0 114.049 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -66.16 156.28 34.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.722 1.609 . . . . 0.0 111.464 174.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 61.0 m -114.0 138.4 50.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.54 1.936 . . . . 0.0 110.111 173.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.89 174.1 9.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.691 1.596 . . . . 0.0 111.25 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.43 -49.03 77.54 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 113.443 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -159.7 -174.29 4.54 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.462 1.505 . . . . 0.0 113.206 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.7 p -61.17 -38.0 84.94 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.04 -46.09 85.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.19 1.396 . . . . 0.0 111.79 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.9 tp -74.64 -41.46 48.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 O-C-N 122.066 -0.397 . . . . 0.0 110.369 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.36 -47.77 82.75 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.731 1.212 . . . . 0.0 112.405 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -59.06 -42.51 90.52 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 111.82 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.0 t -73.6 -27.87 61.52 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.917 0.887 . . . . 0.0 112.598 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -7.33 22.83 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.724 1.61 . . . . 0.0 114.113 175.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 18.84 48.99 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.875 175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.23 150.3 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.779 1.631 . . . . 0.0 111.093 -173.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.3 p -82.74 168.32 17.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.586 0.754 . . . . 0.0 111.488 168.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.58 137.49 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 125.102 1.361 . . . . 0.0 110.064 172.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -92.54 -33.55 14.41 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.698 1.199 . . . . 0.0 112.039 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.3 m -150.93 162.41 40.86 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.708 1.603 . . . . 0.0 112.26 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -76.87 162.91 27.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.43 1.092 . . . . 0.0 112.329 165.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.2 167.63 31.21 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.313 1.435 . . . . 0.0 113.002 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.7 p -66.13 149.09 50.83 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 121.51 -0.994 . . . . 0.0 111.562 169.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.39 145.17 32.04 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.002 0.521 . . . . 0.0 112.194 -176.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.85 157.06 52.21 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.916 2.411 . . . . 0.0 112.359 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.8 p -83.02 -5.84 59.26 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.313 1.445 . . . . 0.0 114.491 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -165.77 86.43 0.1 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.301 1.429 . . . . 0.0 112.171 -177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 tt . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.985 1.714 . . . . 0.0 113.289 175.718 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . 0.272 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -71.5 112.53 7.7 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 126.159 1.783 . . . . 0.0 111.166 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.9 m -65.85 151.64 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.73 1.212 . . . . 0.0 112.162 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.8 m -71.92 121.53 19.23 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.763 0.825 . . . . 0.0 111.677 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.08 99.84 0.54 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.867 1.267 . . . . 0.0 111.294 172.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.9 m -124.26 159.04 58.96 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.605 1.962 . . . . 0.0 110.979 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.12 164.09 29.85 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.341 2.694 . . . . 0.0 112.962 -176.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -81.22 -5.78 58.13 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.8 mt -55.01 131.2 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.222 1.809 . . . . 0.0 110.749 -175.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.1 mt -82.15 78.4 8.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.158 1.783 . . . . 0.0 110.318 175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -130.06 69.64 81.88 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.899 1.28 . . . . 0.0 109.667 175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.19 161.74 38.98 Favored 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.15 1.9 . . . . 0.0 112.44 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.7 157.18 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 127.007 2.123 . . . . 0.0 110.627 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -102.53 114.81 29.34 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.783 0.833 . . . . 0.0 111.674 179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.56 162.33 54.6 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.15 0.881 . . . . 0.0 113.943 173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.2 p -61.74 -26.05 67.82 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.4 1.48 . . . . 0.0 114.228 177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.1 -19.44 54.15 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.67 1.188 . . . . 0.0 112.989 173.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.16 -7.15 32.61 Favored Glycine 0 N--CA 1.471 0.997 0 C-N-CA 127.381 2.419 . . . . 0.0 114.166 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -74.38 158.01 34.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.61 1.564 . . . . 0.0 112.199 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 43.3 m -114.74 125.85 54.18 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 127.658 2.383 . . . . 0.0 110.653 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.17 174.6 6.12 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.884 1.674 . . . . 0.0 111.65 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.56 -49.98 75.46 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.455 1.102 . . . . 0.0 113.751 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -163.18 -175.92 4.55 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.658 1.983 . . . . 0.0 112.665 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.8 m -57.87 -39.28 77.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -56.77 -46.7 81.31 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.062 1.345 . . . . 0.0 111.829 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -75.06 -41.6 45.29 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 O-C-N 122.225 -0.297 . . . . 0.0 110.284 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.87 78.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.445 1.098 . . . . 0.0 112.234 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -59.42 -39.92 85.03 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.032 1.733 . . . . 0.0 112.436 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.7 t -69.9 -34.63 73.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -8.92 17.83 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.889 1.676 . . . . 0.0 114.545 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.84 50.58 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.975 1.274 . . . . 0.0 114.814 176.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.04 156.65 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.912 2.085 . . . . 0.0 110.823 -172.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 m -106.96 139.02 42.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.426 1.09 . . . . 0.0 109.606 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.0 pt -85.56 136.02 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.753 -0.592 . . . . 0.0 111.175 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -90.74 -31.66 16.46 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.818 1.247 . . . . 0.0 112.537 176.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.7 m -158.85 164.55 35.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.886 1.675 . . . . 0.0 111.928 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -80.45 160.64 25.24 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 111.811 171.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.2 159.88 23.71 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.205 1.383 . . . . 0.0 112.425 -173.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.4 p -63.58 143.0 58.19 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.59 -0.947 . . . . 0.0 111.598 171.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.19 149.09 61.51 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 122.05 -0.406 . . . . 0.0 111.89 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.1 155.88 60.65 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.049 2.499 . . . . 0.0 112.104 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.01 -1.61 39.34 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.868 1.267 . . . . 0.0 113.325 -173.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.14 92.2 1.72 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.409 1.481 . . . . 0.0 111.718 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.5 mt . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.383 1.873 . . . . 0.0 110.675 -175.065 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -135.13 159.05 42.76 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.94 1.696 . . . . 0.0 112.378 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.1 -6.08 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 125.81 1.644 . . . . 0.0 112.288 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.7 m -85.43 101.52 12.68 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.351 2.26 . . . . 0.0 110.768 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.16 101.65 0.56 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.323 1.049 . . . . 0.0 111.685 175.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.4 m -129.75 157.84 75.44 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.401 1.88 . . . . 0.0 111.774 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.4 161.44 45.56 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.575 2.85 . . . . 0.0 113.446 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -74.82 -8.3 56.02 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.837 1.655 . . . . 0.0 114.73 -178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -49.47 128.73 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.683 1.993 . . . . 0.0 113.378 -174.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.8 mt -84.85 77.19 10.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 110.178 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -142.4 73.42 20.87 Favored Pre-proline 0 N--CA 1.476 0.841 0 C-N-CA 124.151 0.98 . . . . 0.0 110.69 -176.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.23 164.19 23.6 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.12 1.88 . . . . 0.0 112.551 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -143.15 169.17 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 126.932 2.093 . . . . 0.0 110.383 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -113.7 110.07 19.6 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.415 0.686 . . . . 0.0 110.577 172.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.45 155.14 52.9 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.927 169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.9 t -57.4 -23.37 48.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.802 1.641 . . . . 0.0 114.44 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.32 -24.3 64.82 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.314 1.446 . . . . 0.0 113.086 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.15 -8.03 35.55 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 127.502 2.477 . . . . 0.0 114.01 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 56.9 ttm-85 -78.68 158.75 28.28 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.535 1.934 . . . . 0.0 111.458 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.4 t -116.84 149.57 39.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.662 1.585 . . . . 0.0 112.699 172.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -137.86 177.19 8.06 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.974 2.11 . . . . 0.0 110.814 -177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.58 82.81 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.047 1.128 . . . . 0.0 114.047 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -158.77 -177.35 6.45 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.939 1.696 . . . . 0.0 112.712 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.6 p -58.13 -36.51 73.06 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 46.7 t -63.29 -42.56 99.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.721 1.608 . . . . 0.0 112.248 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 tp -74.88 -44.87 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 O-C-N 121.675 -0.641 . . . . 0.0 110.106 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.04 -43.44 98.89 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.784 1.234 . . . . 0.0 113.215 -173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -61.37 -42.28 98.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.419 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 14.8 t -76.11 -21.29 56.82 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.845 1.258 . . . . 0.0 112.412 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -10.04 39.82 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.84 2.056 . . . . 0.0 113.901 165.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.12 15.03 37.2 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.178 175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.43 148.4 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 118.847 1.324 . . . . 0.0 111.865 -173.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.69 132.42 40.53 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.181 1.793 . . . . 0.0 111.1 175.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.4 mm -80.43 109.62 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.036 0.935 . . . . 0.0 109.999 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -91.72 -35.99 13.84 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.943 0.897 . . . . 0.0 113.062 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.9 t -159.94 168.25 26.13 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.571 1.149 . . . . 0.0 112.276 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.82 163.88 12.02 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.18 1.392 . . . . 0.0 113.645 177.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.56 160.48 23.08 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.481 1.515 . . . . 0.0 112.11 -168.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.0 m -62.61 135.38 57.36 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.997 -0.708 . . . . 0.0 110.685 174.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 146.92 98.7 Favored Pre-proline 0 CA--C 1.55 0.95 0 O-C-N 121.961 -0.462 . . . . 0.0 111.212 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.96 103.89 1.27 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.75 2.966 . . . . 0.0 112.217 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 33.3 p -75.12 63.91 1.34 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.259 1.823 . . . . 0.0 112.984 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.69 4.63 5.11 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.274 1.892 . . . . 0.0 115.176 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.1 mm . . . . . 0 C--O 1.253 1.268 0 C-N-CA 126.494 1.918 . . . . 0.0 111.752 179.483 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.681 0.277 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.46 170.19 21.98 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.27 1.828 . . . . 0.0 111.664 170.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.81 5.27 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 125.737 1.615 . . . . 0.0 112.624 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -133.11 132.45 41.72 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.185 1.794 . . . . 0.0 112.158 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.41 96.92 1.96 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.041 1.336 . . . . 0.0 110.901 170.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.2 m -122.08 155.99 60.45 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.834 1.654 . . . . 0.0 111.106 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.24 155.12 56.58 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.264 2.643 . . . . 0.0 112.272 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -77.72 -6.48 54.09 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.3 tp -45.74 125.46 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.968 2.107 . . . . 0.0 113.459 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 tt -76.9 83.87 3.46 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.288 1.835 . . . . 0.0 109.814 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -145.5 65.36 11.38 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.125 0.97 . . . . 0.0 111.834 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.43 161.45 34.76 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.232 2.621 . . . . 0.0 112.437 -175.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 157.42 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 126.716 2.006 . . . . 0.0 111.024 -175.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -91.18 117.19 29.42 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.146 0.979 . . . . 0.0 110.32 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.5 166.03 42.95 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.437 1.018 . . . . 0.0 114.348 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 78.5 p -56.41 -26.82 54.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.963 1.305 . . . . 0.0 114.412 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -97.4 -4.68 37.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.733 1.613 . . . . 0.0 113.771 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.48 1.19 62.4 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 125.741 1.638 . . . . 0.0 114.489 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -63.24 159.04 18.63 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.926 1.69 . . . . 0.0 111.179 173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -124.43 122.35 37.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.687 1.995 . . . . 0.0 110.252 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.97 175.02 5.58 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.134 1.774 . . . . 0.0 111.196 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.52 87.75 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -157.23 -175.53 5.46 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.9 m -77.84 8.75 4.18 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.3 t -104.8 -46.42 4.32 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.652 1.581 . . . . 0.0 110.714 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.4 tp -67.4 -41.06 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 123.826 0.851 . . . . 0.0 110.233 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.87 -49.76 72.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.876 1.27 . . . . 0.0 111.495 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.263 1.825 . . . . 0.0 112.561 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.9 t -72.85 -32.77 65.68 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.507 0.723 . . . . 0.0 112.319 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -10.57 35.04 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.472 1.509 . . . . 0.0 114.206 174.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.85 13.71 57.53 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.039 1.304 . . . . 0.0 114.951 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.27 132.52 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 126.808 2.043 . . . . 0.0 110.626 -172.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 p -75.48 164.57 26.22 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.727 0.811 . . . . 0.0 111.623 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.5 pp -102.79 135.48 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.402 1.081 . . . . 0.0 109.381 174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -89.17 -35.63 16.13 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.312 1.445 . . . . 0.0 112.488 174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.9 t -160.12 170.12 21.89 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 112.715 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -78.06 153.35 32.35 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.67 1.588 . . . . 0.0 112.904 173.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.18 156.89 13.34 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.996 1.284 . . . . 0.0 112.837 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -58.23 136.55 57.33 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.941 0.897 . . . . 0.0 111.108 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.48 147.67 82.34 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 121.837 -0.539 . . . . 0.0 111.29 176.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -70.46 146.08 54.89 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.766 2.311 . . . . 0.0 111.994 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.8 p -78.41 -5.81 53.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.261 1.424 . . . . 0.0 114.048 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.84 -18.74 0.49 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.885 1.707 . . . . 0.0 114.767 174.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.8 tt . . . . . 0 C--O 1.254 1.3 0 C-N-CA 126.924 2.09 . . . . 0.0 112.201 176.46 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 119.505 -0.283 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 47.24 44.59 15.94 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.54 1.936 . . . . 0.0 113.645 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -64.9 137.08 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.377 1.471 . . . . 0.0 110.62 -178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 32.2 m -79.67 149.36 31.28 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.016 0.926 . . . . 0.0 111.799 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.31 96.13 1.4 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.405 1.082 . . . . 0.0 111.82 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.8 m -128.04 159.53 66.32 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.674 1.99 . . . . 0.0 111.471 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -80.02 167.5 19.94 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.481 2.787 . . . . 0.0 113.488 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -79.63 -7.3 58.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.575 1.55 . . . . 0.0 114.958 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.4 128.42 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 111.261 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.2 mt -80.33 77.97 7.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.484 1.913 . . . . 0.0 110.268 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -133.7 69.19 76.17 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.704 1.202 . . . . 0.0 109.624 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.99 162.89 30.58 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 121.893 1.729 . . . . 0.0 112.644 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.44 145.13 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.59 1.956 . . . . 0.0 110.037 -174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -89.67 118.58 29.39 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.432 0.693 . . . . 0.0 110.803 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.89 161.91 52.56 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.139 0.876 . . . . 0.0 114.326 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.3 t -59.59 -29.67 68.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.811 1.244 . . . . 0.0 113.664 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -74.9 -20.08 59.87 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.489 1.116 . . . . 0.0 113.013 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.94 -8.75 31.66 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 126.741 2.115 . . . . 0.0 114.238 174.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -73.39 161.31 30.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.865 1.666 . . . . 0.0 111.505 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 t -110.52 151.75 27.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.168 1.387 . . . . 0.0 111.838 165.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -132.34 175.33 9.37 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.203 1.801 . . . . 0.0 111.167 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.38 69.51 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.535 1.134 . . . . 0.0 114.041 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -160.93 -175.39 4.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.276 1.83 . . . . 0.0 112.753 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.4 t -57.86 -40.97 81.44 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.1 t -55.89 -47.34 77.59 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.061 1.344 . . . . 0.0 111.869 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.35 -43.95 63.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.21 -49.24 76.61 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.474 1.11 . . . . 0.0 112.253 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -58.3 -42.96 87.8 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.884 1.674 . . . . 0.0 112.2 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.2 t -73.53 -27.54 61.41 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.071 0.549 . . . . 0.0 112.425 -177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.65 -11.52 60.23 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.971 1.708 . . . . 0.0 114.114 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.21 17.33 57.66 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.545 1.069 . . . . 0.0 115.238 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.44 149.01 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.962 1.705 . . . . 0.0 111.38 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -77.12 156.02 31.96 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.411 0.684 . . . . 0.0 110.598 170.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -106.33 126.76 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.257 1.023 . . . . 0.0 109.681 170.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -91.16 -30.06 16.91 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.278 1.831 . . . . 0.0 112.201 -171.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.1 t -162.01 173.37 14.51 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.515 1.926 . . . . 0.0 111.124 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -84.35 164.02 19.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.803 1.241 . . . . 0.0 113.233 172.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.95 166.69 25.77 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.509 1.528 . . . . 0.0 112.69 -172.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 16.9 m -67.39 137.61 56.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.645 -0.915 . . . . 0.0 110.83 172.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 147.84 91.5 Favored Pre-proline 0 CA--C 1.547 0.848 0 O-C-N 122.052 -0.405 . . . . 0.0 111.777 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -72.92 160.84 45.09 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.175 2.583 . . . . 0.0 112.438 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 t -73.65 -14.92 61.25 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.78 79.48 0.14 Allowed Glycine 0 CA--C 1.53 1.029 0 C-N-CA 125.793 1.664 . . . . 0.0 112.52 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.775 1.63 . . . . 0.0 111.683 175.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 120.238 0.066 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -110.33 168.45 9.44 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.146 1.779 . . . . 0.0 111.673 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -112.77 0.05 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 125.571 1.548 . . . . 0.0 112.259 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -147.15 145.72 29.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.724 1.61 . . . . 0.0 111.419 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.97 95.3 5.44 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.528 1.131 . . . . 0.0 111.175 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.59 157.35 73.38 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 125.862 1.665 . . . . 0.0 112.055 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.32 162.52 41.33 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.731 2.954 . . . . 0.0 113.732 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.6 tptt -77.46 -5.42 49.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.474 1.91 . . . . 0.0 114.971 -177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 tt -50.7 131.45 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 126.227 1.811 . . . . 0.0 112.893 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.59 71.36 7.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.126 1.77 . . . . 0.0 110.47 -174.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -132.04 68.69 80.43 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.005 1.322 . . . . 0.0 111.084 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -64.02 161.18 34.36 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.383 2.056 . . . . 0.0 112.756 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.2 m -146.12 152.91 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.11 2.164 . . . . 0.0 110.323 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.08 116.39 30.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.568 0.747 . . . . 0.0 111.152 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.56 164.6 50.82 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.711 1.148 . . . . 0.0 114.284 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 21.4 t -57.42 -30.8 65.27 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.831 1.252 . . . . 0.0 113.373 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.76 -12.29 59.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.116 1.366 . . . . 0.0 113.936 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.79 -2.23 61.98 Favored Glycine 0 N--CA 1.472 1.069 0 C-N-CA 126.028 1.775 . . . . 0.0 114.215 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -68.46 157.83 35.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.928 1.691 . . . . 0.0 110.957 172.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.8 m -112.32 141.42 46.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.104 1.761 . . . . 0.0 110.695 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.98 172.16 12.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.131 1.772 . . . . 0.0 110.961 174.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.35 -48.6 78.58 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -174.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.6 p-10 -160.14 -175.2 4.94 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.444 1.897 . . . . 0.0 112.42 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.5 p -59.65 -38.65 82.01 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 176.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.8 t -57.68 -47.51 82.11 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.171 1.388 . . . . 0.0 111.587 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.1 tp -72.37 -42.06 65.1 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 O-C-N 122.131 -0.356 . . . . 0.0 110.153 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.57 72.51 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.563 1.145 . . . . 0.0 112.106 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -59.26 -41.36 88.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.479 1.512 . . . . 0.0 111.956 175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 11.1 t -74.78 -24.76 58.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.746 0.818 . . . . 0.0 112.497 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.12 -10.58 58.33 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.054 1.742 . . . . 0.0 114.089 170.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.78 15.33 59.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.646 1.117 . . . . 0.0 115.088 176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.56 151.23 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.157 1.783 . . . . 0.0 111.182 -177.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.5 m -84.69 157.09 21.2 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.624 0.77 . . . . 0.0 110.038 168.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 pt -100.51 140.09 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 123.556 0.742 . . . . 0.0 110.31 169.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -92.39 -31.07 15.46 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.659 1.184 . . . . 0.0 111.48 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 99.2 p -160.32 169.02 24.01 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.537 1.535 . . . . 0.0 112.421 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.37 164.38 21.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.338 1.055 . . . . 0.0 112.762 169.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.23 164.2 29.79 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.504 1.526 . . . . 0.0 112.705 -173.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.4 t -65.5 146.73 54.49 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.57 -0.959 . . . . 0.0 111.024 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -88.42 146.54 37.91 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.85 0.86 . . . . 0.0 111.797 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.45 154.99 64.58 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.105 2.537 . . . . 0.0 111.856 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.5 m -121.29 -4.83 9.42 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.625 1.17 . . . . 0.0 112.997 -176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.87 61.23 0.02 OUTLIER Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.588 1.09 . . . . 0.0 113.613 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.349 0 C-N-CA 125.419 1.487 . . . . 0.0 111.443 176.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.93 126.07 21.31 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.806 1.642 . . . . 0.0 110.903 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 t -140.44 141.4 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.947 1.699 . . . . 0.0 109.92 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.5 m -78.3 148.12 33.97 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.714 0.806 . . . . 0.0 112.015 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.27 100.7 1.75 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.336 1.055 . . . . 0.0 111.235 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 89.2 m -129.34 158.33 73.46 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.23 1.812 . . . . 0.0 111.788 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.75 165.55 31.26 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.65 2.9 . . . . 0.0 113.695 -177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -77.51 -8.26 57.51 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 5.0 pt -57.33 113.23 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 126.358 1.863 . . . . 0.0 113.006 -173.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.67 84.61 0.89 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.586 1.554 . . . . 0.0 111.018 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -142.93 75.67 17.51 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 125.364 1.465 . . . . 0.0 109.422 -178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.34 165.19 20.59 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.858 2.372 . . . . 0.0 112.8 -174.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.56 159.79 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.482 1.913 . . . . 0.0 110.058 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.0 t -105.99 119.51 39.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.671 . . . . 0.0 111.944 176.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.01 164.95 53.96 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.732 1.158 . . . . 0.0 114.143 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 26.8 t -59.29 -26.8 65.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.39 1.476 . . . . 0.0 113.534 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -73.38 -17.05 61.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.158 1.383 . . . . 0.0 113.294 174.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.5 -2.0 67.13 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.238 1.875 . . . . 0.0 113.785 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.0 tpp85 -70.04 156.38 39.24 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.558 1.943 . . . . 0.0 111.22 175.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.1 m -114.84 138.04 51.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.581 1.952 . . . . 0.0 110.621 172.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.04 173.1 10.75 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.726 1.61 . . . . 0.0 111.236 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.34 -46.85 85.44 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.395 1.078 . . . . 0.0 113.343 -174.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 26' ' ' ILE . 43.8 p-10 -159.32 -176.36 5.76 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.019 1.328 . . . . 0.0 113.548 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -58.66 -38.6 78.51 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -60.31 -44.8 95.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.368 1.067 . . . . 0.0 112.63 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 23' ' ' ASN . 4.8 tt -73.53 -39.17 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 121.582 -0.699 . . . . 0.0 110.524 178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.19 -50.13 75.2 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.631 1.172 . . . . 0.0 112.458 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -63.9 -34.76 78.68 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.495 1.118 . . . . 0.0 113.414 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 6.3 t -85.05 -21.35 29.43 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.727 1.211 . . . . 0.0 111.982 -173.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -67.12 -7.26 21.92 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.799 1.639 . . . . 0.0 113.775 162.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 21.16 53.53 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.392 0.996 . . . . 0.0 114.874 176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.68 143.01 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.049 1.34 . . . . 0.0 111.28 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.34 135.49 34.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.762 0.825 . . . . 0.0 110.248 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 29.7 pt -81.26 138.01 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 118.74 0.7 . . . . 0.0 111.053 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -94.17 -31.47 14.13 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.293 1.437 . . . . 0.0 112.69 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 t -160.52 174.17 14.46 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.956 1.302 . . . . 0.0 112.078 174.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.09 161.64 16.42 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.921 1.688 . . . . 0.0 111.865 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.41 166.97 24.34 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.613 1.577 . . . . 0.0 113.241 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 m -65.63 137.38 57.3 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.187 0.595 . . . . 0.0 110.545 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 145.23 83.55 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.364 0.666 . . . . 0.0 111.817 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.27 119.85 6.57 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.239 3.292 . . . . 0.0 111.738 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 m -65.41 -17.82 64.83 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.641 1.577 . . . . 0.0 113.987 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.6 68.72 0.25 Allowed Glycine 0 N--CA 1.471 0.99 0 C-N-CA 125.519 1.533 . . . . 0.0 112.364 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.7 tt . . . . . 0 C--O 1.256 1.401 0 C-N-CA 126.022 1.729 . . . . 0.0 113.174 176.453 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.61 143.83 41.66 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.474 1.51 . . . . 0.0 111.785 173.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.85 169.71 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 126.061 1.744 . . . . 0.0 111.989 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.47 133.93 56.55 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.386 0.674 . . . . 0.0 111.975 172.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.34 97.69 0.99 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.628 1.171 . . . . 0.0 111.081 174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 91.9 m -125.05 157.83 65.48 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.992 1.717 . . . . 0.0 111.908 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.75 164.12 32.52 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.748 2.966 . . . . 0.0 113.875 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -76.97 -10.27 59.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.386 1.874 . . . . 0.0 115.37 -174.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 pt -51.55 107.09 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.297 2.239 . . . . 0.0 113.107 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 81.1 mt -69.27 90.61 0.5 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.279 1.832 . . . . 0.0 111.124 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -143.49 68.2 16.85 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 124.837 1.255 . . . . 0.0 111.049 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -63.62 159.07 42.64 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.285 1.99 . . . . 0.0 112.284 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.9 m -144.59 158.83 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.159 2.183 . . . . 0.0 110.463 -173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.0 t -100.17 115.25 29.4 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.602 0.761 . . . . 0.0 110.957 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.38 160.09 53.98 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.494 0.569 . . . . 0.0 113.737 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.3 m -59.9 -24.15 64.06 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -78.23 -14.38 59.47 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.938 1.295 . . . . 0.0 113.197 174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.24 -4.66 55.25 Favored Glycine 0 N--CA 1.474 1.198 0 C-N-CA 127.005 2.241 . . . . 0.0 114.154 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -75.26 157.45 34.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.462 1.905 . . . . 0.0 111.87 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.1 m -111.66 138.04 48.74 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.006 2.123 . . . . 0.0 110.566 173.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.33 174.57 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.886 1.674 . . . . 0.0 111.7 175.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.78 80.37 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.73 1.212 . . . . 0.0 113.662 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -160.82 -174.98 4.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.194 1.398 . . . . 0.0 112.935 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.1 p -59.57 -40.04 86.04 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 36.0 t -57.28 -46.24 83.3 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.029 1.331 . . . . 0.0 111.654 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 tp -73.64 -42.6 55.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.136 0 O-C-N 122.155 -0.34 . . . . 0.0 110.18 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.5 74.96 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.545 1.138 . . . . 0.0 112.384 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -58.55 -39.72 81.01 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.019 1.728 . . . . 0.0 112.433 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.4 t -74.8 -29.27 61.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.797 0.839 . . . . 0.0 112.688 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -9.38 36.19 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.698 1.599 . . . . 0.0 114.38 176.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.56 19.53 51.67 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.643 1.116 . . . . 0.0 114.805 175.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.41 147.82 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.188 1.795 . . . . 0.0 110.358 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 m -80.67 163.04 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.982 -0.449 . . . . 0.0 110.164 172.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.87 131.59 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.929 0.892 . . . . 0.0 109.371 171.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -89.56 -32.61 17.06 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.042 0.937 . . . . 0.0 112.093 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.1 t -159.62 171.24 19.96 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.159 1.384 . . . . 0.0 112.229 172.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.73 160.28 24.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.269 1.828 . . . . 0.0 112.936 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.46 159.16 15.97 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.143 1.354 . . . . 0.0 112.251 -173.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.9 p -62.65 143.74 57.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.521 -0.988 . . . . 0.0 111.808 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.33 146.17 57.31 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.001 -0.437 . . . . 0.0 111.606 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.64 146.46 49.05 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.787 2.325 . . . . 0.0 111.962 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.1 p -96.5 -0.58 48.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.707 1.603 . . . . 0.0 114.192 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.4 -54.69 0.03 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.175 0.893 . . . . 0.0 114.701 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 tt . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.982 1.713 . . . . 0.0 113.919 -179.621 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -140.59 152.44 45.47 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.443 1.497 . . . . 0.0 110.065 177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -131.28 143.42 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.831 1.652 . . . . 0.0 109.235 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.7 m -68.08 137.65 55.15 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.305 0.642 . . . . 0.0 111.637 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.5 96.08 0.88 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.404 1.082 . . . . 0.0 111.652 177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 96.4 m -124.8 159.98 56.0 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.797 2.039 . . . . 0.0 111.155 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -75.1 165.78 30.45 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.328 2.685 . . . . 0.0 114.197 -174.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -75.25 -8.77 57.52 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 126.561 1.944 . . . . 0.0 115.742 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.4 153.97 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 126.923 2.089 . . . . 0.0 112.675 -172.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.5 mt -114.37 81.89 1.62 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.143 1.377 . . . . 0.0 110.579 -170.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -139.63 73.42 35.06 Favored Pre-proline 0 N--CA 1.469 0.497 0 C-N-CA 125.36 1.464 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.1 162.99 24.16 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.988 1.792 . . . . 0.0 112.591 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.4 m -148.07 152.29 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 126.588 1.955 . . . . 0.0 109.962 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.6 t -103.03 122.18 44.1 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.804 0.842 . . . . 0.0 110.761 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.93 166.54 54.43 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.502 1.049 . . . . 0.0 113.536 177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 p -59.47 -22.67 61.88 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.42 -23.93 42.86 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.032 1.333 . . . . 0.0 113.395 172.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 108.49 -5.17 33.13 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.481 1.991 . . . . 0.0 114.325 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -74.66 157.24 35.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.507 1.523 . . . . 0.0 111.643 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.6 m -113.26 136.73 52.42 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.904 1.682 . . . . 0.0 112.115 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -126.68 171.78 10.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.78 1.632 . . . . 0.0 111.707 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.35 93.12 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -157.81 -175.45 5.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.636 1.574 . . . . 0.0 112.559 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.0 p -59.37 -43.22 92.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.005 0.922 . . . . 0.0 113.423 174.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.2 t -55.12 -46.73 75.6 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.619 1.567 . . . . 0.0 111.569 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 tp -72.97 -44.13 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.22 -48.5 80.15 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.217 1.007 . . . . 0.0 112.033 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -60.03 -40.67 90.14 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.824 1.65 . . . . 0.0 112.199 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.0 t -72.4 -28.38 62.95 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.088 0.555 . . . . 0.0 112.386 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.2 -9.51 41.02 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.128 1.771 . . . . 0.0 114.103 174.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.3 16.83 52.4 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.625 1.107 . . . . 0.0 114.752 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.52 156.47 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 126.464 1.906 . . . . 0.0 111.257 -174.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -92.62 155.99 17.39 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.941 0.896 . . . . 0.0 109.935 171.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.98 130.77 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 171.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -85.52 -35.38 21.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.749 1.22 . . . . 0.0 112.343 173.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -156.12 169.47 24.42 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 0.0 112.374 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -82.47 160.03 22.78 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.15 1.78 . . . . 0.0 112.64 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.75 170.31 28.7 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.039 1.304 . . . . 0.0 112.933 -175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.8 m -67.42 138.05 56.38 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.772 -0.84 . . . . 0.0 111.024 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -72.16 152.14 92.5 Favored Pre-proline 0 CA--C 1.549 0.907 0 O-C-N 121.889 -0.507 . . . . 0.0 112.038 177.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.2 170.69 19.24 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.619 2.879 . . . . 0.0 112.619 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.7 m -110.68 -1.08 16.9 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.847 1.259 . . . . 0.0 113.012 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -97.35 -76.9 1.32 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.978 1.275 . . . . 0.0 113.294 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.335 0 C-N-CA 125.969 1.708 . . . . 0.0 112.324 -178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.4 mttm . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.766 0.317 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -87.6 153.51 21.33 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 120.83 -1.169 . . . . 0.0 110.057 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.0 t -97.66 145.65 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.858 1.263 . . . . 0.0 109.174 170.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.5 t -66.35 142.13 57.73 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.628 0.771 . . . . 0.0 111.988 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.43 85.92 2.01 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.524 1.13 . . . . 0.0 112.123 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.5 m -128.2 159.67 65.94 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 127.138 2.175 . . . . 0.0 111.233 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -77.74 160.85 30.96 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.9 2.4 . . . . 0.0 113.614 -173.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -75.07 -9.54 58.63 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.525 1.93 . . . . 0.0 114.409 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.2 mt -60.11 131.84 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.347 1.859 . . . . 0.0 111.09 -171.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.77 63.89 5.34 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.498 2.319 . . . . 0.0 112.022 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -122.91 71.24 41.39 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.347 1.459 . . . . 0.0 110.222 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.03 164.66 24.15 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.723 2.282 . . . . 0.0 112.6 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 m -145.4 151.53 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.714 2.006 . . . . 0.0 110.39 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.6 t -92.42 117.14 29.62 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.443 0.697 . . . . 0.0 110.389 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.5 166.0 39.33 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 124.657 1.122 . . . . 0.0 114.566 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.8 t -57.96 -33.87 69.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.571 1.148 . . . . 0.0 112.878 172.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.09 -19.12 57.45 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.095 1.358 . . . . 0.0 113.441 175.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.3 -5.2 55.27 Favored Glycine 0 N--CA 1.471 0.973 0 C-N-CA 126.545 2.022 . . . . 0.0 114.171 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -68.23 160.09 29.92 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.011 1.724 . . . . 0.0 111.525 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.1 m -116.97 138.88 51.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.201 1.801 . . . . 0.0 111.415 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.25 176.3 8.39 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.4 1.88 . . . . 0.0 111.651 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.11 61.95 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.904 1.281 . . . . 0.0 114.359 -175.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -162.72 178.14 8.74 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.206 1.802 . . . . 0.0 112.689 173.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.9 p -68.5 27.4 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.491 2.316 . . . . 0.0 117.032 -177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.8 t -119.85 -45.04 2.5 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.649 2.379 . . . . 0.0 110.394 174.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.3 tp -69.06 -40.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 O-C-N 121.783 -0.573 . . . . 0.0 110.212 -176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.05 -53.21 59.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.93 1.292 . . . . 0.0 111.202 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -58.63 -36.62 74.37 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.958 1.303 . . . . 0.0 112.872 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.8 t -77.55 -29.54 52.27 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.754 0.822 . . . . 0.0 112.17 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.31 -21.52 62.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.96 1.704 . . . . 0.0 113.56 167.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.45 10.61 33.15 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.563 1.554 . . . . 0.0 115.351 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.46 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.286 1.835 . . . . 0.0 110.798 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.8 p -81.09 170.63 15.95 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.776 0.83 . . . . 0.0 111.027 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -112.99 149.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.798 1.239 . . . . 0.0 110.715 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -110.19 -26.89 9.4 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.698 1.599 . . . . 0.0 112.401 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 t -161.89 170.28 19.72 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.597 1.159 . . . . 0.0 112.938 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 mm-40 -75.41 155.62 36.17 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.412 1.885 . . . . 0.0 111.97 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.16 164.92 28.7 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.575 1.56 . . . . 0.0 113.529 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.7 m -63.2 136.23 57.6 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.717 -0.872 . . . . 0.0 110.971 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.88 148.52 82.04 Favored Pre-proline 0 CA--C 1.548 0.903 0 O-C-N 121.82 -0.55 . . . . 0.0 111.9 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.71 162.24 41.74 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.094 2.529 . . . . 0.0 112.248 176.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.9 m -68.86 -18.52 64.15 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.011 1.324 . . . . 0.0 113.652 -179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.38 103.36 0.19 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.373 1.94 . . . . 0.0 111.73 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.8 tp . . . . . 0 C--O 1.254 1.33 0 C-N-CA 125.847 1.659 . . . . 0.0 113.166 176.856 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.747 0.308 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.4 172.81 14.82 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.022 1.729 . . . . 0.0 111.99 176.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.93 0.92 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 125.8 1.64 . . . . 0.0 111.671 172.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.3 m -76.23 93.89 3.46 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.949 2.1 . . . . 0.0 112.199 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.17 91.61 3.74 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.711 1.204 . . . . 0.0 111.269 173.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 99.2 m -124.23 156.65 66.34 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 126.012 1.725 . . . . 0.0 111.668 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.6 163.39 36.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.544 2.829 . . . . 0.0 113.196 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -84.52 -4.24 58.84 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 tt -48.68 131.56 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 127.085 2.154 . . . . 0.0 113.332 -176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.9 mt -80.76 79.03 7.48 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.646 1.579 . . . . 0.0 110.576 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -143.32 71.48 17.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.835 0.854 . . . . 0.0 110.429 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.55 160.62 45.07 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.013 1.809 . . . . 0.0 112.089 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -148.52 155.19 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.228 2.211 . . . . 0.0 110.198 -172.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.9 t -98.25 112.91 24.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.167 0.587 . . . . 0.0 111.112 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.07 164.42 51.9 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 123.433 0.539 . . . . 0.0 113.005 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 t -64.26 -18.89 65.0 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.35 -22.85 60.2 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.593 1.157 . . . . 0.0 113.242 171.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.7 -3.33 42.2 Favored Glycine 0 N--CA 1.473 1.111 0 C-N-CA 127.043 2.259 . . . . 0.0 114.124 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -83.55 159.8 21.58 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.196 1.798 . . . . 0.0 111.244 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.8 t -113.89 147.95 37.58 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.451 1.501 . . . . 0.0 112.767 173.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -135.79 178.02 7.37 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.248 2.219 . . . . 0.0 110.688 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.35 -49.55 74.09 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.3 p-10 -157.2 -176.87 6.21 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.908 1.683 . . . . 0.0 113.366 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.9 p -73.73 14.0 0.43 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.013 2.125 . . . . 0.0 116.009 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 t -107.12 -48.08 3.55 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.53 1.932 . . . . 0.0 111.179 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 tp -65.57 -41.4 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 121.662 -0.649 . . . . 0.0 110.232 -176.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 34' ' ' ILE . . . -61.59 -42.5 98.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.204 1.002 . . . . 0.0 112.196 -176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -64.25 -37.89 89.09 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.308 1.443 . . . . 0.0 112.597 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -71.8 -29.15 64.14 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.481 0.712 . . . . 0.0 112.01 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.17 -10.44 57.72 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.428 1.891 . . . . 0.0 114.816 174.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.69 14.89 38.95 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.648 1.118 . . . . 0.0 115.326 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.26 159.22 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.9 1.68 . . . . 0.0 111.178 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 p -100.61 158.15 16.15 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.411 1.085 . . . . 0.0 111.814 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 27' ' ' ALA . 37.5 mm -93.34 109.72 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.958 1.303 . . . . 0.0 109.944 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -76.01 -46.0 31.7 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.041 1.336 . . . . 0.0 112.264 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 t -153.73 164.28 38.58 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.817 0.847 . . . . 0.0 112.907 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -84.63 155.19 22.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.421 1.488 . . . . 0.0 112.799 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.09 151.01 13.52 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.715 1.15 . . . . 0.0 111.596 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -61.63 135.44 57.63 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.697 -0.884 . . . . 0.0 111.609 173.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.41 150.56 97.8 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 122.927 0.491 . . . . 0.0 111.557 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.53 161.32 46.45 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.339 2.692 . . . . 0.0 112.633 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.6 m -131.81 32.19 4.13 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.388 1.475 . . . . 0.0 111.592 -172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.32 43.96 5.12 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.805 1.193 . . . . 0.0 113.804 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.5 tp . . . . . 0 C--O 1.254 1.295 0 C-N-CA 126.478 1.911 . . . . 0.0 113.295 176.041 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 52.8 pttt . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -126.12 97.89 5.27 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 125.431 1.493 . . . . 0.0 110.695 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 m -60.4 152.04 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.36 1.464 . . . . 0.0 111.813 172.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.5 m -104.08 145.12 30.64 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.066 0.946 . . . . 0.0 111.326 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.64 73.91 3.33 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.471 1.109 . . . . 0.0 112.042 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m -109.98 155.35 41.8 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.534 1.933 . . . . 0.0 111.904 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -81.26 162.92 19.95 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 123.539 2.826 . . . . 0.0 113.227 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -84.38 -7.94 59.15 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 pt -54.7 133.75 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.093 1.757 . . . . 0.0 112.946 -171.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.9 mt -76.08 76.79 2.93 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.511 1.524 . . . . 0.0 111.21 -176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -132.85 66.97 77.5 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 126.194 1.797 . . . . 0.0 111.337 -176.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -61.69 157.74 40.85 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.926 1.751 . . . . 0.0 111.945 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -143.77 154.96 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.012 2.125 . . . . 0.0 110.262 -175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -90.69 112.62 24.45 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.155 0.582 . . . . 0.0 109.8 173.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.87 159.17 46.55 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.681 0.657 . . . . 0.0 113.496 170.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 p -63.16 -22.41 66.84 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.34 1.456 . . . . 0.0 114.506 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -84.57 -10.27 57.55 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.527 1.131 . . . . 0.0 113.842 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.56 -2.66 60.77 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 126.579 2.038 . . . . 0.0 113.908 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -66.31 157.62 31.21 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.841 1.656 . . . . 0.0 111.444 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 90.1 m -121.97 135.77 54.88 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.396 1.878 . . . . 0.0 110.519 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.32 177.61 6.84 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.33 1.852 . . . . 0.0 111.662 -178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.37 77.93 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -148.83 -179.69 7.19 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.221 1.408 . . . . 0.0 111.846 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.6 p -66.41 -43.97 84.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.475 1.11 . . . . 0.0 113.002 170.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 39.4 t -61.55 -41.67 97.71 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.95 1.3 . . . . 0.0 112.217 -175.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.3 tp -67.39 -42.95 87.93 Favored 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.93 63.11 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.106 1.362 . . . . 0.0 111.431 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -56.73 -41.14 76.97 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.461 1.104 . . . . 0.0 112.54 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.5 t -74.84 -26.49 59.74 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -8.79 41.65 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.855 1.662 . . . . 0.0 114.175 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.27 15.69 46.72 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.914 1.245 . . . . 0.0 114.736 177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.86 142.74 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 126.122 1.769 . . . . 0.0 110.779 -174.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.2 m -84.12 152.68 24.17 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.984 -0.447 . . . . 0.0 109.94 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.47 149.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 167.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -119.18 -22.34 7.21 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.259 1.424 . . . . 0.0 112.853 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.7 p -160.95 167.75 25.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.243 1.417 . . . . 0.0 112.616 168.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.33 154.23 25.4 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.72 1.208 . . . . 0.0 112.264 173.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.11 165.97 36.99 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.362 1.458 . . . . 0.0 113.185 -176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.7 t -60.15 149.66 32.12 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.731 -0.864 . . . . 0.0 111.576 173.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.49 141.24 22.82 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 123.564 0.746 . . . . 0.0 112.186 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.09 133.03 25.74 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.074 2.516 . . . . 0.0 112.32 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.9 p -76.97 72.61 3.54 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.81 1.644 . . . . 0.0 111.955 177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -172.92 82.58 0.08 OUTLIER Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.095 1.331 . . . . 0.0 112.324 -177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.916 2.086 . . . . 0.0 112.316 -179.853 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -106.12 73.14 0.97 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 120.817 1.644 . . . . 0.0 111.52 176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.26 157.88 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.58 1.152 . . . . 0.0 111.271 171.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.7 m -91.31 146.64 23.65 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.624 0.77 . . . . 0.0 111.506 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.95 99.09 1.72 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.467 1.107 . . . . 0.0 111.615 177.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 65.8 m -131.25 158.52 75.0 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 126.069 1.748 . . . . 0.0 112.244 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -75.45 162.56 35.79 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.755 2.97 . . . . 0.0 113.229 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -78.57 -9.17 59.26 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 2.6 pt -50.52 113.9 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 126.942 2.097 . . . . 0.0 113.021 -175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.6 mp -70.8 91.61 0.84 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.796 1.238 . . . . 0.0 110.508 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 69.77 14.46 Favored Pre-proline 0 N--CA 1.471 0.621 0 C-N-CA 124.179 0.991 . . . . 0.0 110.5 177.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.58 161.34 28.48 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.361 2.041 . . . . 0.0 112.214 -178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.89 155.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 127.401 2.28 . . . . 0.0 109.719 -175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.5 t -99.57 114.74 27.95 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.907 0.883 . . . . 0.0 109.584 173.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.96 166.54 40.31 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.547 1.07 . . . . 0.0 114.127 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 t -55.27 -30.2 59.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.997 1.319 . . . . 0.0 113.708 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.35 -18.39 49.2 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.927 1.291 . . . . 0.0 113.777 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.74 -3.87 49.65 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 126.358 1.932 . . . . 0.0 114.328 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -70.61 157.92 37.08 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.294 1.838 . . . . 0.0 111.953 174.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 97.3 m -111.63 141.54 45.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.254 1.822 . . . . 0.0 111.536 173.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -129.13 173.59 10.33 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.527 1.931 . . . . 0.0 111.053 172.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.33 -47.92 82.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.301 1.041 . . . . 0.0 113.741 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.4 p-10 -162.07 -176.38 5.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.343 1.457 . . . . 0.0 113.125 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 t -60.84 -35.61 77.0 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 40.9 t -62.52 -39.17 92.69 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.049 1.34 . . . . 0.0 112.444 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.7 tp -79.7 -42.32 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 O-C-N 121.773 -0.579 . . . . 0.0 110.49 176.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.08 -50.1 70.0 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.287 1.035 . . . . 0.0 112.37 -178.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -57.58 -41.66 81.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.546 1.138 . . . . 0.0 112.846 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.9 t -77.46 -24.08 50.33 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.816 1.246 . . . . 0.0 112.629 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.92 -11.47 60.66 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.29 1.836 . . . . 0.0 113.797 170.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.81 17.92 39.53 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 125.014 1.292 . . . . 0.0 115.22 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.11 146.09 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 126.221 1.808 . . . . 0.0 111.134 -172.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -82.13 147.59 28.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.27 1.028 . . . . 0.0 110.918 173.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 pp -79.83 131.8 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 168.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.2 mmtt -89.79 -40.4 12.49 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.273 1.429 . . . . 0.0 111.98 172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.6 m -145.37 160.33 41.7 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.167 1.387 . . . . 0.0 112.349 178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -76.37 154.14 35.17 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.932 1.293 . . . . 0.0 112.167 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.19 162.39 28.63 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.152 1.358 . . . . 0.0 112.942 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.5 t -64.14 147.19 52.83 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.654 -0.909 . . . . 0.0 111.329 173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.66 143.1 33.29 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.798 0.839 . . . . 0.0 112.08 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -73.6 157.76 48.24 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.813 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.3 t -78.23 -13.95 59.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.505 1.122 . . . . 0.0 113.923 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.97 -13.34 3.86 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 126.534 2.016 . . . . 0.0 114.943 178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 C--O 1.254 1.323 0 C-N-CA 127.149 2.18 . . . . 0.0 110.229 177.335 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -122.25 103.23 8.62 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 125.651 1.581 . . . . 0.0 110.389 -177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.12 136.89 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.335 1.454 . . . . 0.0 109.622 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.3 m -78.11 133.51 37.84 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.232 1.013 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -67.58 95.68 0.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.425 1.09 . . . . 0.0 111.758 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 92.8 m -125.8 158.61 64.79 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 126.866 2.066 . . . . 0.0 111.061 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.9 163.3 35.75 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.479 2.786 . . . . 0.0 113.571 -177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -79.93 -8.34 59.27 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.116 1.766 . . . . 0.0 114.93 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.92 135.43 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.636 1.975 . . . . 0.0 113.077 -171.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.1 mt -82.69 81.11 8.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.367 1.867 . . . . 0.0 111.79 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.29 70.0 77.54 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 125.094 1.358 . . . . 0.0 110.638 172.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.19 161.69 29.42 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.547 2.164 . . . . 0.0 112.817 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.6 m -147.16 153.62 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 126.915 2.086 . . . . 0.0 110.64 -172.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.5 t -99.29 111.61 23.95 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.831 0.852 . . . . 0.0 111.871 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.88 162.56 48.32 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.615 1.102 . . . . 0.0 113.967 172.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.8 m -59.54 -25.45 64.53 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -78.74 -15.86 57.93 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.373 1.069 . . . . 0.0 113.267 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.84 -1.45 59.68 Favored Glycine 0 N--CA 1.471 1.023 0 C-N-CA 126.61 2.052 . . . . 0.0 113.974 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -72.58 158.2 36.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.897 1.679 . . . . 0.0 111.116 173.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.0 m -116.85 140.6 49.25 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.695 1.998 . . . . 0.0 110.595 175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.16 175.83 8.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.981 1.712 . . . . 0.0 111.418 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.67 72.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.508 1.123 . . . . 0.0 113.818 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.92 -174.52 4.44 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.377 1.871 . . . . 0.0 112.491 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.0 p -58.62 -39.87 81.71 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.1 t -57.67 -47.31 82.67 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.451 1.5 . . . . 0.0 111.654 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.5 tp -72.46 -42.56 64.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.129 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.06 74.0 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.543 1.137 . . . . 0.0 112.147 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -56.12 -43.37 78.11 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.64 1.976 . . . . 0.0 112.162 173.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 t -76.18 -24.98 54.78 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.18 -9.73 49.02 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.94 1.696 . . . . 0.0 114.073 174.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.6 15.55 54.65 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.893 1.235 . . . . 0.0 114.906 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.6 162.19 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 126.497 1.919 . . . . 0.0 111.468 -176.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.01 132.3 56.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.249 1.42 . . . . 0.0 109.376 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 pt -78.99 140.97 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 121.998 -0.439 . . . . 0.0 111.245 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -93.12 -35.25 13.29 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.444 1.098 . . . . 0.0 112.285 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.6 m -149.38 161.16 42.63 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.629 1.172 . . . . 0.0 112.303 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.57 160.31 25.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 169.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.3 166.0 40.21 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.48 1.514 . . . . 0.0 113.132 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.9 t -63.11 150.42 42.79 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.926 -0.749 . . . . 0.0 111.282 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.49 137.02 19.27 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.328 1.051 . . . . 0.0 112.39 -177.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.54 155.37 54.95 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 112.765 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 21.9 p -80.67 -5.44 56.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.275 1.43 . . . . 0.0 114.351 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.3 -36.16 0.18 Allowed Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.832 1.206 . . . . 0.0 114.77 173.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mt . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.553 1.941 . . . . 0.0 110.217 178.787 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 110.778 -0.082 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.74 169.53 12.75 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.671 1.189 . . . . 0.0 111.842 173.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.29 153.31 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 126.429 1.891 . . . . 0.0 110.085 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.07 151.06 38.93 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.258 1.423 . . . . 0.0 112.51 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.71 91.88 3.5 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.746 1.218 . . . . 0.0 111.046 173.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 90.4 m -125.77 158.39 65.45 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.512 1.925 . . . . 0.0 110.974 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.72 158.16 57.97 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.16 2.573 . . . . 0.0 113.016 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.83 -5.44 43.54 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.419 1.888 . . . . 0.0 114.73 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 tt -51.24 131.89 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.886 2.074 . . . . 0.0 113.539 -174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 tt -82.12 78.63 8.78 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.116 1.766 . . . . 0.0 109.531 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -143.25 68.39 17.43 Favored Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 111.567 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.22 168.69 12.07 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.741 2.961 . . . . 0.0 113.615 -172.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.06 158.58 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.485 1.914 . . . . 0.0 111.023 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.8 t -98.71 113.17 25.13 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.889 0.875 . . . . 0.0 109.758 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 153.7 51.45 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.434 -0.348 . . . . 0.0 113.414 173.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 t -59.72 -26.41 65.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.112 0.965 . . . . 0.0 113.204 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.06 -19.3 61.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.225 1.41 . . . . 0.0 113.337 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.41 -8.15 40.62 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.859 2.171 . . . . 0.0 114.507 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -75.77 160.15 30.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.486 1.915 . . . . 0.0 111.701 177.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.7 m -111.58 143.31 42.65 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.668 1.987 . . . . 0.0 110.77 166.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -130.34 175.21 9.13 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.559 1.943 . . . . 0.0 110.979 176.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -47.76 79.98 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.201 1.001 . . . . 0.0 113.591 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -156.55 -173.31 4.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.469 1.508 . . . . 0.0 112.433 173.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 p -60.81 -37.14 80.96 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 174.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.9 t -60.53 -46.91 88.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.429 1.492 . . . . 0.0 112.474 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 tp -69.76 -39.71 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 122.359 1.076 . . . . 0.0 110.339 -177.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.77 77.84 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.932 1.693 . . . . 0.0 112.472 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -58.09 -34.56 70.32 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.574 1.55 . . . . 0.0 112.682 169.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.3 t -79.54 -30.73 41.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.432 0.693 . . . . 0.0 111.653 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -66.49 -5.32 10.74 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.128 1.771 . . . . 0.0 113.942 162.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.75 9.66 68.2 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.586 1.565 . . . . 0.0 115.19 175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.8 t -83.0 152.47 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.909 1.283 . . . . 0.0 111.896 -171.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.4 m -85.23 -19.27 31.9 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -168.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 31.2 mm 53.49 88.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 130.74 3.616 . . . . 0.0 112.73 -172.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -75.07 -32.96 61.62 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.022 -1.444 . . . . 0.0 112.778 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 t -160.54 168.79 24.29 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.472 1.109 . . . . 0.0 112.714 172.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -93.18 163.43 13.63 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.813 1.645 . . . . 0.0 112.319 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.05 165.42 26.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.607 1.575 . . . . 0.0 112.63 -171.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.7 t -64.82 147.22 53.64 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.436 -1.038 . . . . 0.0 111.273 173.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.73 143.67 36.03 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.579 0.752 . . . . 0.0 111.902 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.57 86.16 1.61 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.547 2.831 . . . . 0.0 112.971 -176.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 44.7 p -83.74 -10.19 58.3 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.819 1.648 . . . . 0.0 113.979 175.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -83.56 81.36 1.75 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 126.1 1.81 . . . . 0.0 112.559 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.6 tt . . . . . 0 C--O 1.253 1.277 0 C-N-CA 126.957 2.103 . . . . 0.0 112.59 -179.179 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.2 tptm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -140.12 163.97 31.29 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.386 1.875 . . . . 0.0 109.934 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 p -130.07 149.82 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.472 1.509 . . . . 0.0 111.293 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.9 m -66.41 124.7 23.47 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.142 0.977 . . . . 0.0 110.919 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.18 101.08 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.469 1.107 . . . . 0.0 111.508 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.3 m -126.69 157.44 71.2 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.31 1.844 . . . . 0.0 111.625 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.83 161.45 46.04 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.554 2.836 . . . . 0.0 113.366 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.8 -7.0 52.08 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.6 tt -51.61 127.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.321 1.848 . . . . 0.0 113.458 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.9 tp -80.75 97.34 7.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.713 2.005 . . . . 0.0 109.528 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -156.69 72.85 4.8 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 123.486 0.714 . . . . 0.0 111.945 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.99 166.98 16.94 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.238 1.959 . . . . 0.0 113.012 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.5 m -146.38 147.77 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 127.091 2.156 . . . . 0.0 110.113 -175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 53.4 t -89.05 115.93 26.96 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.54 165.66 46.99 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.069 0.842 . . . . 0.0 114.083 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 t -62.06 -27.45 68.91 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.062 0.945 . . . . 0.0 113.154 176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.95 -24.2 58.43 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.918 1.287 . . . . 0.0 113.226 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 106.92 -8.41 39.18 Favored Glycine 0 N--CA 1.472 1.097 0 C-N-CA 126.785 2.136 . . . . 0.0 114.333 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.0 tpp180 -66.95 160.76 25.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.764 1.626 . . . . 0.0 111.088 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.5 t -109.5 156.5 20.03 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.706 1.202 . . . . 0.0 112.022 165.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.28 169.54 17.6 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.702 2.001 . . . . 0.0 110.272 174.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.28 81.41 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -159.13 -176.85 6.08 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.428 1.491 . . . . 0.0 112.461 174.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 p -58.87 -34.86 72.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.92 -43.22 96.6 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.943 1.297 . . . . 0.0 112.65 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -75.83 -38.96 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.704 -0.622 . . . . 0.0 110.255 177.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.81 -51.36 69.89 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.951 1.301 . . . . 0.0 112.519 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -61.11 -32.5 72.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 7.3 t -88.19 -19.56 26.73 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.244 1.417 . . . . 0.0 112.384 -173.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -70.07 -6.27 32.63 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.926 2.09 . . . . 0.0 114.448 170.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.56 13.16 60.12 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.641 1.115 . . . . 0.0 114.736 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.27 168.14 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.054 2.542 . . . . 0.0 110.622 -177.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 t -119.38 167.43 11.92 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.871 1.268 . . . . 0.0 110.642 172.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.91 138.15 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.027 1.331 . . . . 0.0 110.462 -175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -100.94 -31.57 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.846 1.659 . . . . 0.0 113.097 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.4 t -155.89 164.01 39.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.622 1.169 . . . . 0.0 112.022 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -85.29 152.11 23.54 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.66 1.584 . . . . 0.0 112.693 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.46 167.39 28.66 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 124.938 1.256 . . . . 0.0 112.48 -171.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 45.8 t -63.67 148.72 48.29 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.718 -0.872 . . . . 0.0 111.387 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.28 145.42 60.0 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.136 0.574 . . . . 0.0 111.402 174.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.45 149.85 84.45 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.68 2.254 . . . . 0.0 111.573 176.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.9 m 55.38 30.13 14.35 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.215 1.406 . . . . 0.0 113.14 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.43 -65.73 2.77 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.523 1.535 . . . . 0.0 114.72 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.486 1.332 0 C-N-CA 129.765 3.226 . . . . 0.0 113.229 -174.511 . . . . . . . . 0 0 . 1 stop_ save_